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ABSTRACT OF DISSERTATION 
 
 
 
 
 INSIGHTS INTO KEY GENE REGULATORY NETWORKS IN BORRELIA 
BURGDORFERI 
 
Gene regulatory networks are composed of interconnected regulatory nodes 
created by regulatory factors of multiple types. All organisms finely tune gene 
expression in order to adapt to and survive within their current niche. Obligate 
parasitic bacteria are under extreme pressure to quickly and appropriately adapt 
their gene regulatory programs in order to survive within their given host. Borrelia 
burgdorferi is one such organism and persists in nature by alternating between two 
hosts; Ixodes spp. ticks and small vertebrate animals. These two hosts represent 
drastically different environments; requiring a unique gene regulatory program to 
survive and transmit between them. Microbiologists have long sought to better 
understand exactly what stimuli pathogens sense and how that information is 
relayed in to physiologic adaptation.  
 
In this work I aimed to examine two parts of this interesting field. First, I sought to 
better understand the stimuli B. burgdorferi sense in order to adapt to their hosts 
by testing several hypotheses centered on the general notion that B. burgdorferi 
senses both internal and external metabolic cues as primary signals for adaptation. 
I demonstrated that a second messenger system immediately downstream of a 
critical metabolic pathway is important during vertebrate infection and that a key 
regulator of virulence is itself regulated by a factor involved in DNA replication. 
 
Second, I sought to better define the topology of gene regulatory networks, known 
and unknown, that are important for the ability of the bacteria to adapt. The work 
in this section focus on the idea that B. burgdorferi gene regulatory networks are 
extremely complex and are not currently well defined in the literature. My studies 
revealed that B. burgdorferi possesses a large number of previously undefined 
regulatory targets, including extended 5’ and 3’ UTRs of known genes, and 
encodes several hundred-putative small non-coding RNAs. Furthermore, I 
demonstrate that two essential regulatory factors share substantial, independent, 
overlap in their regulons highlighting the still undefined complexity of regulatory 
networks at play in B. burgdorferi. 
 
KEYWORDS: pathogen, gene regulatory networks, gene regulation, growth rate, 
bacteria 
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Chapter 1 Introduction 
Borrelia burgdorferi 
Borrelia burgdorferi is the bacterial agent that causes Lyme borreliosis [40]. This 
bacterium traverses an enzootic cycle alternating between an Ixodes spp. tick vector and 
a vertebrate host, often a small mammal or bird [247] (Fig. 1-1). These two host organisms 
represent drastically different environmental niches for these bacteria, requiring significant 
alterations in behavior and physiology. All organisms maintain homeostasis by adapting 
their physiology through multiple mechanisms, including the regulation of gene and protein 
expression and functional modulation of enzymes. Bacteria, archaea, and single-celled 
eukaryotes are under significant evolutionary pressure to rapidly adapt to dynamic 
environments. Temperature, water content, nutrient availability, pH, and numerous other 
variables are often in constant flux, and single-celled organisms are more vulnerable to 
these fluctuations than multicellular organisms. In the studies described herein, I sought 
to better define the regulatory mechanisms, input, and topology of gene regulatory 
networks important for adaptation during the enzootic cycle of B. burgdorferi.  
Clinical Manifestations 
Originally identified as an unusual outbreak of rheumatoid arthritis in children near 
Lyme, Connecticut, in 1976 [295], Lyme Borreliosis has become the leading tick-borne 
disease worldwide and represents a significant global disease burden [296]. These initial 
cases clustered near forested areas and were associated with tick bites, suggesting a 
potential tick-borne disease. In 1982, at the Rocky Mountain Laboratory, a spirochetal 
bacterium within Ixodes scapularis ticks was identified and eventually shown to be the 
etiologic agent of disease [40]. 
Following tick bite, acute infection is marked by the development of the distinctive 
erythema migrans (Latin, “chronic migrating redness”) or “bullseye” rash centered on the 
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site of the bite [291, 296]. This is often accompanied by general flu-like symptoms, which 
can last several days or weeks [291, 296]. The bullseye rash is common in the United 
states, but in Europe it is often less distinct and defined [296]. Lyme borreliosis manifests 
with diffuse symptomology, which can complicate accurate diagnosis [296]. 
Following acute infection, dissemination spreads primarily through skin, with a 
small subset of spirochetes transmitting via the blood stream, but not at high levels and or 
for extended periods of time [293]. The chronic phase of infection is characterized by 
arthritis, carditis, and neural complications [296]. The manifestation of these and other 
symptoms vary across the globe, with European disease manifesting with more frequent 
neural complications and the northeast American disease with more frequent arthritis 
[296]. The differences in these symptoms have variously been postulated to be dependent 
on genetic differences in the spirochetes or the patient population, but the exact cause 
remains unclear.  
The diffuse and variable symptoms often make diagnosis difficult and are 
complicated by significant misinformation regarding diagnostic approaches [5]. Standard 
treatment is a 2-week course of doxycycline for adults, or amoxicillin for children or 
pregnant women [292]. A small fraction of patients (<10-20%) continue to report symptoms 
following treatment, including extended, >4-week treatment regimens [293]. Randomized 
trials aimed at testing the effect of extended antibiotic regimens have not found a 
significant difference in reported symptomology between treated and untreated groups 
[25]. The reason for this continued symptomology is not entirely clear, but persistent 
infection [94, 276], autoimmune dysfunction [31, 294], and psychological causes [287], 
amongst others, have been proposed. Histological and molecular examinations of synovial 
tissue before, during, and following antibiotic treatment demonstrate that chronic 
inflammation continues even in the absence of detectable spirochetes [280]. These 
 3 
findings suggest that the persistent symptoms may be related to immune mediated 
damage at sites of previous infection.  
Epidemiology 
The range of both vectors and hosts of B. burgdorferi sensu lato is vast and 
encompasses significant swaths of North America, temperate Europe, and Asia. These 
include foci in the northeast and north-central United states, central Europe, Russia, 
China, and Japan [206]. Since the onset of surveillance in the U.S. in 1992, cases of Lyme 
have been on the rise, with an estimated 15,000 new cases each year in 2001 and 
300,000/year by 2015 [291, 296]. This rise incidence is attributed to both higher rates of 
reporting and surveillance, as well as geographic expansion of the tick vector. The primary 
agent of Lyme borreliosis in the U.S. is B. burgdorferi, sometimes referred to B. burgdorferi 
sensu stricto. Recent work has indicated other related pathogenic Borrelia species, 
namely Borrelia mayonii [151, 245] and Borrelia miyamotoi [21, 218] are also present in 
certain areas of the U.S. and transmitted by the same species of ticks, though seemingly 
causing disease at much lower rates. In the U.S., the distribution of Lyme disease caused 
by B. burgdorferi is regional, but the incidence of disease appears to be rapidly expanding 
[205]. The locations with the highest incidence of disease are the northeast, mid-Atlantic 
coast, and north-central regions. A smaller range extends along the western U.S. coast 
from California to Washington. Interestingly, while both Canada and Mexico are colonized 
by competent vectors, the incidence of disease is much lower [206]. Less than a thousand 
cases were reported nationally in Canada from 2009 to 2013, and no evidence for human 
Lyme disease has been found in Mexico.  
 The incidence of Lyme borreliosis is wide-spread throughout western, central, and 
eastern Europe. In Europe, there are at least five recognized genospecies of B. burgdorferi 
sensu lato: B. burgdorferi, B. afezlii, B. garinii, B. valaisiana, and B. lusitaniae, which vary 
in relative abundance regionally, although only the first three have been demonstrated to 
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cause disease in humans [206]. This variation is proposed to be a result of regional 
differences in primary reservoir hosts. Incidence of disease is highest in central and 
northeastern European nations, with Austria, Estonia, Lithuania, and Slovenia leading, 
with annual reported cases sometimes ranging upwards of 100 cases per 100,000 
individuals. Incidence generally decreases in all directions as one travels away from this 
central node [206]. 
 The distribution of ticks capable of transmitting B. burgdorferi genospecies extends 
over large portions of Eurasia, including Russia, China, and Japan, and infected ticks are 
found across this range. Human incidence is variable, and in endemic areas is reported 
between 5-10 cases per 100,000 individuals annually. Infected ticks and animals have 
been found in at least 20 provinces of China, but information on human disease appears 
sparse. Incidence in Japan is very low (0.1 cases per 100,000 population) but is 
consistently reported, particularly on Hokkaido Island [205]. It is not entirely clear whether 
the lower rates of reported infection are due to differences in the enzootic cycle, genetics 
of the bacteria, or simply underreporting. 
Populations particularly at risk across the globe are those that spend significant 
time outdoors in forested areas (i.e. the preferred environment for Ixodes spp. ticks) [205]. 
It is thought that the reforestation of the northeastern U.S., beginning in the mid-20th 
Century, following centuries of intensive development, partially explains the emergence of 
Lyme disease through the reestablishment of the vector and reservoir hosts’ natural 
environments [20]. In the U.S., the highest rates of infection are in children aged between 
5-15 years and adults older than 50 years of age. The incidence in males of all groups is 
higher, but this sex disparity is shrinking, and, in Europe, the distribution favors higher 
rates of infection in females [206]. These differences are thought to be explained by 
behavioral, rather than physiological, differences. 
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Ecology 
Borrelia burgdorferi sensu lato is transmitted by a several species of hard-bodied 
Ixodes spp. ticks [20, 40, 206, 247]. Ixodes spp. ticks are from the family Ixodidae, which 
progress through three life stages before reaching maturity and mating [247]. At each 
stage of life, the ticks take a single blood meal, at which time bacteria can be acquired or, 
if already acquired, transmitted. The ixodid ticks that vector B. burgdorferi are slow feeders 
that remain attached to their hosts for several days. Well known vectors for B. burgdorferi 
sensu lato include Ixodes scapularis in the northeast and northcentral U.S., Ixodes ricinus 
in Europe, Ixodes pacificus in the western U.S., and Ixodes persulcatus in Eurasia [206]. 
The ranges of several of these species are overlapping and confound the identification of 
defined enzootic cycles in some locations [206].  
The most well described enzootic cycle in the northeastern U.S. is thought to be 
maintained by cycling between Ixodes scapularis ticks and the field mouse Peromyscus 
leucopus [177] (Fig. 1-1). The larval and nymphal stages of tick feed on the same host 
and thereby propagate the cycle. Adult ticks feed on larger mammals, including white 
tailed deer and occasionally humans. Transovarial (mother to egg) transmission of B. 
burgdorferi does not occur, but ticks maintain infection during intervening molts [258].  
Larval ticks emerge in the late summer and feed on their first host. They molt over 
the winter before emerging as nymphal ticks in the early spring of the following year. While 
nymphal ticks preferentially feed on small vertebrates, they occasionally do feed on larger 
mammals, such as humans. These nymphal ticks are thought to be the most common 
vector for human disease [247], due to their small size, approximately the size of a poppy 
seed, and the resultant difficulty of detection. Following a blood-meal, nymphs molt over 
the summer into adults, which are then active in the late summer and fall. Adults primarily 
prey on larger mammals and nymphs on smaller vertebrates, but as indicated above, 
nymphal ticks do also occasionally feed on humans. There is correlation between the burst 
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in nymphal activity in the early spring and outbreaks of Lyme disease in the summer due 
to this occasional feeding and the difficulty in the detection of nymphal ticks. Adult ticks 
are detectable by eye and frequently removed quickly, prior to bacterial transmission [241]. 
Nymphal ticks, on the other hand, often go unnoticed.  
Critical aspects of each life stage 
Colonization of each niche and transmission between them require extensive 
physiologic reprogramming, including drastic alterations to the cell surface and cellular 
metabolism. A significant difficulty has been, and remains, that many proteins encoded in 
the B. burgdorferi genome lack recognizable homologues outside the genus [58, 100] and, 
as a result, functional annotation is sparse. What has been reasonably inferred and 
demonstrated is that the physiology of the bacteria is significantly different when they 
occupy the tick vector or the vertebrate host [146, 242, 247]. The extracellular milieu which 
the bacteria occupy is vastly different between the vertebrate and tick. This difference 
impacts what surfaces the bacteria must adhere to, release from, and traverse through. In 
addition, the nutrient sources they rely on are quite different between niches [76, 237, 
318]. Two critical environmental components for the enzootic cycle that have been 
investigated in some detail are host factor binding interactions and carbohydrate 
metabolism.  
Many of the proteins that have been demonstrated to play a role in the survival 
and adaptation of the bacteria are lipoproteins involved in host or vector interaction. OspC, 
OspA, OspB, DbpA, DbpB, VlsE, and the Erp family of lipoproteins [349] are merely a 
small number of lipoproteins that have experimental support for a role in host interaction 
of the >120 lipoproteins thought to be encoded in the B. burgdorferi genome [83, 101]. 
Extensive research has been aimed at understanding how these factors are regulated, 
what stage of the cycle they are important for, and with what host/vector factors they 
interact. It is outside the scope of this work to detail what each lipoprotein interacts with. 
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It is sufficient to note that different factors are required to be expressed and repressed at 
different stages of the life cycle, and these lipoproteins and their functions are well 
reviewed elsewhere [247, 301]. 
 Enzymes and transporters involved in carbohydrate metabolism have also been 
shown to play a key role in adapting B. burgdorferi to each particular niche. B. burgdorferi 
encodes a large number of validated and putative carbohydrate transporters [101],  but 
appears to only survive on a relatively restricted number of sources [326]. Glucose is 
generally abundant in vertebrate hosts, is thought to be the carbohydrate of choice during 
infection, and defects in its uptake result in significant attenuation of ability to infect [76, 
318]. In the tick vector, following the digestion of the blood meal, glycerol and chitobiose 
are thought to be the predominate carbon and energy sources [38, 76, 146, 237, 312, 
313]. High-throughput transposon insertion sequencing has highlighted this difference in 
carbohydrate utilization both in vitro and in vivo [318]. As expected, the enzymes and 
proteins involved in carbohydrate utilization appear to be very tightly regulated and in 
tandem play a role in regulating other factors [169].  
Gene regulatory networks 
Homeostatic control of physiology is one of the defining characteristics of life. In 
all studied living organisms, a key mechanism of this homeostatic control is the regulated 
expression of genes and proteins. The mechanisms we today know as gene regulation 
were likely first identified during Barbara McClintock’s seminal studies on transposable 
elements found in maize [204]. These studies were followed by the elucidation of the lac 
operon by Francois Jacob and Jacques Monod in Escherichia coli [148]. These findings 
sparked a revolution in the understanding of biology. From these works, and innumerable 
others, came the notion of the regulated operon: sets of genes of connected function that 
are produced and regulated in unison by one or more factors.  
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As data accumulated it became clear that some regulators impacted the 
expression of more than one operon. Maas and Clark coined the term regulon to describe 
this phenomenon [199]. Instead of a one regulator one operon system, it became clear 
that some regulators have more widespread effects and impact the expression of multiple 
operons. Some of these regulators span multiple biological processes and are now known 
as “global regulatory factors,” controlling expression from vast swaths of the genome. 
Specific cases of the induction of a “virulence program” are present in numerous 
pathogens [6, 41, 48, 60, 84, 86, 153, 184, 189, 192, 215, 217, 221, 256, 262, 334] along 
with more general responses such as the heat shock [225] stringent responses [61, 244]. 
These global and more narrowly acting regulatory factors are increasingly known to 
interact with one another. Some regulators converge on operons while individually 
regulating others [18, 79, 80, 198, 200, 201]. Thus, the concept of the gene regulatory 
network (GRN) was born. 
Gene regulatory networks can be thought of as interconnected networks of 
regulatory proteins, both receiving and relaying signaling information. These networks 
allow for crosstalk and convergent regulation of genes and proteins at multiple levels, 
resulting in a rich physiologic response to dynamic environmental stimuli. The network 
architecture allows for a more robust and sensitive response, as well as creating 
redundancy in the system. From the perspective of Homo sapiens seeking to interrupt the 
ability of microorganisms to cause disease, these networks represent a key target. Some 
portions of the network have redundant mechanisms of activation and thus are resilient in 
the face of upstream interference (i.e immune responses or antimicrobial therapy), 
whereas other portions act as central nodes of information processing and take in many 
inputs and relay many outputs. It is these central nodes that possess the greatest potential 
for disruption. Defining the topology and logic of the networks allows scientists and 
physicians to not simply target the upstream signaling input or downstream enzymatic 
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activity of a process, but to target and interrupt these crucial information processing 
centers. Furthermore, understanding the topology of the network allows the informed 
development of multipronged approaches that target multiple, non-overlapping nodes. 
This is of key importance in combatting both microbial resistance as well as the in situ 
evolution of cancer during treatment [207]. By targeting multiple processes, we may 
ensure that microorganisms or cancerous cells do not develop a mechanism to circumvent 
a single node (i.e. the development of resistance). 
Mechanisms of regulation 
The expression of genes and proteins is regulated at numerous points along the 
central dogma of molecular biology [77]. The most well studied control point in many 
organisms is at the level of transcription initiation. Briefly, the RNA polymerase (RNAP) 
holoenzyme assembles at defined points along the genome called promoters. The RNAP 
core enzyme is composed of β, β’, α, and ω subunits [90]. To bind to promoter DNA and 
become the RNAP holoenzyme, an additional subunit, called the σ subunit is required 
[145]. The σ subunit serves to define which promoter sequences a given RNAP 
holoenzyme will interact with and potentially transcribe. Upon binding to DNA, the RNAP 
holoenzyme can form an open complex, separating the strands of DNA, and begin 
transcribing RNA from the DNA template. A major point of control is the ability of RNAP to 
interact with a given promoter and form a productive transcriptional complex. This control 
can be accomplished, among other mechanisms, by altering which σ factor is present in 
the holoenzyme or by the binding of a protein near the promoter.  
B. burgdorferi encodes three sigma factors: the housekeeping RpoD, and 
homologues to two alternative sigma factors called RpoS and RpoN [100]. The titles 
“RpoN” and “RpoS” in B. burgdorferi are entirely based upon homology to E. coli proteins 
and do not reflect their biological function [48]. The nomenclature can occasionally cause 
confusion as these sigma factors are not involved in nitrogen starvation or the stationary 
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phase, respectively, as are their E. coli homologues are. Both RpoN and RpoS are 
absolutely essential for vertebrate infection, and their absence results in the dysregulation 
of a large number of genes [48, 99]. The two alternative sigma factors have been proposed 
form a linear regulatory cascade that acts as the key gatekeeping mechanism regulating 
the induction of vertebrate-associated genes and the suppression of tick-specific genes 
[139]. The upstream signal for the activation of this proposed cascade is not well 
understood but is thought to involve the histidine kinase HK2 and the response regulator 
Rrp2 [28, 43, 230, 346]. Rrp2 is homologous to enhancer binding proteins (EBPs) [118] 
which are typically necessary for the RpoN-bound RNAP to recognize its unique -12/-24 
promoter architecture. The stimuli which HK2 responds to has not been elucidated. 
A small, but increasing, number of DNA-binding regulatory proteins in B. 
burgdorferi have been predicted or experimentally characterized [16, 34, 42, 100, 155, 
173, 183, 210]. Some of these have been shown to be essential for the enzootic cycle, 
while others appear to be absolutely essential for viability. B. burgdorferi encodes at least 
four nucleoid associated factors proposed or demonstrated to play a role in the structure 
of the borrelial nucleoid: EbfC, Hbb, Dps, and Gac [153, 172, 173, 183]. BadR and BosR 
interact with the rpoS promoter at multiple sites, some of which are overlapping [140, 211, 
231, 233, 234]. BadR is the only DNA binding protein studied in B. burgdorferi to date that 
is directly responsive to metabolites, namely phosphorylated sugars [210]. Additional 
DNA-binding proteins have been predicted based upon sequence homology [101] but 
have not yet been experimentally characterized, and additional yet unknown factors likely 
exist. There are other mechanisms which control the ability of an open complex to form, 
including local DNA structure and chemical microenvironment [172, 254].  
The next major point of control is after transcription has begun and functions 
through transcriptional termination. There exist multiple mechanisms to control gene 
expression at this junction, but I will focus on those that have relevance to my studies: 5’ 
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untranslated regions (UTRs) and intrinsic terminators. Most transcripts contain regions of 
DNA, both 5’ and 3’ of the coding sequence, which are transcribed but do not code for 
amino acids. In these UTRs, there can exist structural sequence motifs that cause RNAP 
to stall and potentially disassociate from the DNA template. A well-studied class of these 
structures are called intrinsic, or Rho-independent, terminators [121] which act to 
terminate transcription independently of additional protein cofactors. A G+C rich hair pin 
followed by a poly-uridine tract, as identified in E. coli and Bacillus subtillis, is an example 
of such [121]. The poly-uridine tract causes the RNAP to pause, and the hairpin both traps 
and causes extreme destabilization of the elongation complex [121, 347]. The exact 
sequence and free energy of the hairpin differs significantly across and between different 
organisms and has confounded the bioinformatic identification of such terminators. 
The next point of regulatory control is post-transcriptional and often involves RNA 
structure, small RNAs, and RNA-binding proteins. As indicated above, most mRNAs are 
transcribed with a 5’ UTR of variable length that can act as potential regulatory target. 
Some 5’ UTRs can contain significant secondary structures that are responsive to a 
number of stimuli, including temperature and small molecules. This structural motif may 
overlap the ribosome binding site (RBS) and inhibit translation of the downstream protein. 
The binding of small RNAs, proteins, or both can induce or relax this inhibition depending 
on the particular system at hand [19, 95, 203, 228, 274]. Furthermore, proteins may bind 
directly over the RBS and impede productive translation [19, 158]. Five RNA binding 
proteins have been identified and experimentally characterized in B. burgdorferi: HrpA, 
CsrA, BpuR, SpoVG, and Hfq [155, 158, 163, 165, 195, 262, 266, 269, 307, 308]. All five 
have been shown to regulate the expression of varying numbers of proteins at the post-
transcriptional level, though the exact mechanisms remain to be completely elucidated. 
HrpA is a helicase and significantly impacts the expression of several hundred proteins, 
though it remains unclear if these results are a pleotropic effect of perturbing RNA 
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biogenesis or the specific effect of a regulatory protein [262, 263]. CsrA [163, 165, 235, 
266, 307, 308], BpuR [155, 158], and Hfq [195] have more well-defined mechanisms, with 
experimental evidence supporting direct interaction with mRNA and regulation of 
translation. BpuR is a major focus of this work and will be described in additional detail in 
Chapter Four.  
Numerous mechanisms exist in other model systems which control protein function 
after translation: phosphorylation [255, 346], methylation [124, 178], acetylation [52, 135], 
targeted proteolysis [152], and sequestration [85], among others. B. burgdorferi encodes 
proteins either proposed or demonstrated to have a role in the post translational control of 
key proteins. These include two homologues to the Lon protease [67, 68] and a protein, 
BBD18, which regulates RpoS [86].  
An additional mechanism of post-translational control is the production and 
sensing of signaling molecules called second messengers. The unifying theme of these 
factors is that they act by binding other proteins and impacting their function. These protein 
targets range in function from metabolic enzymes, polymerases, two component systems, 
and DNA/RNA binding proteins, and thus span all levels of gene regulatory control. 
Signaling molecules produced by B. burgdorferi include AI-2[13, 253, 297, 300, 325], 
cyclic-di-GMP [256], cyclic-di-AMP [268], cyclic-AMP [169], and (p)ppGpp [38, 61, 72, 84, 
216, 244]. 
AI-2 is a molecule, sometimes interconverted to furosyl borate diester, produced 
by some bacteria as a quorum sensing molecule that can be sensed by different 
mechanisms in different bacteria. AI-2 and its involvement in B. burgdorferi gene 
regulation will be discussed in additional detail in Chapter 3. Cyclic di-GMP (c-di-GMP) 
and cyclic di-AMP (c-di-AMP) are generated by the cyclization of two tri-phosphate 
nucleotides, guanosine triphosphate or adenosine triphosphate, respectively. Single 
enzymes to produce both second messengers are encoded by B. burgdorferi. c-di-GMP 
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is produced by the diguanylate cyclase, Rrp1 and degraded by one of two 
phosphodiesterases, PdeA or PdeB. Rrp1 is proposed to be part of a two-component 
system that is essential for the tick stage of the enzootic cycle [126] and mutations in Rrp1 
appear to have drastic transcriptomic effects [256]. c-di-GMP is proposed to exert much 
of its function through the only known c-di-GMP binding protein in B. burgdorferi, PlzA 
[104, 127]. The role of c-di-AMP in B. burgdorferi remains enigmatic. Enzymes to both 
generate and degrade the molecule, CdaA and DhhP respectively, are encoded in the 
genome [268, 348]. Intriguingly, while over expression of CdaA appears to have little to 
no effect on cultured B. burgdorferi [268], the phenotype of a conditional dhhP deletion 
mutant is significant and complete deletion mutants are not viable [348]. A role in the 
enzootic cycle for this second messenger remains to fully defined elucidated. Guanasine 
pentaphosphate (p)ppGpp represents the final known major second messenger produced 
by B. burgdorferi discussed in this work.  In some systems, (p)ppGpp is produced during 
nutrient limitation in response to the accumulation of uncharged tRNAs [61]. In E. coli, this 
accumulation leads to the synthesis of (p)ppGpp by the enzyme RelA [244]. The hydrolytic 
enzyme, SpoT cleaves (p)ppGpp [244]. In other bacteria, including B. burgdorferi, 
synthesis and hydrolysis is accomplished by a compound enzyme that possesses both 
synthetase and hydrolase activities. One mechanism by which (p)ppGpp exerts its 
function is through binding of RNAP and destabilizing open complex formation, particularly 
at ribosomal RNA promoters [125] but the exact mechanism of varies across species. In 
B. burgdorferi, the enzyme Rel is important for survival during in vitro nutrient limitation, 
tick colonization, and mutations in the gene result in drastic differences in the 
transcriptome [38, 84]. An enzyme to generate cyclic-AMP also appears to be encoded 
by B. burgdorferi but its role is not well studied [169]. 
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Summary 
In this work described in the following chapters I studied two important aspects of 
B. burgdorferi biology; how these bacteria sense, and how they adapt to their dynamic 
and challenging enzootic lifecycle. B. burgdorferi has evolved to survive and transmit 
within a unique two-host life cycle with each niche representing a distinct environment with 
its own distinct set of challenges. I first sought to characterize how B. burgdorferi has 
evolved to sense key aspects of this life cycle and then I provide insight in to how the 
organism modulates gene regulatory networks to successfully adapt to these hosts. 
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Figure 1-1: Enzootic Cycle of B. burgdorferi 
The natural enzootic cycling of B. burgdorferi is depicted with its accompanying vector and 
reservoir hosts found in the northeast United States. Larval ticks are born free of the 
bacteria and both larval and nymphal ticks can only acquire it during a blood meal. The 
bacteria persist within the tick midgut during the molt and can then be transmitted to a 
naïve host during the nymphal blood meal. Adult ticks must feed on larger mammals and 
may also transmit the bacteria at this time. This figure was provided by Dr. Brian 
Stevenson. 
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Chapter 2 Materials and Methods 
Strains and bacterial cultivation. 
B. burgdorferi B31e2 is an easily transformable, noninfectious, laboratory-adapted 
clone of the B31 type strain. B. burgdorferi B31-A3 is a clonal fully infectious derivative of 
the species type strain [93]. It contains all of the naturally-occurring DNA elements of the 
sequenced culture of strain B31 except cp9. Absence of cp9 does not have any detectable 
effects on B. burgdorferi physiology either during infection or in culture [57, 101, 175, 246]. 
Immediately prior to all transcriptomic studies, the DNA content of B31-A3 cultures was 
assessed by multiplex PCR [39] to confirm the presence of all naturally-occurring 
plasmids.  
Mutant strains of B31-A3 used for transcriptomic analyses, namely ∆rpoS, ∆rpoN, 
∆badR, and ∆csrA were previously constructed by Dr. Patricia Rosa, Dr. Frank Gherardini, 
and Dr. Janakiram Seshu using allelic exchange [86, 99, 163, 210]. For studies 
investigating the role of luxS during vertebrate infection, an isolate of B. burgdorferi 
297::luxS (AH309) and its congenic parent was kindly provided by Dr. Michael Norgard. 
B. burgdorferi 297 is infectious isolate derived from human cerebrospinal fluid. This 
particular strain was constructed using allelic exchange targeting the luxS loci for insertion 
with an erythromycin resistance cassette. These mutants were then selected for by 
antibiotic treatment and passaged through a mouse. A significant caveat of this strain is 
that they have been strongly selected for suppressor mutations which mask the defect of 
luxS during animal infection.  
B. burgdorferi were cultured in Barbour-Stoenner-Kelly II (BSK-II) liquid medium, 
prepared in-house [350]. Culture conditions (condition variations temperature, serum 
percentage, and total dilution) depended upon the particular experiment but, in general, 
are identical to those conditions described by Jutras et al 2013 [157].  
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For all studies, bacteria were inoculated 1:100 from glycerol stocks into 5mL of 
fresh media and incubated at 35C until cell density reached mid-late exponential phase 
(~1-5x107 cells/mL). For RNA-Sequencing these cells were diluted into 30mL of fresh 
BSK-II to a final density of 1x105 and incubated at 35C. For the sequencing described in 
Chapter 5, aliquots of each culture were removed when bacterial densities reached the 
equivalents of early-exponential (~1x106), mid-exponential (~1x107), and stationary 
phases of growth (1 day after plateauing at 1x108). For the experiments described in 
Chapter 6, the total culture was harvested at ~1x107.  
Nucleic acid isolation (gDNA, plasmid, and RNA) 
Genomic DNA of B. burgdorferi for use in routine PCR was isolated using a 
DNeasy Blood and tissue kit (Qiagen, Germantown, MD) according to the manufacturer’s 
instructions. For use in validation of primer specificity and as a reference for quantification 
studies of the luxS mutants, total bacterial DNAs were purified from mid-exponential-
phase cultures (~107 bacteria/mL) of strains 297 and AH309 by use of DNeasy blood and 
tissue kits (Qiagen, Germantown, MD). For analyses of bacterial loads in mouse tissues, 
total DNAs were isolated from the indicated tissues using the Mo Bio Ultraclean tissue and 
cell DNA isolation kit (Mo Bio Laboratories, Carlsbad, CA) per the manufacturer’s 
instructions. For rapid screening of E. coli colonies, standard colony PCR methods were 
used as described in Woodman et al. 2016 [339]. RNA for qRT-PCR and RNA-Sequencing 
was extracted using the Direct-zol purification kit (Zymo, Irvine, CA) with an on-column 
DNase I digestion or Turbo DNase (ThermoFisher, Waltham, MA) step according to 
manufacturer’s instructions. RNA integrity and quantity was assayed using the RNA Nano 
6000 Kit on an Agilent Bioanalyzer (Agilent, Santa Clara, CA) if the sample was to be used 
in RNA-Seq studies. If RNA was to be used for qRT-PCR, quantities were assessed by 
UV-Vis measuring absorbance A260 on a Nanodrop 2000 (ThermoFisher, Waltham, MA). 
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Polymerase Chain Reaction (PCR, qPCR, and qRT-PCR) 
For routine detection and amplification of DNA sequences, rTaq (Bulldog Bio, 
Portsmouth, NH) was used according to the manufacturer’s instructions. For routine PCR 
screening, primers were used at a final concentration of 300nM and depending on 
template, between .5ng and 50ng of isolated nucleic acid material or a small picking of a 
E. coli colony was used. Optimal annealing temperatures were determined for each for 
each primer pair and extension times were determined based upon the size each fragment 
to be amplified (in general, 30 seconds per kilobase). For all cloning steps and EMSA 
probe generation, the following proof reading polymerases were used according to their 
manufacturers protocols: Long Expand High Fidelity (Roche, Basel, Switzerland), Q5 
Polymerase (NEB, Ipswitch, MA), or DeepVent Polymerase (NEB, Ipswitch, MA). 
Selection of enzyme alternated between particular applications (long template versus 
short template) and based on optimizing for the enzyme providing the highest yield. 
Concentrations of primers, template, annealing temperatures, and extension times were 
all determined for each particular primer pair, the nature of the template, and the length of 
the product, according to the respective manufacturers instructions. 
Bacterial burdens in mouse tissues were assessed using Idaho 
Technologies/BioFire buffers (BioFire Diagnostics, Salt Lake City, UT) and Platinum Taq 
polymerase (Life Technologies, Grand Island, NY) with a CFX96 Touch real-time PCR 
detection platform (Bio-Rad, Hercules, CA). Cycling was performed as follows: 94°C for 3 
min and 40 cycles of 94°C for 10 s followed by 30 s at 60°C. Standard curves for each 
oligonucleotide pair were generated by diluting a known quantity of genomic DNA in a 
series of 10-fold serial dilutions. Threshold cycle (CT) values obtained for experimental 
samples were then plotted against this curve to determine quantities of each target. 
Melting curve analyses were performed to validate the presence of single products. 
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Results were analyzed using CFX Manager software (Bio-Rad, Hercules, CA). Data 
comparisons were analyzed by unpaired two-tailed t tests. 
Isolated gDNA depleted RNA was converted to cDNA using the iScript cDNA 
synthesis kit (Bio-Rad, Hercules, CA). qRT-PCR was performed essentially as previously 
described [212], using a Bio-Rad CFX96. Comparisons were made using the CT 
method [271] normalizing against ftsK or the geometric mean of ftsK and flaB as reference 
genes [14]. Samples lacking reverse transcriptase enzyme mixture were prepared and 
assayed in tandem to ensure efficient depletion of gDNA. 
Animal Infections  
BALB/cJ mice were used for both the luxS individual and competitive infection 
studies. Mid-exponential cultures (~107 cells/mL) were adjusted to a density of 105 
cells/mL using phosphate buffered saline (PBS). For individual infection studies, 8 
BALB/cJ mice per group were subcutaneously inoculated with 104 of either 297 or 
297::luxS bacteria. For competitive infection studies, 8 BALB/cJ mice were inoculated 
subcutaneously with 104 of each 297 and 297::luxS (AH309) at a 1:1 ratio. B. burgdorferi 
for use in routine PCR was isolated using a DNeasy Blood and Tissue Kit (Qiagen, 
Germantown, MD), according to the manufacturer’s instructions. For use in validation of 
primer specificity and as a reference for quantification studies of the luxS studies, total 
bacterial DNAs were purified from mid-exponential-phase cultures (approximately 
107 bacteria/mL) of strains 297 and AH309 by use of DNeasy Blood and Tissue Kits 
(Qiagen, Germantown, MD). For analyses of bacterial loads in mouse tissues, total DNAs 
were isolated from the indicated tissues using the Mo Bio Ultraclean Tissue and Cells DNA 
Isolation Kit (Mo Bio Laboratories, Carlsbad, CA) per the manufacturer’s instructions. 2016 
[339]. RNA for qRT-PCR and RNA-Sequencing was extracted using the Direct-zol 
Purification Kit (Zymo, Irvine, CA) with an on-column DNase I digestion or Turbo DNase 
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(ThermoFisher, Waltham, MA). RNA integrity and quantity was assayed using the RNA 
Nano 6000 Kit on an Agilent Bioanalyzer (Agilent, Santa Clara, CA) if the sample was to 
be used in RNA-Seq studies.  
Cloning and plasmid analysis 
pGJ1 was previously constructed by Grant Jones [158]. pWA11 was constructed 
using the Gibson Assembly method implemented in the Gibson Assembly Kit (NEB, 
Ipswich, MA). Briefly, the plasmid pJSB268 was linearized by PCR removing the luc gene 
and adding 15nt overhangs complimentary to the bpuR locus. The bpuR locus was PCR 
amplified and 15nt overhangs complimentary to either side of the insertion site in 
pJSB268. Gibson assembly was performed per the manufacturer’s instructions and cloned 
into TOP10 E. coli (Invitrogen, Carlsbad, CA). All clones were screened by colony PCR 
[339] and clones containing an insert of the correct size were selected, subcultured, 
miniprepped, and sequenced to ensure no mutations were introduced. B. burgdorferi dnaA 
was cloned in to the pET200 vector per the manufacturer’s instructions. All clones 
generated in these studies that appeared to have a correctly sized insertion by colony 
PCR were subcultured, plasmid DNA isolated, and sequenced to ensure no mutations had 
been introduced.  
RNA-Seq Library preparation 
Cells harboring pWA10 were inoculated 1:100 from -80°C stocks and grown at 
34°C until reaching mid-exponential phase (~1x107 cells/mL). An aliquot of these cells was 
passaged to 2 sets of triplicate cultures of fresh BSK-II to a final density of 1x105 cells/mL 
in 20mL of BSK-II and placed at 34˚C. Upon reaching ~1X106 cells/mL IPTG was added 
to a concentration of 0.5mM to three of the cultures and cultures were returned to 34°C. 
These cultures were harvested upon reaching 1x107 cells/mL (~24 hours) by 
centrifugation at 8200XG for 30 minutes at 4°C. One of the un-induced cultures could not 
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be harvested due to contamination. Pellets were suspended in pre-warmed (60˚C) Trizol 
(ThermoFisher, Waltham, MA) and stored at -80°C. 
  Cell-TRIzol suspensions were thawed at room temperature. RNA was isolated 
from 500mL of cell suspension using the Zymo RNA Direct-Zol Miniprep Kit (Zymo, Irvine, 
CA) and eluted in in 35µl RNase-free water. Isolated RNA was stored at -80°C. RNA 
integrity was assayed by microfluidic analysis using an Agilent 2100 Bioanalyzer and with 
the Agilent RNA 6000 Nano chip kit (Agilent, Santa Clara, CA) and all samples assayed 
were of high quality, with a RIN score > 9. RNA quantity was also assayed using a 
Nanodrop 2000 (ThermoFisher, Waltham, MA) 
 Illumina cDNA libraries were generated using the RNAtag-seq protocol essentially 
as described, with minor modifications [14, 281], by Jonathan Livny and Jessica Alexander 
at the Broad Institute. Briefly, 840ng of total RNA was fragmented, depleted of genomic 
DNA, dephosphorylated, then ligated to DNA adapter barcodes. Barcoded RNAs were 
pooled and depleted of rRNA using the RiboZero rRNA Depletion Kit (Illumina, San Diego, 
CA). Pooled barcoded RNAs were converted to Illumina cDNA libraries in 3 main steps: 
(i) reverse transcription of template by priming a constant region of the barcoded adaptor; 
(ii) degradation of the RNA followed by template switching addition of a second poly G 
priming site; (iii) PCR amplification using primers that target the constant regions of the 3’ 
and 5’ ligated adaptors and contain the full sequence of the Illumina sequencing adaptors. 
cDNA libraries were sequenced an Illumina Nextseq 500 (Illumina, San Diego, CA) in the 
paired end configuration for 75 cycles. 
RNA-Seq Data Analysis 
For the analyses of RNAtag-Seq data, reads from each sample in the pool were 
identified and deconvoluted based on their associated barcode using custom scripts [191]. 
Up to 1 mismatch in the barcode was allowed, with the caveat that it did not enable 
assignment to more than one barcode. Quality of reads was assessed prior to quality 
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trimming using FastQC (v0.11.5) [10]. Paired FastQ files were trimmed of low quality 
sequences and reads before being filtered to remove reads which contained less than 25 
bases using Trimmomatic (v0.36) [30]. A custom transcriptome file described previously 
was indexed using the Salmon –index function set for quasi mapping with default settings 
and auto library detection (v0.8.2) [238]. Mapping and counting was conducted using 
Salmon (v.0.8.2) in quasi mode with seqBias and GCbias flags activated. All code, QC 
metrics, read mapping statistics, and intermediary data files for data generated in Chapter 
6 are available on Figshare (https://doi.org/10.6084/m9.figshare.5502175). Raw reads 
have been deposited to the NCBI SRA database under Bioprojects (PRJNA408156 and 
PRJNA339291).  
Flow Cytometry 
B. burgdorferi B31e2 harboring pGJ1 were inoculated from glycerol stocks and first 
passaged as described above. Mid-exponential-phase cultures of each transformed B. 
burgdorferi strain were passaged in to BSK-II supplemented with 6% rabbit serum 
(complete media), BSK-II supplemented with 1.2% rabbit serum, or complete media 
diluted to 25% strength supplemented with 6% rabbit serum with PBS. Upon reaching mid-
exponential phase cultures were pelleted, washed and resuspended in PBS and were 
assayed for GFP expression using a FACSCalibur flow cytometer (BD Biosciences, San 
Jose, CA), with excitation at 488 nm and detection at 530 nm. KS20 cultures harboring 
the promoter-less GFP plasmid (pBLS590) were used as negative controls to subtract for 
autofluorescence. Each experiment involved measuring a minimum of 75,000 events.  
Western Blotting 
BpuR, SodA, and FlaB western blots of BpuR overexpressing strains were 
performed essentially as described previously [158]. Cells were grown and induced 
identically to those used for RNA-Seq and qRT-PCR with the modification of an increase 
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to 50mL of total culture volume. Cells were pelleted at 4˚C at 27,000XG for 15 minutes 
following a 24hr induction with .5mM IPTG and resuspended in 10mL ice cold, filter-
sterilized PBS. Cells were pelleted at the same centrifugation conditions as noted above 
with the modification of being spun for 10 minutes. Cells were washed twice more in equal 
volumes of PBS before being resuspended in 250ul ddH2O. An equal amount of 2X SDS 
Loading dye was added and samples were boiled for 10 minutes. Aliquots of 20ul were 
loaded on 12.5% resolving SDS-PAGE gels and electrophoresed at 100V through the 
stacking layer before being electrophoresed at 200V for 60-80 minutes. Proteins were 
electroblotted on to nitrocellulose membranes. Membranes were stained with Ponceau S 
to confirm approximately equal loading. Ponceau S was removed by repeated, short 
washes in room temperature ddH2O before being blocked in 5% milk in TBS-T overnight 
at 4˚C or for 1 hour at room temperature. Primary rabbit anti-BpuR (1:100) and Mouse 
anti-SodA (1:2000) antibodies were incubated overnight at 4˚C. The production of 
Polyclonal BpuR and monoclonal FlaB antibodies has been described previously [158], 
and SodA antibodies were generously provided by Dr. Janakiram Seshu [96]. Anti-FlaB 
monoclonal antibody was incubated with agitation for 1 hour at RT. Membranes were 
washed 3 times with agitation in 10-15mL of TBS-T for 10 minutes each at RT. Horse 
radish peroxidase (HRP) conjugated secondary antibodies (protein A-HRP and goat anti-
rabbit IgM-HRP) (GE Life Sciences, Marlborough, MA), were diluted 1:10,000 in TBS-T 
and incubated with agitation on membranes for 1 hour at RT. Membranes were developed 
using the Super Signal West Pico substrate (ThermoFisher, Waltham, MA) and imaged 
by autoradiography.  
2D-PAGE 
2D gel electrophoresis was performed essentially as described previously [324] 
using the BioRad 2D-PAGE Starter Kit (BioRad, Hercules, CA). Briefly total cell pellets of 
B. burgdorferi that constitutively express high levels of BpuR or those transformed with an 
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empty vector control and express wild-type levels of BpuR were resuspended in 
equilibration buffer and loaded on to precast IPG strips (BioRad, Hercules, CA) (pH 4-7). 
Strips were subject to isoelectric focusing at 3000 Volt-hours (V-hrs). Following focusing 
strips were equilibrated and loaded into the tops of conventional 12.5% SDS-PAGE gels 
and electrophoresed for 100 min. Gels were stained with Sypro Ruby (ThermoFisher, 
Waltham, MA) and imaged using a conventional UV box imaging system.  
Electrophoretic Mobility Shift Assay 
Nucleic acids utilized as probes in this study are described in Table 2-1. Double-
stranded DNA probes were generated either by PCR or by annealing complimentary 
oligonucleotides as essentially as previously described [16, 158]. RNA probes were 
synthesized by a third party (IDT, Coralville, IA). Longer probes were prepared by PCR 
using Q5 polymerase with a biotinylated 5’ primer and an unlabeled 3’ primer (IDT, 
Coralville, IA) using genomic DNA isolated from B31 MI-16. These amplified probes were 
gel purified by gel extraction using the PCR Clean-Up Kit (Promega, Madison, WI) and re-
amplified. Competitors were generated by proofreading PCR or by annealing of 
oligonucleotides (IDT, Coralville, IA). Oligonucleotide competitors used in EMSA were 
annealed by mixing equimolar quantities, heating to 98C, and then allowing to cool to room 
temperature. 
EMSAs were performed as described previously [16, 42, 158]. Binding reactions 
took place in EMSA binding buffer (50mM Tris, 1mM EDTA, 1mM DTT, 10% Glycerol v/v, 
2.4% Protease inhibitor cocktail v/v, and .6% phosphatase inhibitor cocktail v/v) with 1nM 
biotin labeled nucleic acid, various amounts of recombinant protein, and 100nM of various 
competitors where appropriate. After incubation at room temperature for 20 minutes, 2.5µl 
of loading dye (15% w/v Ficol, .04% w/v Orange G) was mixed with the reaction, and 5.5µl 
of this was electrophoresed on 6% TBE acrylamide gels (ThermoFisher, Waltham, MA) 
for 60 minutes at 100V. Labeled DNA was then electroblotted to nylon Biodyne B 
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membranes (ThermoFisher, Waltham, MA) for 45 minutes at 100V on ice. Nucleic acids 
were crosslinked to the membrane using a Stratagene UV Crosslinker (Stratagene, San 
Diego, CA) on the automatic setting. Labeled nucleic acid was visualized using the 
Chemiluminescent Nucleic Acid Detection Module Kit (ThermoFisher, Waltham, MA). 
DNA-Affinity Chromatography 
DNA affinity chromatography was performed essentially as described previously 
[161]. Primers BiobpuRP-1 and bpuRP-2 (Table 2-1) were used to PCR amplify the bpuR 
promoter coding sequence from B31-A3 genomic DNA. This DNA fragment was purified 
by gel extraction and re-amplified to obtain sufficient amounts. Cleaned, isolated probe 
was mixed with 200µl of streptavidin coated magnetic beads. Magnetic beads were mixed 
with crude cytoplasmic extracts of mid-log (1x107 cells/mL) B. burgdorferi B31-A3 in the 
presence of 10µg/mL Poly (dI-dC) to compete for nonspecific binding of DNA. These 
bead:DNA:protein complexes were then washed repeatedly in buffer BS/THES 
supplemented with 10µg/mL Poly (dI-dC). Proteins were eluted from DNA by washing in 
the presence of increasing amounts of NaCl to disrupt protein:DNA interactions. Total 
fractions were run on 12.5% SDS-PAGE and stained with Sypro Ruby. Lanes which 
contained distinct bands were excised using clean fresh razors and submitted to the 
University of Kentucky Mass Spectrometry Core for identification.   
Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry (LC-
ESI-MS/MS) Analysis 
All mass spectra reported in this study were acquired by the University of Kentucky 
Proteomics Core Facility. The protein gel slice was subjected to dithiothreitol reduction, 
iodoacetamide alkylation, and in-gel trypsin digestion using standard protocols and the 
tryptic peptides were subjected to shotgun proteomics analysis as previously described in 
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Yang et al. [344]. The resulting tryptic peptides were extracted, concentrated, and injected 
for nano-LC-MS/MS analysis. 
LC-MS/MS analysis was performed using an LTQ-Orbitrap mass spectrometer 
(ThermoFisher Scientific, Waltham, MA) coupled with an Eksigent Nanoflex cHiPLC™ 
system (Eksigent, Dublin, CA) through a nano-electrospray ionization source. The peptide 
samples were separated in? a reversed phase cHiPLC column (75 μm x 150 mm) at a 
flow rate of 300 nL/min. Mobile phase A was water with 0.1% (v/v) formic acid, while B 
was acetonitrile with 0.1% (v/v) formic acid. A 50-minute gradient condition was applied: 
initial 3% mobile phase B was increased linearly to 40% in 24 min and further to 85% and 
95% for 5 min each before it was decreased to 3% and re-equilibrated. The mass analysis 
method consisted of one segment with eight scan events. The 1st scan event was an 
Orbitrap MS scan (300-1800 m/z) with 60,000 resolution (FWHM) or parent ions followed 
by data dependent MS/MS for fragmentation of the 7 most intense multiple charged ions 
with collision induced dissociation (CID) method.  
MS/MS Protein Identification  
The LC-MS/MS data were submitted to a local mascot server for MS/MS protein 
identification via Proteome Discoverer (version 1.3, ThermoFisher Scientific, Waltham, 
MA) against a custom database containing 990 reviewed proteins of Borrelia burgdorferi 
(downloaded 08/19/2015). Typical parameters used in the MASCOT MS/MS ion search 
were: trypsin digest with maximum of two miscleavages, cysteine carbamidomethylation, 
methionine oxidation, a maximum of 10 ppm MS error tolerance, and a maximum of 0.8 
Da MS/MS error tolerance.  A decoy database was built and searched. Filter settings that 
determine false discovery rates (FDR) are used to distribute the confidence indicators for 
the peptide matches. Peptide matches that pass the filter associated with the FDR rate of 
1% and 5% are assigned as high and medium confident peptides, respectively. An 
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extracted ~58kD band was positively and unambiguously identified as the B. burgdorferi 
DnaA homologue. 
Recombinant protein expression and isolation 
For recombinant protein expression and purification, the B. burgdorferi dnaA gene 
was PCR amplified (Table 2-1) using Q5 polymerase, cloned in to the pET200 vector 
(ThermoFisher, Waltham, MA) and transformed in to E. coli Top10 cells (ThermoFisher, 
Waltham, MA). Transformants were screened by colony PCR [339] for insertion size and 
positive colonies were isolated, miniprepped (Zymo, Irvine, CA), and sequenced using 
flanking T7 promoter and terminator primers (Eurofins Genomics, Louisville, KY) to 
validate that no mutations had been introduced. Error-free plasmids were transformed into 
Rosetta 2 DE3 pLysS (Millipore, Billerica, MA) cells. An isolated colony was picked and 
grown over night in LB media containing 50µg/mL of kanamycin and 34µg/mL of 
chloramphenicol. These overnight cultures were passaged 1:100 in to 2L of super broth 
and cultures were induced with 0.5mM IPTG once the culture reached an OD ~0.8. 
Cultures were allowed to continue for 2 hours before harvesting by centrifugation at 
8200XG at 4˚C for 10 minutes. Pellets were stored at -80°C until further processed. 
 Pellets were thawed and resuspended in 20mL of ice cold washing/binding buffer 
(100mM HEPES, 10mM Imidazole, pH 7.5). An appropriate number of EDTA-free 
protease inhibitor mini tablets (1 tablet/10mL suspension) were added for the volume used 
(ThermoFisher, Waltham, MA). Cell suspensions were lysed by sonication with a Branson 
102C sonicator (Emerson, St. Louis, MO) at amplitude of 20% for 15 seconds. This was 
repeated for a total of 5 cycles. Cellular debris was pelleted by centrifugation at 4°C for 30 
minutes at 27,000XG. Soluble fractions were mixed with 1mL MagneHis beads (Promega, 
Madison, WI) at 4°C for 1 hour. Beads were pulled down by magnet, decanted, and 
washed with fresh washing/binding buffer. This was repeated 5 times. Remaining bound 
proteins were eluted in a three-step series of 500µl fractions using Elution buffer (100mM 
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HEPES, 500mM Imidazole, final pH 7.5). Fractions positive for protein by A280 
measurement were pooled and dialyzed overnight in 10K MWCO cassettes 
(ThermoFisher, Waltham, MA) against EMSA Dialysis buffer (10% v/v Glycerol, .5mM 
EDTA, 50mM Tris pH 8.0, .1% PMSF, .01% Tween-20, 50uM KCl, 1mM DTT). Dialyzed 
samples were concentrated using Amicon 50K Ultra Centrifugal Units (Millipore, Billerica, 
MA). Concentrated protein was aliquoted and frozen at -80C. 
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Table 2-1 Oligonucleotide primers used in these studies 
Oligonucleotide 
Name 
Sequence  Purpose 
NidoF CCAGCCACAGAATACCATCC Specific detection of 
mouse chromosomes 
NidoR GGACATACTCTGCTGCCATC Specific detection of 
mouse chromosomes 
flaBF GGAGCAAACCAAGATGAAGC Specific detection of 
bacterial DNA 
flaBR TCCTGTTGAACACCCTCTTG Specific detection of 
bacterial DNA 
LuxSF GAGCACATAGGAGCTACTTTACTT Specific detection of 
uninterupted luxS allele 
LuxSR TTCCTTAAAACATGCAGGAATTGAC
G 
Specific detection of 
uninterupted luxS allele 
ErmCF AAACGCTCATTGGCATTACTTT Specific detection of 
erythromycin cassette 
ErmCR TGAGCTATTCACTTTAGGTTTAGGA Specific detection of 
erythromycin cassette 
BioBpurProbe1 BIO/CCTTCTTTTTAAATCGCCCGCC Generation of bpuR 
promoter pulldown probe 
Bpur Probe2 GATTTATTGTAATGTTATTTTTAGCTA
GC 
Generation of bpuR 
promoter pulldown probe 
BpurP-1 CAATTTCCTCCACACAAGTTTTTG bpuR promoter 
competitor 1 F 
BpurP-2 GTACAATTAATTTAGCTTAAATGTAG
TCAAGT 
bpuR promoter 
competitor 1 R 
BpurP-3 GACTACATTTAAGCTAAATTAATTGT
AC 
bpuR promoter 
competitor 2 F 
BpurP-4 GATTTATTGTAATGTTATTTTTAGCTA
GC 
bpuR promoter 
competitor 2 R 
BpurP-5 GCTAGCTAAAAATAACATTACAATAA
ATC 
bpuR promoter 
competitor 3 F 
BpurP-6 GGACGCAATACAATAATTTACTTATA
T 
bpuR promoter 
competitor 3 R 
BiobpuRp-11 BIO/CAATAATTTACTTATATAAAAA bpuR promoter EMSA 
probe F 
bpuR-14 CCACACAAGTTTTTGTACTTGAC bpuR promoter EMSA 
probe R 
sodA 5' (RNA) AUCAUAACCAAGUUCUGGCAGCUU
AAACAUAAAAACCUCCUGUUUUAAC
UUUUGCCAUGA 
sodA RNA for BpuR 
binding 
BioRNAbpuRp-F 
(RNA) 
CUUAAAUGUAGUCAAGUACAAAAAC
UUGUGUGGAGGAAAUUGAUGGGAG
AGAGAGGGGAAGUAUACUCU 
Positive control for BpuR 
binding 
BioRNAbpuRORF 
(RNA) 
AAACUAUUUACAGAGUCUGAGAGAA
CUUAUUUUUUUAAUGUCAAGGAAAA
UAGAAAAGGAGAUUAUUUU 
Negative control for BpuR 
binding 
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Table 2-1 Cont 
Bio oriC F BIO/GAAGAATCAAAAATTATTTTAAA
C 
Labeled oriC probe F 
oriC R GAAGAATCAAAAATTATTTTAAAC Unlabeled oriC probe R 
oriC F CATGATGCCTCCTTATATATTCTATT
AC 
Unlabeled oriC probe F 
ospC F CTTGCTGTGAAAGAGGTTGAAG qPCR  
ospC R CTCCCGCTAACAATGATCCA qPCR  
rpoN F GGCCAATGAACTTGAGCATTT qPCR  
rpoN R GCTCCACCAACAGAGCTAAA qPCR  
sodA F TGTCCTGAGAGTGGCCTTA qPCR  
sodA R GCATGCTCCCAAACATCAATAC qPCR  
dbpA F GCTGCTCTTAAGGGCGTAAA qPCR  
dbpA R CTACTGTAGTAGCTCGCACTTT qPCR  
ftsK F GACCTTCTGATGAGCCAATGT qPCR  
ftsK R GCTGCTCTGTTGTAACCTATCT qPCR  
qlp28-4 F GCGTATAGTTCGTTGGCTGTA qPCR  
qlp28-4 R GCAGTGGGTCTAGGCATATTAC qPCR  
qDnaA F CCAAFTCCAACTCCACCATAAA qPCR  
qDnaA R GGGCCAAATAATAAACTTGCTTACA qPCR  
bpuR F GGCTCTTCTGCAAGGCATAAT qPCR  
bpuR F GCCCGCCTGATAAATGAGATT qPCR  
hslU F CAAACCGCCAATTCCCATATC qPCR  
hslU R GCAGGTGAGCTTGATGATACTA qPCR  
hslV F ATGATGCTTGTTGCTGATTCTAAC qPCR  
hslV R CACCACTGCCAATCGAAATAAC qPCR  
flaB F CCTTCTCAAGGCGGAGTTAAT qPCR  
flaB R AGCACCTAAATTTGCCCTTTG qPCR  
rpoS F TTTGGGACTATTGTCCAGGTTAT qPCR  
rpoS R CCCTTGAACAAGATTCAACTCTAAA qPCR  
 
This table contains the sequences of all primers used in these studies and their purpose.  
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Chapter 3 Metabolic linkages of signaling and gene regulation 
This work described in this chapter has been published: Arnold WK, Savage CR, 
Antonicello AD, Stevenson B. 2015. “Apparent role for Borrelia burgdorferi LuxS during 
mammalian infection.” Infect Immun 83:1347-1353. 
 
Introduction 
Many bacteria occupy complex multicellular communities composed of both kin 
and non-kin species of bacteria [213]. Members of these communities often exhibit 
communicative behavior through either direct contact [108] or the secretion of signaling 
molecules [24, 74, 213]. One of the better studied examples of the signaling molecule 
secretion system is that of Vibrio harveyi and Vibrio fischeri, marine organisms which 
luminesce in response to high cell density [213]. This behavior and the mechanisms 
defining it are termed “quorum sensing.” Different organisms utilize different types of 
systems and, even within the same species, there can be multiple types of quorum 
sensing, involving different signals, receptors, and pathways. The studies described in this 
chapter focus will on the role of the small molecule 4,5-dihydroxy-2,3-pentanedione (DPD) 
and its various equilibrium products, collectively known as autoinducer 2 (AI-2) during B. 
burgdorferi pathogenesis.  
DPD and homocysteine are produced by the enzyme LuxS. Numerous pathogenic 
bacteria, including Salmonella enterica serovar Typhimurium [305], Vibrio cholera [214], 
and Borrelia burgdorferi [253, 297, 300], possess homologues of the LuxS enzyme and in 
several cases, the enzyme has been shown to play an important role in virulence [259]. 
LuxS is a component of the activated methyl cycle, which detoxifies and recycles the toxic 
byproducts of methylation reactions utilized for physiological processes. Briefly, S-
adenosylmethionine (SAM) is used to methylate various substrates, including DNA [29] 
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and proteins [124, 178], through the activity of methyl transferases. This reaction 
generates the toxic byproduct S-adenosylhomocysteine (SAH). In some organisms, SAH 
can be directly converted to homocysteine and adenosine through the activity of SAH 
hydrolases, which B. burgdorferi does not encode [253]. SAH can also be detoxified by 
the activity of Pfs, which converts SAH to S-ribosylhomocysteine (SRH) and adenine. SRH 
is nontoxic, and the related spirochete, Treponema pallidum, appears terminate the 
pathway at this step [336]. Most other bacteria use a complete version of one of these 
cycles to regenerate homocysteine for reuse in the activated methyl cycle. The case of B. 
burgdorferi is an interesting one in that it encodes an incomplete cycle but continues to 
the LuxS step (Fig. 3-2). If SRH is non-toxic and other organisms with highly reduced 
genomes seem to have successfully dispensed with their LuxS homologue [325], why then 
is it retained in B. burgdorferi? 
Our lab has previously shown that wild-type B. burgdorferi luxS can complement 
an E. coli ∆luxS mutation, and B. burgdorferi secretes a molecule into media which induces 
luminescence in V. harveyi reporter assay [297, 300, 325]. These results indicate that B. 
burgdorferi produces an AI-2-like molecule that elicits signaling responses in other 
bacteria. Furthermore, adding exogenous AI-2 to cultures of either ∆luxS mutant or wild-
type B. burgdorferi results in differences in expression of multiple proteins, including 
several involved in vertebrate infection: VlsE, ErpA, and LA7. The expression of ErpA and 
VlsE was examined specifically upon the addition of exogenous AI-2 in wild type B. 
burgdorferi and while both were expressed in absence of exogenous AI-2, their expression 
was notably increased upon its addition [17]. The expression of luxS was measured during 
both in vitro and in vivo cultivation and is most highly expressed during exponential growth 
[253] and during tick feeding [223], both of which are periods of relatively rapid growth 
rates [242]. 
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It came as quite a surprise, when the ability of luxS mutant bacteria to traverse the 
full enzootic cycle was tested, there were not significant differences between the mutant 
and wild-type strains. In two studies, a mutant strain of B. burgdorferi unable to produce 
LuxS, and thus AI-2, was able infect mice by needle inoculation, be acquired by feeding 
ticks, survive tick molting, and then transmit to naïve mice. In addition, development of 
disease, as measured by histopathology scoring, was not significantly different between 
strains [27, 137]. However, these studies unfortunately suffer from several key 
shortcomings.  
First, no quantitative information regarding bacterial burdens was measured. While 
there were no significant differences in the number of mice or ticks that became infected 
following the experiment, it remains unclear if the relative numbers of bacteria differed 
between wild type and mutant during any stage of the infection. Second, and more 
importantly, the mutant was selected for in an unusual way that is likely to have generated 
suppressor mutants. Possible mutants were initially identified by erythromycin sensitivity 
screening and, following electroporation and selection, were immediately inoculated into 
sterile dialysis chambers and implanted into rat peritoneal cavities. These bacteria were 
allowed to grow for an additional 15 days in the dialysis chamber before being removed 
and syringe inoculated intraperitoneally in to wild-type mice. After two weeks, ear punch 
biopsies were performed and viable, erythromycin resistant spirochetes were plated and 
isolated as single colonies. While this method certainly enriches for ∆luxS mutants who 
retain the full required compliment of plasmids for infection, it also strongly selects for 
mutants that have suppressed the effect of any deleterious effects on vertebrate infection 
of the mutation. As the Stevenson lab has already demonstrated, the effects of AI-2 on B. 
burgdorferi gene regulation does not appear to act as an ON-OFF switch, but as a tunable 
response [325]. This led me to hypothesize that B. burgdorferi unable to sense or produce 
AI-2 would be at a competitive disadvantage to those that could. As the mechanism of 
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sensing AI-2 in B. burgdorferi is not well understood, I chose to examine the effects of 
altering production of the molecule. 
In this chapter I performed studies aimed at testing this hypothesis while 
addressing the first above mentioned concern, namely that there may exist quantitative 
differences in bacterial burden between wild type B. burgdorferi and those that are 
mutated in luxS. 
Absence of luxS does not result in loss of fitness during single strain infection  
I tested if wild type or luxS mutant bacteria grew to different densities in the context 
of a vertebrate infection. To test this in the context of the previously described studies [27, 
137], I chose to perform the below-described studies using the same mutants derived in 
those studies. Eight BALB/cJ mice were infected by needle inoculation with 1x104 wild 
type (297) or ∆luxS mutant (AH309) bacteria from mid-exponential phase cultures. Mice 
were euthanized the mice after 28 days, allowing sufficient time for the establishment of 
disseminated infection, and sterilely harvested hearts and ears. Total DNA was isolated 
from these samples.  
To examine bacterial burden, I measured the abundance of the single copy B. 
burgdorferi gene, flaB, compared to the single copy M. musculus gene, nido by qPCR as 
proxies for genome equivalents. Mice infected with AH309 contained slightly higher 
numbers of bacteria in their hearts than did mice inoculated with 297 (P = 0.049), but there 
were no statistically significant differences in the bacterial loads of ears from mice infected 
with 297 or AH309 (Fig. 3-3). These data further demonstrate that the ∆luxS mutant does 
not have any significant metabolic deficiencies that inhibit mammalian infection. 
Loss of LuxS results in a quantitative loss of fitness during competitive infection  
Many mutations result in subtle phenotypes when examined in isolation [15, 26, 
193, 322]. To test for subtle effects and to more closely model natural environments where 
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subtle negative genotypes present in a multi-strain infection are selected against by 
evolution, competitive models have been increasingly utilized. To test the effect of a ∆luxS 
mutation in a more sensitive manner, I examined relative bacterial burdens of B. 
burgdorferi strains 297 (WT) and AH309 (∆luxS) in a competitive infection model. Alyssa 
Antonicello and I simultaneously inoculated with equal numbers (1x104 cells) of both 297 
and AH309. After 28 days Alyssa and I harvested sterilely hearts, ears, and urinary 
bladders and isolated total DNA from the tissues. 
To discriminate between the wild-type and ∆luxS mutant strains in the mixed 
infection samples, PCR primers were designed which specifically amplify only the wild-
type or mutant ∆luxS locus (Fig. 3-4). Control PCRs with purified DNA from each strain 
confirmed that the oligonucleotide pairs were equally efficient at priming PCR from their 
respective templates and could be compared. I performed qPCR analyses of heart, ear, 
and urinary bladder tissues of eight dually-infected mice. The analyzed tissues were all 
distant from the site of inoculation and therefore measured the bacteria's ability to 
disseminate through mice and colonize, rather than simply survive at the site of injection. 
Comparisons of resultant data indicated that all tissues of all mice contained statistically 
significantly larger numbers of wild-type than mutant bacteria (Fig. 3-5). Variations in wild-
type/mutant ratios occurred between mice and between tissues of the same animals. The 
greatest degree of variation was found in the most distal tissue, the ears, with 3-fold to 18-
fold more wild-type borreliae. Less variability was seen in the internal organs, i.e., the 
hearts and urinary bladders. 
Discussion 
These data highlight several salient aspects that have been widely 
underappreciated in the field of microbial pathogenesis. First, perturbations (either 
deletions or overexpression) of many genes result in subtle effects on the ability of 
microbial pathogens to infect and cause disease in their hosts, especially when examined 
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outside of their natural context. Quantitative measurements, particularly in a competitive 
or community setting, are critical to delineating these subtler effects.  
Second, AI-2 based signaling is intimately tied to microbial growth and physiology. 
As noted above not all LuxS enzymes are necessarily involved in what is typically known 
as quorum sensing behavior. LuxS plays an essential role in recycling of homocysteine 
and perpetuation of the activated methyl cycle in many bacteria. On the other hand, this 
intimate linkage offers a unique mechanism with which to tie metabolic activity to bacterial 
communication. It would seem a reasonable hypothesis that some organisms make dual 
use of this pathway. The B. burgdorferi LuxS produces both AI-2 and homocysteine, but 
current evidence suggests that B. burgdorferi is unable to recycle homocysteine [325].  
 A significant question remains regarding how B. burgdorferi senses the AI-2 
molecule and affects the previously observed gene regulatory changes. Sensing of AI-2 
is most often associated with a two-component type LuxPQ or an ABC-transporter type 
Lsr system [128]. B. burgdorferi encodes two two-component regulatory systems, 
Hk2/Rrp2 and Hk1/Rrp1, neither of which share significant homology to the LuxPQ system 
[101]. The signals for either system remain unknown, but they are essential for the 
vertebrate adaptation stage of the infectious cycle or for cellular viability, respectively. In 
the light of the above findings, namely that LuxS is not absolutely essential for vertebrate 
infection, I find it less likely that AI-2 is the cognate signal for either system.  
 S. typhimurium also lacks a recognizable LuxPQ system and instead imports AI-2 
via an ABC transporter with homology to those that import ribose [310], termed the Lsr 
system. B. burgdorferi encodes numerous transporters to support its extreme auxotrophy 
and harvest required nutrients from the extracellular milieu, including a large repertoire of 
ABC transporters with homology to carbohydrate transport systems. One of these systems 
is annotated as having homology to a ribose ABC transporter, but B. burgdorferi does not 
utilize ribose as a nutrient source [326]. AI-2 molecules bear significant similarity to ribose 
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molecules, and, in Actinobacillus actinomycetemcomitans, the ribose binding protein, 
RbsB, also binds AI-2 at the same active site as it does ribose [149]. A reasonable 
hypothesis is that the annotated ribose transporter in B. burgdorferi may, in fact, act to 
import AI-2 into the cell. A potential link from this import to the observed changes in gene 
expression is through the carbohydrate responsive DNA-binding protein BadR. BadR 
regulates several hundred genes (described in further detail in Chapter 6), though the 
number of directly regulated targets remains relatively unknown, and DNA binding activity 
is regulated by carbohydrate binding. Namely, the addition of phosphorylated sugars, 
including ribose-5P to DNA binding assays inhibits the ability of BadR to bind at least one 
of its targets, rpoS [210]. Potential mechanisms thus exist to generate, import, and sense 
extracellular and intracellular production of AI-2.  
 Examining the response to exogenous AI-2 on mutants in BadR or the other 
putative carbohydrate responsive DNA binding protein XylR-1 could prove interesting. If, 
in fact, either of these proteins were responsive to AI-2, I would expect that response to 
be ablated in their absence. Furthermore, transposon mutants exist for many of the 
carbohydrate transporter subunits. Tracking the import of labeled AI-2 in these mutants 
could shed light on whether AI-2 is transported back into the cell and if any of these 
transporters are required, or if AI-2 is sensed extracellularly. 
 In summary, AI-2 and quorum sensing in B. burgdorferi remains an interesting and 
relatively unexplored area of study. A focus on “all or none” pathogenesis and a relatively 
unusual set of studies have unfortunately reduced enthusiasm for the field. The relatively 
straightforward studies described above could reignite interest in the study of the system.
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Table 3-1 Results of the competitive infection study 
  Heart Bladder Ear 
  297 AH309 297 AH309 297 AH309 
Animal Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
1 31.068 0.729 32.86 0.281 30.863 1.422 33.555 0.208 30.55 0.811 32.775 0.661 
2 30.265 0.296 32.763 0.272 30.673 0.534 33.893 0.419 31.62 0.44 32.798 0.511 
3 31.173 1.667 33.18 0.913 30.293 0.571 32.17 0.612 30.493 0.456 33.683 1.429 
4 30.37 0.921 33.143 0.452 30.728 2.049 31.733 1.112 30.865 0.389 33.325 0.106 
5 30.703 1.517 33.13 1.3 30.138 0.676 32.763 1.055 30.81 0.819 34.763 2.401 
6 31.395 1.759 33.015 0.843 30.68 1.953 30.738 0.787 30.17 0.561 32.355 0.324 
7 29.795 1.186 33.035 1.138 30.638 0.296 31.88 1.612 30.578 0.096 32.883 1 
8 30.295 1.193 31.79 0.707 30.375 0.423 33.003 0.604 33.083 2.005 34.08 0.042 
P value < 0.0001 0.0015 0.0003 
 
CT values were measured by qPCR for each target gene in each tissue in eight individual mice. Values represent the means for two 
separate trials, with two measurements per trial. Student’s t test was performed on the CT values obtained for target loci of strains 297 
and AH309. 
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Figure 3-1: Production of AI-2 in B. burgdorferi 
The activated methyl reaction as it exists in B. burgdorferi. Compared to the complete 
cycle depicted, B. burgdorferi lacks either SAH hydrolase or mechanisms to recycle 
homocysteine.   
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Figure 3-2: Bacterial burdens during individual infection 
Burdens of B. burgdorferi were measured in mouse tissues 28 days after needle 
inoculation. Equal amounts of WT or ∆luxS mutant bacteria were inoculated in to separate 
groups of 8 mice by intraperitoneal injection. Quantitative PCR targeting the single copy 
B. burgdorferi gene flaB and the single copy mouse gene nido as proxies for genome 
equivalents in the samples. 
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Figure 3-3: Validation of primers for discrimination between strains 
(A) The structure of the luxS locus in WT (297) and mutant (AH309) bacteria is given along 
with the locations of primers used for qPCR. The ermC erythromycin resistance marker 
was inserted in to the native locus by allelic exchange [27].  
(B) Agarose gel demonstrating the specificity of amplification for each set of primers on 
each strain. Lane 1 and 2 use primers luxS-F and luxS-R and lanes 3 and 4 utilize primers 
ermC-F and ermC-R. Lanes 1 and 3 were performed on DNA from strain 297 and lanes 2 
and 4 were performed on DNA from AH309. 
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Figure 3-4: Relative bacterial burden between WT and ∆luxS mutant 
One set of 8 mice was infected with equal numbers (1x104) of each strain, 297 and AH309. 
After 28 days, (A) hearts, (B) bladders, and (C) ears were harvested and genomic DNA 
was isolated. Relative burden was assayed by qPCR with primers specific for either the 
mutant or wildtype locus and is reported as fold difference of WT/Mutant. (D) The data are 
summarized as a mean competitive index across all animals and strains. 
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Chapter 4 Mechanistic links between regulators of virulence and DNA replication 
 
This work is being prepared for submission to Molecular Microbiology under the working 
title: The expression of BpuR, a key regulator of virulence determinants, is controlled by 
the master regulator of DNA replication. This was a highly collaborative work, spanning 
several years across multiple labs. Data and strains were generated and analyzed by 
myself (IPTG-inducible BpuR construct, RNA-Seq, flow cytometry, SDS-PAGE, EMSA, 
DNA affinity chromatography), Dr. Brandon Jutras (2D-PAGE, RIP-PCR, Tet-inducible 
BpuR construct), Dr. Grant Jones (GFP reporter plasmid and strain construction), Kathryn 
Lethbridge (qRT-PCR validation), Jonathan Livny and Jessica Alexander (RNAtag-Seq 
library construction and sequencing), and was supported by the University of Kentucky 
Flow Cytometry and Proteomic Core facilities. Quantitative measurements of bpuR 
expression in ticks was performed at Rocky Mountain Labs by Dr. Patricia Rosa, Aaron 
Bestor, Dr. Phil Stewart, and Dr. Kit Tilly. Measurements of bpuR expression in vertebrates 
was performed at the University of North Dakota by Dr. Catherine Brissette and Dr. Robert 
Gaultney. Junior trainees Allison Pecaro, Leeza Kenner, and Walt Finch all assisted with 
various assays over the course of several years. 
 
Introduction 
All cells must eventually relay the information they sense about either 
external or internal processes (nutrient availability, signaling molecules, etc.) into 
action, including changes in gene and protein expression or activity, or fail to adapt 
and die. In the previous chapter, I described a specific metabolite, AI-2, that plays 
a role in signaling gene and protein expression changes important for infection. A 
key limitation of that work was a lack of understanding regarding the mechanism 
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by which the bacteria relayed that information sensed. In this chapter, the focus is 
on a key regulator of virulence proteins, titled BpuR, and how it is controlled. 
BpuR is PUR domain containing protein originally identified by the 
Stevenson lab as a binding protein that interacted with the erp operator DNA [155]. 
BpuR binds RNA, dsDNA, and ssDNA, in that order of affinity. In vitro assays 
indicated that BpuR acts as a corepressor of the erp loci, having no effect on 
expression unless the primary repressor, BpaB, was also present. Finally, 
expression of BpuR was examined during in vitro differential growth conditions 
known to partially mimic aspects of the enzootic cycle and was found to be 
negatively correlated with growth rate (i.e. BpuR expression was high when growth 
rate was low and vice versa) [155]. In a follow-up study, it was demonstrated that 
BpuR not only regulated the transcription of the erp loci, but that it also bound its 
own mRNA and negatively regulated its translation [158]. This previous work set 
the stage for the following questions posed in this chapter: specifically, how is 
BpuR regulated, and what are the more global consequences of differential 
expression of this nucleic acid binding regulatory protein? 
BpuR is highly expressed in unfed ticks but not vertebrates 
Considering the regulated expression of BpuR in vitro and the role of PUR domain 
proteins as pre- and post-transcriptional regulators in B. burgdorferi and other model 
organisms [116, 132, 158], I hypothesized that BpuR levels would be regulated during 
different stages of the enzootic cycle. In order to test this hypothesis, our lab collaborated 
with Dr. Patricia Rosa’s group at the Rocky Mountain Laboratory and Dr. Catherine 
Brissette’s laboratory at the University of North Dakota. Levels of bpuR mRNA at several 
stages of the life cycle of B. burgdorferi were assessed: within unfed ticks, at two time-
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points during tick feeding, after tick drop off, and during an established murine infection. 
Naïve, laboratory-reared I. scapularis larvae were fed to repletion on mice infected with 
wild type B31 MI-16 B. burgdorferi. These ticks were allowed to molt to nymphs. In replete 
larvae and post-molt, unfed nymphs, we found that B. burgdorferi produce high levels of 
bpuR mRNA (Fig. 4-1A). During tick feeding, B. burgdorferi enter a replicative burst [242] 
and begin expressing genes and proteins important for transmission and vertebrate 
infection [146, 264, 272, 298]. At the same time, they begin repressing genes important 
for tick colonization [146, 220, 272]. When we examined bpuR mRNA levels at 24 and 48 
hours after the onset of tick feeding, we found that bpuR mRNA levels significantly 
decreased when compared to levels within an unfed tick (Fig. 4-1A). Levels of bpuR mRNA 
in untransmitted bacteria rebounded following tick drop off after feeding. It is unclear if this 
relative increase in bpuR levels compared to those during feeding occurs because all 
remaining bacteria upregulate bpuR levels to pre-feeding levels or that the population of 
bacteria which fail to transmit are those which persistently express high levels of bpuR 
and thus are enriched following the completion of feeding).  
We then examined bpuR levels in the context of a disseminated vertebrate 
infection. Expression of flaB and bpuR mRNA was assayed in the joints and hearts of mice 
28 days after needle inoculation. We found that while flaB was readily detected, bpuR 
mRNA was undetectable, even after 40 cycles of amplification (Figure 4-1B). These data 
suggest that bpuR expression is important for the adaptation B. burgdorferi to the tick 
vector but not for the vertebrate host, or that bpuR expression is deleterious within the 
vertebrate host. 
Perturbations of BpuR have a minimal impact on in vitro transcriptomes 
Considering the wider role of the other erp regulatory proteins EbfC and BpaB [63, 
153] and BpuR’s regulated expression in vivo and in vitro [158]; I hypothesized that BpuR 
may regulate additional targets. Since bpuR is most highly expressed within a tick, is 
  46 
undetectable within a vertebrate, and co-represses the erp genes, I hypothesized that 
BpuR may act to induce “tick-like” physiology by repressing vertebrate factors, inducing 
tick specific factors, or a combination of both. Repeated attempts to delete the bpuR locus 
by allelic exchange have been unsuccessful and, to my knowledge, the bpuR locus has 
not been successfully targeted during transposon mutagenesis screens [185, 186, 317]. 
For this reason, I chose to perturb bpuR levels by overexpression. This methodology has 
been used to successfully study other essential regulatory factors in B. burgdorferi [158].  
To test the hypothesis that BpuR affects the transcription of other genes outside 
the erp loci, we performed RNA sequencing in collaboration with Jonathan Livny and 
Jessica Alexander at the Broad Institute on strains that produce either wild-type levels of 
bpuR or those induced to produce higher levels in vitro. I transformed a wild-type infectious 
B. burgdorferi strain B31-A3 with the plasmid pWA10, generating a strain (WA11) that 
expresses high levels of BpuR following the addition of IPTG. I induced high level BpuR 
expression with the addition of 0.5mM IPTG for 24 hours before harvesting cells. These 
were compared to uninduced controls. Only two transcripts were statistically and 
biologically significantly impacted (Fig. 4-2) as defined by FDR corrected p<.05 and a 
greater than two times change in expression in either direction. As expected, the transcript 
for bpuR was increased 4.28 times. The only other transcript affected was hslU 
(BB_0295), which was increased 2.58 times. hslU encodes the ATPase subunit of the 
proteasome-like complex HslUV. No other genes in the operon containing this gene were 
impacted, including the other component of this complex, hslV (Bb_0296). Kathryn 
Lethbridge and I examined the expression of bpuR, hslU, and a number of other 
transcripts by qRT-PCR from independently grown and induced cultures (Fig. 4-3). As was 
observed by RNA-Seq, bpuR abundance was significantly increased, but no other 
transcripts assayed in this experiment were significantly differentially expressed. Notably, 
hslU was not significantly impacted by the over expression of bpuR when examined by 
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qRT-PCR of independently grown cultures, suggesting the impact on hslU transcript is not 
reproducible.  
BpuR impacts the proteome of B. burgdorferi 
In work aimed at testing if BpuR was a global regulator of B. burgdorferi gene 
expression Dr. Brandon Jutras performed a number of global expression studies.  After 
demonstrating that BpuR was a dual RNA/DNA binding protein, Dr. Jutras undertook 
studies to test the effect of elevated levels of BpuR production on the B. burgdorferi 
proteome. B. burgdorferi that were engineered to express higher than normal levels of 
BpuR were assayed by 2D-PAGE and compared to those that did not. A large number of 
protein spots were identified as differentially abundant between samples. Several of these 
protein spots were extracted from the 2-D PAGE gels and identified by LC-MS/MS [158]. 
One protein that was less abundant in induced compared to uninduced cultures was 
identified as SodA.  
SodA is a superoxide dismutase that is essential for vertebrate infection and its 
deletion results in complete attenuation of B. burgdorferi during vertebrate infection. Dr. 
Jutras further demonstrated that sodA mRNA coprecipitated with BpuR protein in live cells 
assayed by RNA-Immunoprecipitation (Unpublished). To test if BpuR bound a similar 
region in sodA as it does its own mRNA, I designed a biotinylated RNA probe spanning 
60bp encompassing the start of the sodA coding sequence and tested for BpuR binding 
by EMSA (Figure 4-4A). Labeled sodA RNA probe was incubated with several increasing 
concentrations of BpuR protein and I found that BpuR specifically bound this region. 
Control RNAs composed of the bpuR 5’ UTR  and start of translation or downstream 
coding sequence that BpuR has been previously demonstrated to bind and not bind 
respectively described in Jutras 2013 [158], were used to confirm that this batch of 
recombinant BpuR’s activity was sequence specific.  
  48 
Unlike previously observed BpuR-RNA binding sites, I found that increasing 
amounts of BpuR protein resulted in the formation of one and then two shifted complexes. 
BpuR is thought to bind its nucleic acid targets in a dimeric form [154]. These results may 
suggest that this sodA RNA probe may either possess multiple BpuR binding sites or that 
monomeric BpuR can bind this specific site and increasing concentrations of BpuR result 
in the previously described dimeric binding. The use of variant BpuR mutants deficient in 
dimerization could provide support for the latter hypothesis. The location of this BpuR 
binding site is consistent with a model, similar to the previously described BpuR:bpuR 
mRNA interaction, in which BpuR binds sodA transcript near the ribosome binding site 
and potentially interferes with productive translation. Supporting this model is the 
existence of a perfect Shine-Dalgarno sequence in the middle of the probe.  
The transcript encoding sodA was not impacted by BpuR overexpression as 
assayed by RNAtag-Seq. Considering the result of my RNA-Sequencing study, which 
utilized a newly constructed inducible BpuR construct, I confirmed that the newly derived 
strain produced similar changes in protein abundance across multiple protein spots when 
comparing induced and uninduced cells by 2D-PAGE. These data suggest that, during in 
vitro propagation 34˚C, BpuR exerts its regulatory effects primarily at the post-
transcriptional level. 
DnaA binds bpuR promoter DNA 
The next set of questions I addressed are centered around how and by what 
mechanism BpuR is regulated. Transcript levels of bpuR are altered over the course of 
the enzootic cycle. For this reason, I chose to examine bpuR promoter activity using green 
fluorescent protein (GFP) fusion assays, in which the bpuR promoter was fused to the 
GFP protein coding sequence. I grew the previously-generated B. burgdorferi strain 
harboring this construct [158] in established [157] fast and slow growth conditions 
(34˚C/Full media, 34˚C/1.2% Serum Media, 34˚C/25% BSKII Media) and assayed the 
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expression of GFP by flow cytometry (Fig 4-5). I found that bacteria cultured at slow growth 
conditions produce substantially more GFP than those cultured in fast growth conditions. 
This suggests that the bpuR promoter driving GFP expression is more active during 
periods of slow growth in B. burgdorferi. 
To begin investigating potential mechanisms for this difference in activity, I tested 
if any protein(s) produced by B. burgdorferi would bind the bpuR promoter DNA. I 
performed electrophoretic mobility shifts assays (EMSAs) using total cytoplasmic extract 
and a fragment of DNA which spanned the bpuR promoter. I found that at least one protein 
bound this probe (Fig 4-6). To ascertain the identity of this protein or proteins, I used DNA-
Affinity Chromatography as an unbiased assay to pull down proteins which specifically 
interact with the bpuR promoter. I generated a biotinylated dsDNA probe that spanned the 
bpuR promoter and several hundred nucleotides of the coding sequence (CDS). The 3’, 
CDS proximal end of this was biotinylated to ensure the actual binding site was accessible 
when the DNA probe was bound to streptavidin coated magnetic beads. Beads were 
coated in the DNA bait and the procedure was performed as previously described [161]. 
Specifically-bound proteins were eluted by serial washes of high salt buffer and eluents 
were separated by SDS-PAGE. Three different sized bands were excised across all 
eluents and submitted for mass spectroscopy identification. Two of these three were found 
to be OspC and OspA protein, and I hypothesize that these represent membrane 
contamination, as they are two of the most abundant lipoproteins that B. burgdorferi 
expresses at 34°C. The B. burgdorferi homologue of DnaA was unambiguously identified 
in a ~58kD band extracted. One other protein, Ef-Tu, was also identified at low abundance. 
I chose not to pursue OspC, OspA, and Ef-Tu during these studies, as they had no 
previously recognized DNA binding activity and are more likely to represent non-specific 
contaminants.  
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I cloned and purified recombinant DnaA, with the assistance of Allison Pecaro and 
Leeza Khenner, and tested its ability to specifically interact with the bpuR promoter by 
EMSA. I first tested the ability of recombinant DnaA to interact with a known target, the 
origin of replication [239, 240], by incubating increasing amounts of recombinant protein 
with a labeled DNA fragment containing the B. burgdorferi oriC. I found that DnaA 
specifically interacts with the origin of replication, but not an unrelated DNA fragment (Fig. 
4-7A). DnaA bound this DNA in the presence of 100X molar excess of unrelated DNA, but 
binding was competed away in the presence of unlabeled probe. 
I then tested if and at what location DnaA bound the bpuR promoter. To identify 
where the DnaA binding site was located, I utilized a competitive EMSA approach. I 
generated a labeled DNA probe by PCR that spanned 147bp of the upstream bpuR DNA, 
including the 5’ UTR, promoter, and ~70bp upstream of the promoter. Three unlabeled 
fragments of DNA that span the entire probe sequence, in overlapping segments of 
approximately the same length, were generated by PCR for use as competitors (Fig 4-
7C). EMSAs were performed that included each of these sub-fragments individually (Fig 
4-7B). Competition for binding was only observed for a single fragment, Fragment 2. This 
fragment is centered over the core promoter of bpuR, and the only unique sequences not 
covered by the other probes is the sequence located between the -10 and -35 sites. 
Discussion 
When I began these studies, current data suggested that BpuR was a global 
transcriptional regulator that also possessed post-transcriptional, autoregulatory activity. 
My current studies do not support the hypothesis that BpuR is a global transcriptional 
regulator in these specific culture conditions. Rather, my data support the hypothesis that 
BpuR’s primary role in these conditions is that of a post-transcriptional regulator. 
Specifically, the transcriptomes of bacteria which express higher levels of BpuR are not 
significantly different than those that express normal levels. On the other hand, when 
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examining the proteomes of these bacteria, both Dr. Brandon Jutras and I found significant 
differences in the abundance of multiple proteins. BpuR was the third RNA binding protein 
identified in B. burgdorferi [195, 262, 263, 308]. These data also suggest that the effects 
of BpuRs activity on the proteome are primarily mediated by through modulation of 
translation, rather than by impacting transcript stability. While significant effort was 
dedicated to ensuring that BpuR levels truly were elevated at the transcript and protein 
levels and that the bpuR gene on the overexpression plasmid remained free of mutation 
following induction, there remains a possibility that unknown suppressor mutation(s) 
developed elsewhere in the genome, blunting the expected transcriptomic differences. 
Full genome sequencing of generated mutants or generation of independent mutant 
strains could shed light on this. These experiments served to set the stage for the following 
section focused on examining the mechanisms by which BpuR is regulated. 
Previous studies demonstrated that BpuR controlled its own translation, but not its 
transcription. This led to the question, is BpuR only regulated post-transcriptionally, or do 
other factors affect its transcription? Importantly, BpuR has never been identified in the 
differentially expressed gene set of any regulatory factor yet examined in B. burgdorferi 
[38, 99, 126, 146, 147, 230, 251, 256, 262, 329]. That suggests that if it is regulated by 
any of these factors, that regulation is context dependent, and that context has also not 
yet been identified. Alternatively, it could be that a novel regulatory factor is at play. This 
work provides the first conclusive evidence that bpuR is regulated at the level of 
transcription, both in culture and during the enzootic cycle. I then showed that some 
protein(s) bound the DNA containing the bpuR promoter in a DNA-Pulldown system. I was 
able to identify at least one of these proteins as DnaA, marking the first time, to my 
knowledge, that DnaA has been implicated in the control of virulence in a pathogenic 
bacterium. While DnaA has been long known to play a role in the control of transcription 
in several species of bacteria [70, 133, 134, 162, 209, 285, 332], much remains to be 
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learned regarding the mechanism of control. My competitive EMSA data suggest that the 
mechanism in this case may be that of a repressor. By binding DNA containing regions of 
the core promoter, it seems likely that DnaA would compete with RNAP, inhibiting its ability 
to bind and form a productive transcriptional complex.  
Many questions remain regarding this potential regulatory function remain. Does 
DnaA truly repress transcription? What are the binding kinetics of the interaction? Does 
ATP/ADP bound status impact the binding as it does in other systems [290]? While many 
questions remain, it seems clear that DnaA has an underappreciated role in the control of 
physiology in bacteria outside of its role in the initiation of DNA replication. I present a 
potential model in Figure 4-9 that includes preliminary information from our own work as 
well as inferences from other bacteria. It is presented not as fact, but merely, to this author, 
as a reasonable model to frame and test future hypotheses. 
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Figure 4-1: mRNA levels of bpuR throughout the enzootic cycle 
(A) Total RNA was isolated from Ixodes scapularis larvae ticks that were fully engorged 
and dropped off naturally (DO L). Those ticks molted and RNA was isolated from unfed 
nymphs (Unfed N). During nymphal tick feeding on naive mice, ticks were removed at 48 
and 72 hours post attachment, and B. burgdorferi RNA isolated (48N and 72N, 
respectively). RNA was also isolated from ticks that had dropped off naturally following 
repletion (DO N), and 1-week post drop off (1 Wk N). All RNA samples were reverse 
transcribed into cDNA, and qRT-PCR was used to determine copies of bpuR (bb0047) 
mRNA relative to house-keeping flaB copies [32]. Statistical significance was determined 
using Turkey’s Multiple comparison test (p<0.5). * and ** Indicate statistical significance 
in bpuR mRNA between bracketed samples. Data was generated and analyzed by Dr. 
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Patricia Rosa, Dr. Kit Tilly, Aaron Bestor, and Dr. Phil Stewart at Rocky Mountain Labs. 
Adapted with permission from Jutras et al. 2013.  
(B) Total RNA was isolated from infected mouse tissues after one month of infection. RNA 
was reverse transcribed into cDNA, and qRT-PCR was used to determine flaB and bpuR 
(bb0047) in each tissue. Data was generated and analyzed by Dr. Catherine Brissette, Dr. 
Robert Gaultney, and Brandee Stone at The University of North Dakota. 
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Figure 4-2: Differentially expressed transcripts following bpuR induction 
MA (log ratio between samples vs. mean abundance of transcripts) of B. burgdorferi 
expressing elevated levels of bpuR compared to those which produce wild-type levels. B. 
burgdorferi that harbored an IPTG inducible copy of bpuR on a plasmid (WA11) were 
grown at 34˚C in BSK-II. Bacteria were inoculated at 1x105 cells/mL and induced when 
cultures reached 1x106 cells/mL. Induced and un-induced cultures were harvested after 
24 hours (Approximately 1x107 cells/mL). RNA was isolated, Illumina cDNA libraries were 
prepared, and sequenced [14] as described previously. Reads were mapped to the B. 
burgdorferi genome and counted using Salmon [238], and tested for differential expression 
using DESeq2 [194] in R [1]. 
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Figure 4-3: Validation of RNA-Seq 
qRT-PCR measurements of select impacted and non-impacted transcripts. All 
measurements were normalized to the mean expression of the house-keeping genes flaB 
and ftsK and are relative to the uninduced samples.  
bp
uR
db
pA
dn
aA
hs
lU
hs
lV
os
pC
so
dA
rp
oS
0
1
2
3
4
5
qRT-PCR Validation
Transcript
R
e
la
ti
v
e
 N
o
rm
a
li
z
e
d
 E
x
p
re
s
s
io
n
Uninduced
Induced
  57 
 
 
Figure 4-4: BpuR impacts SodA protein levels and binds sodA RNA and 
(A) Expression of BpuR, SodA, and FlaB was assayed in uninduced and induced B. 
burgdorferi WA11 by western blot using antisera against BpuR and SodA and 
monospecific antibodies against FlaB. Band intensity was quantified using the ImageJ 
densitometry plug-in. 
(B) BpuR was tested for binding of a 60bp biotinylated RNA probe centered on the sodA 
start codon by electrophoretic mobility shift assay. Lane 1 contains no protein and Lanes 
2-5 contain increasing amounts of recombinant BpuR.  
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Figure 4-5: bpuR is regulated at the level of transcription 
The previously constructed bpuR promoter : GFP reporter fusion [158] was introduced into 
the readily transformable B. burgdorferi strain B31e2. Transformed bacteria were grown 
in fast growth or slow growth conditions. Cells were pelleted, washed with and 
resuspended in PBS and assayed by flow cytometry for GFP expression.  
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Figure 4-6: Evidence that protein(s) specifically bind the bpuR upstream DNA 
Whole cytoplasmic lysates were incubated with biotinylated bpuR upstream DNA in 
increasing amounts (Lane 2-3). SC indicates the lane contains 100X molar excess of 
specific competitor (unlabeled probe) and NSC indicates the lane contains 100X molar 
excess of a non-specific competitor (unlabeled, unrelated DNA). Lane 1 contains labeled 
DNA alone. 
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Figure 4-7: DnaA binds the bpuR promoter 
(A) Increasing amounts of rDnaA (Lanes 2-4) incubated with 1nM labeled B. burgdorferi 
oriC. Lane 1 contains labeled DNA alone. SC and NSC contain 100X molar excess of 
specific and non-specific competitors respectively. (B) Testing for binding of DnaA to the 
bpuR promoter using three overlapping competitors. Specificity was tested in additional 
EMSAs, but is also confirmed here by Fragments 1 and 3 failing to compete, and only 
Fragment 2 competing. (C) Diagram of bpuR promoter and three competitors used to 
define DnaA binding region. 
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Figure 4-8: Proposed mechanism of DnaA interaction with the bpuR promoter  
(A) During fast growth or high nutrient conditions and (B) during slow growth or nutrient 
limited conditions where I predict active DnaA levels are lower. 
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Chapter 5 Investigations into the B. burgdorferi transcriptome yield insight into 
transcriptomic dynamics and architecture 
 
This work described in this chapter has been published: Arnold WK, Savage CR, Brissette 
CA, Seshu J, Livny J, Stevenson B. 2016. “RNA-Seq of Borrelia burgdorferi in multiple 
phases of growth reveals insights into the dynamics of gene expression, transcriptome 
architecture, and noncoding RNAs.” PloS One 11:e0164165. 
 
I generated the source RNA for total RNA-sequencing of the wild-type strain B31-A3 and 
performed the downstream filtering analysis of 5’ ends, putative non-coding RNAs, and 
investigation of intrinsic termination sites. Library construction, read filtering and mapping, 
and prediction of transcriptional units was performed in collaboration with Dr. Jonathan 
Livny at the Broad institute. qRT-PCR validation was performed with the assistance of 
Kathryn Lethbridge and Christina Savage. The B31-A3 strain was acquired from Dr. 
Patricia Rosa. Multiplex PCR validation of plasmid content was performed by Drs. Bobby 
Gaultney and Catherine Brissette. 
 
Introduction 
A major interest of this work and of the Stevenson laboratory as a whole is to better 
understand both the input (Chapters 3 and 4) and the topology (Chapters 5 and 6) of the 
gene regulatory networks (GRNs) important for B. burgdorferi’s challenging life cycle. To 
this end, I specifically sought to identify novel regulatory mechanisms encoded in the 
genome of B. burgdorferi (this chapter) and to better define the topology of the known 
GRNs important for allowing this bacterium to adapt to and survive within its unique, two-
host lifecycle (Chapter 6).  
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As described in previous chapters, numerous genes and proteins are differentially 
expressed over the course of the enzootic cycle. A handful of factors, including nucleic 
acid (DNA and RNA) binding proteins,[16, 42, 62, 153, 156, 160, 163, 173, 195, 210, 231, 
254, 262, 269, 283, 308], alternative sigma factors [284], two-component systems [28, 
256], and second messengers [227, 268, 348] have emerged as key players in the 
regulation of many of differentially expressed genes and proteins. The most extensively 
studied of these are 2 two-component regulatory systems (HK1/Rrp1 and HK2/Rrp2) and 
alternative sigma factors (RpoS and RpoN). In addition to these two-component systems 
and alternative sigma factors, an increasing number of nucleic acid binding and second 
messenger signaling proteins have studied in varying degrees of detail. Some of these 
nucleic acid binding proteins are essential for completion of the enzootic cycle  [46-48, 
127, 211] while others appear to be essential for cellular viability [153, 158, 185, 348]. 
Numerous transcriptomic studies have sought to identify the regulons of these factors in 
order to better understand the regulatory architecture important for vector or vertebrate 
adaptation. Generally, these studies have been confounded or limited by variances in 
choice of experimental condition, strain, and technology [14, 38, 84, 99, 126, 147, 251, 
255].  
The studies described in this chapter sought to provide additional insight into the 
dynamics and structure of the B. burgdorferi transcriptome using the novel method of 
RNAtag-Seq. Nearly all previous transcriptomic studies of B. burgdorferi were performed 
using microarrays that solely examined the expression of protein coding ORFs [147]. In 
the last several years, a handful of RNA-sequencing studies were performed, but they 
also only investigated the expression of protein coding genes and were not strand specific 
[46, 84, 153, 169]. As a result of this technological limitation, no comprehensive 
characterization of transcriptome architecture (5’ transcript ends and termination sites) or 
putative non-coding RNAs had been attempted.  
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RNA Sequencing approaches have the significant benefit when compared to other 
expression profiling technologies in that they lend themselves to both discovery and 
hypothesis testing within the same experiment. Though numerous bacteria, including B. 
burgdorferi, are known to differentially express genes during batch cultivation [87, 103, 
136, 143, 174, 250], no comprehensive evaluation had taken place to examine the effect 
of culture phase on B. burgdorferi transcriptomes over time in the same culture. Different 
researchers often harvest cells at different growth phases or even refer to different culture 
densities as the same growth phase. To test if, and to what extent transcripts are 
differentially expressed across different growth phases, we performed RNAtag-
Sequencing and differential expression analysis of B. burgdorferi at multiple points during 
batch cultivation. This work provides a resource for other researchers to understand the 
transcriptomic context of their own experiments. 
The second component of this study sought to identify novel targets or 
mechanisms of regulation that had not been explored in a comprehensive, global, manner. 
Low throughput analyses using 5’ RACE and primer extension have been performed on 
select genes [67, 91, 123, 226, 232, 253] but, prior to this work, nothing was known 
regarding the length, content, and/or structure of 5’ transcript ends (and potential 5’ UTRs) 
on a genome wide scale. Additionally, while a small number of intrinsic terminators [347] 
had been identified [82, 249], manual identification of more than a handful had proven 
difficult due to B. burgdorferi’s very low G+C content. My more global analysis provides 
greater insight in to both how transcripts begin and how they end. Of interest to our lab 
and others within the field is the identification of extended 5’ UTRs preceding  important 
genes and the presence of terminators between genes or within transcripts. 5’ UTRs can 
adopt secondary structures that are responsive to small molecules, temperature, and 
other stimuli [22], or act as targets for RNA binding regulatory proteins [228]. Intrinsic 
terminators are structural sequence elements that can cause robust and immediate 
  65 
termination of transcription, and, while more widely known as signals to terminate 
transcription at the end of a gene, numerous regulated terminators exist that are 
responsive to temperature, small molecules, proteins, and RNAs at the end, middle, and 
beginning of genes [267]. 
Finally, a bioinformatic analysis aimed at identifying potential small RNAs in B. 
burgdorferi was performed in 2004 [229], but only a small number of targets were identified 
(eleven transcripts total). These primarily consisted of highly conserved stable RNAs (6S, 
tmRNA, srp, rRNA) and a single, small regulatory RNA, dsrA, which is now known to post-
transcriptionally regulate the production of RpoS. Those authors concluded that B. 
burgdorferi encoded relatively few small RNAs. However, that study suffered from several 
significant limitations. First, it was performed very early on in the days of prokaryotic small 
RNA biology, and, therefore, the data sets queried for homology were relatively limited. 
Second, small RNAs are notoriously difficult to identify based upon homology or sequence 
identity alone. In the case of small regulatory RNAs, they often target small portions of 
coding genes by binding complementarity and thus can be less conserved than protein 
coding homologues at the nucleotide sequence level. Finally, this approach solely 
examined intergenic regions and was not able to successfully detect any antisense 
transcripts. Global measurements of transcript abundance across the genome at a single 
nucleotide resolution provide a direct route to the identification of these difficult to predict 
transcripts.  
In this study, I generated insight into the dynamics and architecture of the B. 
burgdorferi transcriptome, serving as a future resource for both the Stevenson lab and the 
field at large. We first identified the transcriptomic changes that B. burgdorferi undergo 
during batch cultivation, providing a deep understanding of the background physiology of 
the organisms when performing future studies of cultured organisms. We then used this 
total RNAtag-Seq data set to globally identify 5’ transcript ends and providing experimental 
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support for the bioinformatic prediction of intrinsic terminators. Finally, we identified nearly 
350 novel, putative, small, non-coding RNAs transcribed from across the genome.  
RNA-Sequencing of cultured Borrelia burgdorferi 
Across all nine samples (3 time points in triplicate), between 2.57 and 46.5 million 
reads were sequenced, with a mean of 17.9 million reads per sample (Table 5-1). As 
ribosomal RNAs were depleted prior to library construction, the majority of reads aligned 
to coding sequences, with a smaller fraction aligning to intergenic or antisense regions 
(discussed in more detail below). Between 0.97% - 8.27% of reads aligned to ribosomal 
RNA regions. Presumably due to their highly processed and modified nature, tRNAs were 
underrepresented in our sequencing data. Some samples had lower numbers of reads 
successfully mapping to the genome for an as of yet undetermined reason. Even in the 
low mapping sample, nearly 1 million reads successfully aligned to the genome. A depth 
of one million aligned reads has been empirically demonstrated to detect the majority of 
ORFs in a bacterium with a genome twice the size of B. burgdorferi [122]. Furthermore, a 
more deeply sampled RNA-Seq data set was subsampled down to 600,000 reads and 
was still able to detect 60-90% of differentially expressed genes identified in the full set, 
depending on fold change cut off.  
 The sequenced isolate of B. burgdorferi B31 genome encodes 1386 annotated 
genes across the main chromosome and small replicons. Expression was detected in at 
least one replicate from 92% of these genes as determined by counting >10 FPKMO 
(fragments per kilobase per million reads aligning to annotated ORFS). Individual samples 
had detectable expression of 81.8% - 87.8% of annotated genes with a mean of 84.9%. 
Expression measurements of biological replicates were highly correlated, with a Pearson 
correlation exceeding r = 0.96.    
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B. burgdorferi differentially expresses numerous genes depending on growth 
phase 
It is well known that bacteria alter their transcriptional profiles during in vitro 
cultivation as they transition through growth phases (lag phase, exponential, stationary 
phase, and death phase) [174]. We chose to assay the transcriptomes of bacteria at the 
first three stages of growth, as they are the most commonly examined by other groups 
and serve as the best resource for future comparisons. A total of 243 (17.6%) annotated 
ORFs were found to be differentially expressed when comparing any of the three growth 
phases. A key finding of these differential expression testing results was that previously 
presumed invariant housekeeping genes, such as flaB and recA, are in fact differentially 
expressed depending on growth phase (discussed in further detail below).  
I found relatively small numbers of transcripts are differentially expressed during 
the transition from early to mid-exponential phase (Figure 5-1A and Appendix Table 8-1), 
with only 9 transcripts of annotated genes being differentially expressed between early-
exponential and mid-exponential cultures. Four transcripts increased and 5 decreased 
during the transition to mid-exponential stage. Of the four transcripts that increased, three 
are of unknown function, and the fourth is a putative bacteriophage integrase on the small 
replicon lp56. Of the five genes that were statistically and biologically significantly reduced, 
four are bpaB genes encoded on the cp32 prophages. Previous studies found that bpaB 
transcript levels decreased as B. burgdorferi growth rate increased [157] consistent with 
BpaB’s role in repressing erp gene transcription [160].  
Significantly greater numbers of transcripts were altered during the transition in to 
stationary phase (2 days following the attainment of 108 cells/ml). These differences were 
most accentuated when comparing early-exponential phase to stationary phase with 129 
genes expressed at higher levels and 98 genes expressed at lower levels (Figure 5-1B 
and Appendix Table 8-3). When comparing mid-exponential phase with stationary phase, 
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66 genes were increased and 7 genes decreased in transcript abundance (Figure 5-1C 
and Appendix Table 8-2). 
Transcripts of several genes important for infection and host surface adhesion 
were elevated during stationary phase, including dbpA, dbpB, and sodA (2.4, 4.5, and 
2.25 times respectively). The most highly elevated when comparing early-exponential to 
stationary phase transcript encodes the RNA component of the signal recognition particle 
(11.5 times). Among the genes that decreased in abundance during the exponential-
stationary transition were factors involved in DNA repair and replication (dnaA, polA, recD, 
and recB), genes involved in central metabolism (pfs and metK), and those involved in 
sperimidine uptake and metabolism. The transcript encoding the alternative sigma factor 
rpoN, which is important for vertebrate infection, was also expressed at significantly lower 
levels during stationary phase. Those observations are consistent with an overall 
slowdown of cellular metabolism and cessation of DNA replication and are consistent with 
the hypothesis that genes important for host adaptation are responsive to changes in 
growth rate [157].  
Relative expression levels of select genes were assessed by qRT-PCR, permitting 
comparisons of transcript level determination by the RNA-Seq and qRT-PCR methods. 
Transcripts that RNA-Seq indicated were increased, decreased, or remained stable 
across all three culture stages were assayed. When comparing early-exponential to 
stationary phase of growth an increase in dbpA transcript and a decrease in rpoN 
transcript was detected by both DEseq [9] analysis of RNA-Seq and by qRT-PCR. When 
assayed by qRT-PCR and DESeq, sodA levels did not significantly change during 
cultivation. DESeq analysis of ospC indicated a dip in transcript abundance in mid-
exponential phase, which was not detected by qRT-PCR. This last measurement, of ospC, 
highlights the exquisitely sensitive tuning of expression of this particular transcript that will 
be discussed in additional detail in Chapter 6. 
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The flaB transcript is frequently used as a reference transcript qRT-PCR [164, 
212]. The recA mRNA has also been used on occasion as a reference, under the same 
assumption of invariance [164, 348]. However, our RNA-Seq analyses consistently 
revealed differences in both flaB and recA transcript levels when comparing early or mid-
exponential to stationary phases. For this reason, we mined our data for a more stably-
expressed mRNA. The ftsK message was identified as being nearly unchanged across 
growth phases, varying at most by 0.98 times. Therefore, all qRT-PCR results in this 
particular study were analyzed using ftsK as the internal, constant standard. 
Genome wide mapping of 5’ transcript ends 
Methods have been developed that can enrich for RNAs that carry a 5’ 
triphosphate and therefore may represent primary transcripts [277]. These approaches 
allow for the differential examination of RNA-Seq (dRNA-Seq) libraries, which are enriched 
in primary transcripts. While such methods facilitate identification of transcript start sites, 
data from RNAtag-Seq can also be analyzed to identify probable transcription starts. 
Newly-developed methods for analysis of total RNA-Seq data have mapped start sites 
that agree well with both dRNA-Seq and low throughput methods such as 5’ RACE [330] 
further supporting the power of this approach. RNA-Seq was also recently used by another 
group to identify the putative transcriptional promoters of the B. burgdorferi tamB and 
bamA genes [144].  
To this end, we mined our RNAtag-Seq data for increases in read coverage within 
a narrow window upstream of coding sequences. Between 591–793 (591 in early 
exponential, 599 in mid-exponential, and 793 in stationary phase) putative transcript 5’ 
ends were identified as functions of growth phase. Though this number and location varied 
slightly, dependent on growth phase, the highest density of these putative 5’ ends mapped 
between 20 and 40 base pairs upstream of the nearest annotated start codon (Figure 5-
2) for all examined conditions.  
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While many transcripts appeared to begin relatively near the beginning of their 
start codon, some key operons known to be important for the enzootic cycle were 
transcribed along with extended 5’ UTRs. The glycerol utilization (glpFKD) operon is 
required for maximal survival within an unfed tick and encodes proteins for the uptake and 
utilization of glycerol in glycolysis and membrane synthesis [237]. The glpFKD operon 
transcript’s 5’ end was detected at the -190 position in both early and mid-exponential 
phase, which is consistent with data from a separate study placing the transcriptional start 
site at position -196 [4]. Furthermore, a recent study identified sequences that appear to 
be important for transcriptional control of the operon within this region [120]. 
The transcriptional start sites of several B. burgdorferi operons have previously 
been mapped by methods such as primer extension, 5’ RACE, or, more recently, RNA-
Seq. The majority of previously-determined 5’ ends were also identified in our data set 
and matched either exactly or within a few bases of our identified 5’ ends, adding to 
confidence that these newly-identified 5’ ends are likely to represent accurate 
transcriptional start sites (Table 5-3). 
Identification of intrinsic termination sequences 
Rho-independent, or intrinsic, terminators can abruptly end extension of a 
transcript, or serve as regulatory sequences. Prior to performing RNA-Seq, the B. 
burgdorferi B31 genome sequence was analyzed by combined use of three separate 
intrinsic terminator prediction programs implemented in the sRNA detection pipeline 
SIPHT [190]. Those in silico analyses predicted the existence of 201 Rho-independent 
termination sites across the B. burgdorferi genome (Appendix Table 8-4). 
I manually inspected RNA-Seq data for abrupt drops in mapped reads surrounding 
those sites, as expected from active Rho-independent termination. Many of the predicted 
terminators were followed by distinct reductions of reads mapped (Figure 5-3 and Figure 
5-4), although some exceptions were found. Some of these discrepancies may reflect the 
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fact that the Rho-independent terminator prediction algorithm with the largest number of 
predicted terminators, Transterm, was trained and vetted on B. subtillis, whose nucleic 
acid composition is substantially different from that of B. burgdorferi (43.5% versus 29% 
G+C, respectively). Visual examination of read mapping across the genome supports this 
notion, as many transcripts appeared to terminate abruptly, similar to those near predicted 
Rho-independent terminators, but were not predicted by sequence analysis. Without 
additional study, it is difficult to say if these were the result of Rho-independent termination 
or if these represent processed transcripts.  
Of the 201 in silico predicted Rho-independent terminators that were supported by 
RNA-Seq data, 99 (49%) resided within 100bp 3’ of a stop codon or had transcriptomic 
support for an extended 3’ UTR that ended at the predicted terminator. Examples include 
flaB and the bmpDCAB operon (Figure 5-3). The flagellin-encoding flaB gene is expressed 
at relatively high levels so a strong terminator that prevents read-through into the unrelated 
downstream gene is likely quite important. The bmpDCAB locus constitutes a complex 
operon. Two intrinsic terminators have previously been identified previously, residing 
between bmpD and bmpC, and between bmpA and B [82, 249]. The algorithms used in 
this study predicted the bmpD–bmpC terminator, which was supported by RNA-Seq read 
mapping (Figure 5-3). The bmpA–bmpB terminator was neither predicted algorithmically 
nor apparent from experimental data. 
Intrinsic terminators residing within the 5’ UTR or inside the coding region of an 
mRNA can have regulatory effects on transcriptional elongation and, therefore, protein 
expression. Nineteen percent of the predicted terminators are located within 150bp of a 
start codon of an annotated gene. Two representative examples are shown in Figure 5-4 
and include apparent early termination in holA and Bb_0709. holA encodes the delta 
subunit of DNA polymerase and has been shown to be repressed during the stringent 
response in E. coli, though the mechanism was unclear [89]. The remaining percentage 
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of identified intrinsic terminators resided either well within genes or were located 
intergenically and not within 100bp of any annotated gene or putative ncRNA. 
Other transcripts were associated with distinct decreases in coverage at their 3’ 
ends that did not overlap a predicted Rho-independent terminator, suggesting that these 
3’ boundaries may be due to RNA processing of longer transcripts or highlight that the 
sequence requirements for Rho-independent termination in B. burgdorferi vary 
significantly from those in other model organisms. 
The 3’ ends of the majority of genes lacked any predicted intrinsic terminator and 
lacked discrete ends. These transcripts generally ended with regions of gradually declining 
transcript abundance after the stop codon. This gradual trailing off of transcript coverage 
could be a result of a number of reasons, including Rho-dependent termination or 
degradation. Because of these uncertainties and the variability in length of decline, I chose 
not comprehensively analyze 3’ ends of transcripts that did not contain apparent Rho-
independent terminators. 
B. burgdorferi expresses hundreds of putative small non-coding RNAs 
Modern approaches to/. the preparation of RNA-Seq libraries have the ability to 
investigate transcriptional activity from both strands of DNA. This allows the unbiased 
discovery of both intergenic noncoding RNAs (ncRNAs) and RNAs that are transcribed 
antisense to protein-coding ORFs (asRNA). To identify candidate B. burgdorferi ncRNAs, 
we mined our RNA-Seq data for relatively short (<425nt) putative transcriptional units 
located in non-coding regions of the genome or antisense to annotated protein encoding 
genes. This analysis yielded 351 putative ncRNAs (Appendix Table 8-5), of which 129 
were transcribed from the main linear chromosome, 82 from the resident cp32 prophages, 
and 140 from the remaining linear and circular plasmids. Slightly more than half (186) of 
the ncRNAs were transcribed antisense to annotated coding sequences. Sixty-two 
putative ncRNAs were encoded in intergenic regions without any overlap of known ORFs. 
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One hundred and three contained both antisense and intergenic sequences, of which 39 
included sequences that are antisense to or overlap with pseudogenes. 
Among the most highly expressed ncRNAs were homologs of stable regulatory 
and catalytic RNAs, including 6S rRNA [333], tmRNA [167], and the RNA subunits of 
RNase P [171] and SRP [8] (Figure 5-5ABCD). Levels of the srp RNA were significantly 
increased upon entry into stationary phase. The other stable RNAs were not differentially 
expressed over the course of the experiment. The last remaining previously identified 
small RNA, dsrA, an ncRNA that regulates translation of the RpoS alternative sigma factor, 
was also readily detected (Figure 5-5E). One of the most highly-expressed transcripts 
under all culture conditions was a previously unannotated transcript of 401 nucleotides. 
This novel RNA was designated bsrW (borrelial small RNA W). It is encoded by a 
chromosomal locus that is between the genes fusA and Bb_0542 (Figure 5-6A). Although 
unannotated in the NCBI genome entry for B. burgdorferi B31, the nucleotide sequence is 
conserved across much of the genus. Upon manual inspection, bsrW was found to contain 
a small ORF predicted to encode a 76 residue polypeptide. BLAST-P analyses 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) revealed homology with other bacterial proteins 
that contain KTSC (Lysine tRNA synthetase C-terminal domain) domains. Although such 
proteins are found in other bacterial species, their functions are not known. If bsrW does 
in fact encode a small protein, it would have unusually long 5’ and 3’ untranslated regions 
(102 and 82 nucleotides, respectively). Those lengths are on the upper bound of the 
previously described distribution of lengths identified in my data set, and suggest the 
potential protein is tightly regulated. 
I was also able to identify 186 transcripts that are transcribed antisense to coding 
sequences. I chose a relatively conservative expression cutoff in order to minimize false 
positives. Many of these putative ncRNAs overlap genes important for infection and tick 
colonization, including rpoN, glpF, and Bb_0347 (Figure 5-6BCD). Antisense RNAs can 
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have myriad effects on their cognate genes, including influencing transcriptional initiation 
and read through efficiency via polymerase competition or base pairing with 
complementary transcripts to alter transcript stability [303]. 
Discussion 
All organisms regulate the expression of their genes and proteins in order to adapt 
to and survive in dynamic environments. In this study, I sought to identify novel regulatory 
mechanisms by characterizing the dynamics and architecture of the B. burgdorferi 
transcriptome. I hypothesized that additional regulatory complexity existed in the B. 
burgdorferi genome and would be identifiable using transcriptomics. 
Decades of work prior to this study demonstrated unequivocally that B. burgdorferi 
alters gene and protein expression during in vitro cultivation in response to various stimuli 
[33, 54, 273, 298, 299, 316], including, but not limited to, changes in growth phase [250]. 
Yet with that knowledge in hand, no comprehensive analysis of gene expression during in 
vitro batch cultivation had been performed. This factor is confounding for gene expression 
studies within the field, as different groups often classify early, mid, late-exponential and 
stationary phases differently, raising the possibility that studied differences. While one 
group may harvest cells at 1X107 cells/mL as mid-exponential, another may refer to mid-
exponential as 9X107 (A difference of nearly a logarithm and 36 hours!). While these 
represent the extremes, many points in between these two are commonly referred to as 
mid-exponential. 
Prior to this work, little to no information existed regarding 5’ transcript ends (and, 
by extension, 5’ UTRs), intrinsic termination sites (thus, terminator anti-terminator 
systems), or non-coding RNAs (thus, antisense and sRNA regulatory systems). These 
three transcriptional features have the potential to exert significant regulatory control, as 
is known in other model systems, but most stuides regarding B. burgdorferi biology have 
thus far focused on only a handful regulatory factors that generally control transcriptional 
  75 
initiation. The work described in this chapter as well as the two additional studies described 
below set the stage for a new era of B. burgdorferi biology. 
Immediately following the publication of the work described in the chapter, two 
additional groups published studies using specific approaches aimed at defining either 
transcriptional start sites or small RNAs [4, 243]. While I have not completed a 
comprehensive comparison between the 5’ ends and putative non-coding RNAs identified 
in our data sets, examining several examples of special interest suggested general 
agreement. Not surprisingly both studies, due to their tailored approaches, identified 
significantly greater numbers of each feature (Over 1000 putative small RNAs and over 
2000 5’ transcript ends respectively). 
Rho-independent terminators in E. coli and B. subtillis are composed of G+C rich 
stems followed by poly-U tracts, and their composition may not be strongly conserved in 
B. burgdorferi. For this reason, this method may have substantially underestimated the 
true number of Rho-independent terminations in B. burgdorferi. 
These studies, in total, represent a quantum leap in the study of B. burgdorferi 
biology and gene regulation. They offer a comprehensive resource for those interested in 
where transcripts begin, end, and where previously unknown transcriptional activity exists. 
Future work to integrate these resources would be of tremendous benefit. As these 
resources were all built using effectively the same technology (RNA-Seq), the raw data 
could be combined and a well-defined transcriptome could be constructed using newer 
transcriptome assembly tools [102, 115]. It would be intriguing to investigate operon 
structure more closely and perform a more comprehensive analysis of the 3’ ends of 
transcripts without predicted intrinsic terminators. This work has already served as a 
resource in our lab, and all putative ncRNAs identified have been added to a custom index 
used for transcript quantification in Chapter 6. 
  
Table 5-1 Metrics of RNA-Sequencing of wild-type B. burgdorferi 
Sample Total 
Reads 
Total Reads 
Aligned 
Percent Reads 
Aligned 
Percent 
Ribosomal 
A3 E1 6.07E+06 2.41E+06 72.81 4.78 
A3 E2 1.17E+07 5.09E+06 78.89 2.76 
A3 E3 1.53E+07 6.79E+06 82.42 3.52 
A3 M1 2.57E+06 8.65E+05 56.60 1.44 
A3 M2 4.65E+07 1.31E+07 47.56 0.97 
A3 M3 3.56E+07 1.10E+07 53.62 2.41 
A3 S1 1.72E+07 2.62E+06 24.47 6.41 
A3 S2 1.57E+07 3.31E+06 35.05 8.27 
A3 S3 1.05E+07 2.91E+06 47.32 2.59 
 
Sequencing metrics for each sample including sample name, total reads, total reads aligned to the B31-MI genome, percentage of 
reads aligned to the B31-MI genome, and the percentage of reads mapping to ribosomal RNA loci. 
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Table 5-2 Comparison of predicted transcriptional start sites with previously identified transcriptional start sites 
Gene 5’ End Mapped Citation RNA-Seq 
Early-exponential 
RNA-Seq 
Mid-exponential 
RNA-Seq Stationary 
ospC -20 [86] -21/-21/-19 -21 -16 
secA-sod -100 [87] -100 -100 -100/-27 
bpuR -42 [18] -44 -44 -44 
chbC -42 [88] -24/-25/-28 -29/-41/-46/ -26/-24 
lon-1 -19 [75] Not detected -17 -17 
Bb_0794 -13 [71] Not Detected -13 -13 
bamA -343 [71] Not Detected -348 -348 
 
 
Comparison of genes with previously identified transcriptional start sites that were also identified by RNA-Seq. Columns list the gene, 
the previously identified location, citation for that determination, and RNA-Seq determined sites during early-exponential, mid-
exponential, and stationary phases of growth. For some operons, transcriptional unit identifying algorithms identified different start sites 
from different cultures; in which case, all called start sites are listed. 
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Figure 5-1: Volcano plots of differentially expressed genes across growth phases 
Fold changes between genes were plotted compared to adjusted p-value when comparing 
(A) early-exponential against mid-exponential, (B) mid-exponential against stationary, and 
(C) early-exponential against stationary. Criteria of >2X change in expression and <0.05 
adjusted p-value were used to define significantly changed genes, and are shown on the 
plot with the appropriate limiting lines. Genes which met the criteria and were expressed 
at higher levels in a particular comparison are shown in red and those which were 
expressed at lower levels are shown in blue.  
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Figure 5-2: Histograms of distances of unambiguous 5’ ends from start codon 
Distributions of unambiguously identified 5’ ends compared to their closest start codon in 
(A) Early-exponential, (B) Mid-exponential, and (C) Stationary phases of growth. 
Consistent with other studied bacteria, the largest proportion of 5’ ends cluster within 30-
50bp of the start codon [277]. 
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Figure 5-3: Predicted intrinsic termination sites with transcriptomic support. 
(A) flaB; (B) Bb_0323; and (C) bmpDCAB. Thin red lines indicate transcript abundance 
from the + strand (left to right) and thin blue indicate transcript abundance from the – 
strand (right to left), and are shown above (+) and below (-) the central axis. Genes are 
noted below coverage plots and directionality is indicated by arrows at the ends of genes. 
Relative orientation of genes on the X axis is consistent with RefSeq annotations. 
Coverage per base is given on the Y axis to the left of the plot. Predicted Rho-independent 
terminators are indicated by red boxes on the same plane as the gene annotations and 
directionality is indicated by arrows. Terminators and the associated coverage at their 
location are highlighted by grey boxes.  
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Figure 5-4: Examples of termination events within or upstream of genes 
(A) holA and (B) Bb_0709. Thin red lines indicate transcript abundance from the + strand 
(left to right) and thin blue indicate transcript abundance from the – strand (right to left), 
and are shown above (+) and below (-) the central axis. Genes are noted below coverage 
plots and directionality is indicated by arrows at the ends of genes. Relative orientation of 
genes on the X axis is consistent with RefSeq annotations. Coverage per base is given 
on the Y axis to the left of the plot. Predicted Rho-independent terminators are indicated 
by red boxes on the same plane as the gene annotations and directionality is indicated by 
arrows. Terminators and the associated coverage at their location are highlighted by grey 
boxes.  
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Figure 5-5: Examples of stable non-coding RNAs 
Red lines indicate transcript abundance from the + strand (left to right) and blue indicate 
transcript abundance from the – strand (right to left), and are shown above (+) and below 
(-) the central axis. Genes are noted below coverage plots and directionality is given by 
arrows at the ends of genes. Relative orientation of genes on the X axis is consistent with 
RefSeq annotations. Coverage per base is given on the Y axis to the left of the plot. Neither 
dsrA (E) nor 6S (C) are currently annotated in either GenBank or RFAM. dsrA is shown 
as the longest possible transcript described in [196]. 
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Figure 5-6: Example of newly identified putative noncoding RNAs  
Read coverage histograms newly identified ncRNAs that are intergenic or overlap; rpoN, 
glpF, and ORF Bb_0347. Red lines indicate transcript abundance from the + strand (left 
to right) and blue indicate transcript abundance from the – strand (right to left), and are 
shown above (+) and below (-) the central axis. Genes are noted below coverage plots 
and directionality is given by arrows at the ends of genes. Relative orientation of genes on 
the X axis is consistent with RefSeq annotations. Grey boxes highlight the coordinates 
called for each newly identified transcript. Coverage per base is given on the Y axis to the 
left of the plot. Terminators are indicated by red boxes, and directionality is shown by 
arrows at their ends. 
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Chapter 6 Dissection of key gene regulatory networks in B. burgdorferi 
 
This work has been published: Arnold, W. K., Savage, C. R., Lethbridge, K. G., Smith, T. 
C., 2nd, Brissette, C. A., Seshu, J., & Stevenson, B. (2018). Transcriptomic insights on 
the virulence-controlling CsrA, BadR, RpoN, and RpoS regulatory networks in the Lyme 
disease spirochete. PLOS ONE, 13(8), e0203286. doi:10.1371/journal.pone.0203286 
 
The ∆badR and ∆csrA deletion strains were acquired from Dr. Janakiram Seshu and Dr. 
Trever Smith [165, 210]. Dr. Patricia Rosa and Dr. Frank Gherardini provided the ∆rpoS 
and ∆rpoN [98] strains respectively [98]. Dr. Catherine Brissette and Dr. Robert Gaultney 
performed plasmid content analysis on A3, ∆rpoN, ∆rpoS, ∆csrA, and ∆badR strains. Dr. 
Jonathan Livny and Jessica Alexander prepared and sequenced RNAtag-Seq libraries. 
Christina Savage performed qRT-PCR validation of the sequencing results. 
 
Introduction 
The comparison of experimental findings related to gene regulation in B. 
burgdorferi from disparate groups, or even the same group over time, has been 
confounded by variations in experimental design, including choice of strain background or 
media composition. Strain background appears to significantly affect gene expression and 
response to a stimulus, including the basal and induced expression of key virulence 
factors, such as OspC [202, 340, 342]. Similarly, culture media composition is also known 
to strongly affect cultured B. burgdorferi’s response to environmental stimuli, specifically 
temperature and pH shifts [315, 327, 345]. It comes as no surprise then, that different 
groups, using different strains, in different culture conditions, using different technologies, 
would come to contradictory or uncorrelated results [46, 49, 99, 127, 147, 230, 255, 256].  
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In the decades following the discovery of B. burgdorferi, a number of regulatory 
factors essential for vertebrate infection, including alternative sigma factors and nucleic 
acid binding proteins, have been discovered. CsrA is an RNA binding protein, well studied 
in other bacteria, and is essential for B. burgdorferi pathogenesis and also seems to 
directly regulate genes involved in motility. BadR is a carbohydrate and DNA binding 
protein that has been shown to regulate >200 genes [210]. Two alternative sigma factors, 
RpoN and RpoS, have been previously proposed to form a linear cascade, in which RpoN 
allows the transcription of rpoS, which allows recognition of select promoters by RNAP to 
transcribe a regulon important for transmission and infection. 
In the previous chapter, I utilized RNA-Seq to provide deeper insight into the B. 
burgdorferi transcriptome and to shed light on novel potential regulatory mechanisms. In 
this chapter, I use the same technology to examine how the regulons of four essential 
regulatory factors; CsrA, RpoS, RpoN, and BadR interact with and overlap one another to 
better understand the structure of regulatory networks that allow vertebrate adaptation. I 
made a number of important observations in that regard. I supported the hypothesis that 
the CsrA and BadR regulons share substantial overlap in their identity and direction of 
impacted transcripts but do not appear regulate one another. Further, I provide evidence 
refuting several hypotheses regarding sigma factor selectivity. Importantly, and in the 
same vein of study as the previously described flaB variability (Chapter 5), I provide 
evidence that plasmid maintenance in B. burgdorferi is also a dynamic process. Gene 
regulatory studies that examine population-level statistics should consider the described 
data in the future. 
CsrA impacts the expression of a substantial number of genes involved in 
virulence and cell physiology 
CsrA (Carbon storage regulator A) is well known in other systems to regulate 
diverse cellular processes including virulence through its RNA binding activity. While not 
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as extensively studied in B. burgdorferi, previous studies have provided significant 
evidence that CsrA is important for the life cycle of the organism [163, 266, 307]. In B. 
burgdorferi, CsrA appears to regulate a number of important virulence-associated 
lipoproteins, binds RNAs of motility-associated genes, and is essential for the vertebrate 
stage of infection [165, 266, 307, 308]. To further delineate the role of CsrA in the biology 
of B. burgdorferi, we examined the transcriptomes of bacteria that harbored deletions of 
the csrA locus.  
The deletion of csrA caused dysregulation in 239 transcripts, with 153 expressed 
at lower levels and 86 expressed at higher abundance (Fig. 6-1A and Appendix Table 8-
9). The majority of these DE transcripts were composed of mRNAs encoding ORFs and 
were plasmid encoded. Of key note, the deletion of csrA had no impact on the expression 
of the three other regulatory factors under examination in this chapter (ie rpoN, rpoS, or 
badR). The known or proposed functions for the differentially expressed (DE) ORFs 
include those involved in both infection and housekeeping functions. The deletion of csrA 
negatively affected the expression of several genes encoding proteins associated with 
transmission from ticks and survival within the vertebrate host; including ospC, dbpB (Fig 
6-2), vlsE, and arp [142, 202, 257, 279, 314]. This downregulation could be a direct result 
of CsrA inducing their expression when present, or through an effect on a secondary 
regulator.  
Metabolic adaptation of pathogens to their particular hosts is becoming 
increasingly well known to play a major role in virulence [95, 192, 236, 288]. The 
expression of transcripts encoding several key nutrient scavenging enzymes, including 
those known to be important for vertebrate colonization, were positively affected by the 
deletion of csrA. Specifically, those genes involved in purine scavenging (guaA and 
BB_B23) and glucose transport (BB_B29) were all expressed at higher levels in the csrA 
mutant when compared to wildtype. It is interesting to note that, while surface factors that 
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are known to play a role in vertebrate colonization are expressed at lower levels in the 
mutant, transcripts encoding proteins important for metabolic adaptation are expressed at 
higher levels.  
While I have not performed a comprehensive GO-Term or pathway enrichment 
analysis for the affected ORFs, the data generally support the hypothesis that CsrA acts 
to regulate vertebrate adaptation by regulating, directly or indirectly, surface lipoproteins 
and metabolic genes. Of key importance is that the deletion did not affect the expression 
of either rpoS or rpoN, the hypothesized gatekeepers of vertebrate adaptation (Fig. 6-2). 
This suggests that there are alternative mechanisms beyond these two alternative sigma 
factors that help adapt B. burgdorferi to its respective niche. 
BadR regulates the expression of genes and involved in metabolism and virulence 
Previous work has demonstrated that the deletion of badR results in large changes 
in several hundred transcripts as measured by microarray [210]. A number of these 
transcripts encode proteins involved in the uptake of metabolites from extracellular milieu. 
Under the growth conditions I examined, a total of 235 transcripts that were differentially 
expressed (DE) by the deletion of badR (Fig 6-1B and Appendix Table 8-8). Of these 135 
transcripts were decreased in expression and 100 were increased in expression. Similar 
to the findings from the ∆csrA strain, a significant fraction of the affected transcripts was 
composed of newly identified small ncRNAs identified in Chapter 5. As noted for the csrA 
mutant, the badR mutant did not affect the expression of csrA, nor any of the other 
examined regulatory factors. Transcripts that were affect by both badR or csrA will be 
discussed in further detail in a later section; the remainder of this section will focus on 
transcripts affected only by badR. 
Several transcripts encoding genes associated with second messenger signaling 
were also affected by the deletion. A single cyclic-di-AMP synthase, CdaA [268], has been 
identified in B. burgdorferi, and the expression of its transcript was significantly reduced 
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(2.15 times) in the badR mutant. Furthermore, the gene encoding one of the few potential 
cyclic-di-AMP binding proteins, cabP [268], was also reduced in expression. Intriguingly, 
the phosphodiesterase responsible for the degradation of c-di-AMP was unaffected. 
These findings are consistent previous work highlighting the complexity of synthesis, 
signaling, and degradation of the c-di-AMP regulatory network [268, 348] in B. burgdorferi. 
c-di-AMP is essential for viability for B. burgdorferi, but little else of its role in the physiology 
of the organism is understood [348].   
Glycerol is a key carbohydrate essential for maximum fitness during tick 
colonization [237]. The operon encoding the genes important for this function, glpFKD, is 
regulated by a number of proteins and signaling molecules including SpoVG, RpoS, 
(p)ppGpp, and cyclic-di-GMP [38, 46, 120, 269]. This operon also appears to be regulated 
by BadR. In the mutant badR strain, all four genes, glpFKD and an ORF of unknown 
function, were significantly upregulated. An antisense RNA to glpF, ncRNA0042, was 
down regulated (-3.6 times). A reasonable hypothesis is that BadR or a BadR-regulated 
trans-acting factor regulates the transcription of ncRNA0042 (the anti-glpF sRNA), which 
then negatively regulates transcription from the glpFKD operon. This asRNA could also 
have effects on the translation or stability of existing glpFKD transcripts in the cell, but 
significant additional study outside the scope of this work is required to support this 
hypothesis. 
Of substantial note, while a previous study had demonstrated a role for BadR in 
the regulation of rpoS using transcriptional profiling of this same badR mutant and DNA 
binding assays of recombinant BadR [211], I found no such impact. Neither rpoS, nor any 
of its known regulators (dsrA, hfq, bosR, or rpoN) [11, 98, 141, 195, 231, 283], were 
affected by the deletion in badR in this study. I will elaborate on possible explanations for 
this inconsistency in this chapters’ discussion. 
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The CsrA and BadR regulons share substantial overlap 
As described above, the primary focus of this study was to better define how the 
regulons of four important regulatory factors (CsrA, BadR, RpoS, and RpoN) intersect and 
diverge with one another. None of the factors described in this work appeared to regulate 
one another in our conditions. Transcriptomic studies of ∆rpoN and ∆rpoS strains 
previously indicated that both factors affected the expression of several hundred genes. I 
was not able to recapitulate those findings in my current study. The transcription of several 
genes (ospC and dbpBA) has been described as absolutely dependent on the activity of 
RpoS or RpoN [92]. This work, and the work of others [59], unequivocally demonstrates 
that such assumptions are unsubstantiated. I will further describe these findings in the 
following section and for the moment focus exclusively on the substantial overlaps 
between the BadR and CsrA regulons. 
Overlap analysis indicated that the BadR and CsrA regulons dually regulate 150 
transcripts under the examined conditions. Of these, 81 transcripts were expressed in 
lower amounts in both mutants and 66 were expressed more highly in both. The remaining 
3 transcripts were affected in opposite directions. In total, 98% of transcripts that were DE 
in both mutants were DE in the same direction. When combined with the fact that neither 
factor affected one another, these data suggest that, when the BadR and CsrA regulons 
overlap, they generate a nearly identical transcriptomic program. It is impossible to discern 
how much of this similarity is due to each factor acting independently on the same targets 
or by converging on a single, other, trans-acting factor without additional study. One trans-
acting factor in particular, however, emerges as a potential candidate. 
Both BadR and CsrA mutants affected the abundance of a transcript encoding a nucleic 
acid binding global regulatory factor titled SpoVG [41, 156, 269]. The transcript encoding 
SpoVG was increased 3 times in the badR mutant and 2.3 times in  the csrA mutant. 
SpoVG binds both DNA and RNA and affects the expression of multiple house-keeping 
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and virulence associated proteins in B. burgdorferi. Studies are still ongoing in the 
Stevenson lab to critically evaluate the scope of SpoVG’s role in the life cycle of B. 
burgdorferi, but early indications suggest it plays a critical role in regulating the physiology 
of the cell [269]. 
Cell wall synthesis appears to be a significant point of dual regulation.  Mutations 
in badR were previously shown to have a significant effect on the expression of genes 
involved in chitobiose uptake and utilization [210]. That observation was mirrored in this 
study. In fact, the genes composing the chitobiose operon represented three of the most 
highly upregulated transcripts in this experiment (chbCAB was upregulated between 35-
65 times). Deletion of csrA had a similar, though less profound, effect, with an 2.8-5.2 
times induction. Chitobiose is a dimer of N-acetylglucosomine, which can be used as an 
energy source but is also required for the synthesis of peptidoglycan utilized in newly 
synthesized cell walls [111]. Chitobiose has been proposed to be the other major nutrient, 
glycerol being the predominant nutrient, during utilized during tick colonization as chitin 
and chitobiose derived from tick cuticle are present in substantial amounts in the midgut 
[252, 309, 312, 313]. NanE is an epimerase that converts N-acetylglucosamine-6-
phoshpate into GlcNAc-6P, and its transcript was increased in both mutants. Finally, MurG 
is a key enzyme involved in the formation the cell wall, transferring GlcNAc moieties from 
lipid intermediate I to lipid intermediate II. The transcript encoding this enzyme was 
biologically and statistically increased by 3 times and 2.6 times in badR and csrA mutants, 
respectively.  
Carbohydrate-utilization pathways and other host associated metabolic pathways 
were also impacted by both mutations. These included increased levels of transcripts 
encoding the putative sugar transporter IIABC component (BB_408) (2.5X and 2.8X, 
respectively) and a subunit of another putative carbohydrate ABC transporter (BB_0678) 
(2.2 foldand 2.9 times, respectively). Polyamines are cationic, organic bases that are 
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present at significant levels within vertebrate hosts and can affect a wide variety of 
biological processes, including those involved in stress and osmotic responses [275]. In 
B. burgdorferi, the polyamines spermine and sperimidine are important for bacterial growth 
control and expression of vertebrate associated proteins. Polyamines can be transported 
by the PotABCD transporter or produced de novo from arginine. B. burgdorferi seems to 
encode part of the arginine deaminase pathway, consisting of the enzymes ArcA, which 
converts arginine to citrulline, and ArcB, which converts citrulline to ornithine and 
carbamoyl-phosphate [101, 187]. Both badR and csrA mutants exhibited increased 
expression of arcA (9.2 times and 2 times, respectively), arcB (6.7 times and 2.2 times, 
respectively), and potD (2.1 times and 2.3 times, respectively). 
Key virulence genes are expressed independently of RpoS and RpoN 
I did not detect significant changes in the transcriptomes of bacteria mutated in 
either of the genes encoding the alternative sigma factors rpoN or rpoS (Fig. 6-1CD). While 
this certainly hindered any ability to make inferences regarding the structure of these two 
regulons in the context of mutations in csrA and badR, it did provide substantial evidence 
arguing against the long-standing hypothesis that RpoN and RpoS constitute a regulatory 
cascade in which RpoN directs the transcription of rpoS, which goes on to transcribe a 
vast regulon, suggested to include >400 genes [48, 147, 284]! It has been previously 
reported that RpoS is absolutely essential for the transcription of several essential 
transmission and vertebrate specific factors, namely ospC and dbpBA. I found, in these 
specific conditions, that the deletion of rpoS or rpoN had no impact on the expression of 
these genes (Appendix Table 8-7 and Appendix Table 8-6). Additionally, I found that the 
expression of rpoS was not impacted by the loss of RpoN in these conditions, suggesting 
that, in this particular case, rpoS is transcribed via a previously-described, housekeeping, 
RpoD-dependent promoter [197]. When I examined read mapping near the 5’ portion of 
the rpoS locus, I found additional support for this hypothesis (Figure 6-7). I found no 
  
 
92 
obvious difference between reads mapped spanning the rpoS promoter in the ∆rpoN strain 
compared to wild-type, suggesting that, in both strains, rpoS is transcribed from the RpoD-
type promoter. 
Discussion 
This work represents the first comprehensive transcriptomic examination of more 
than two of B. burgdorferi’s essential regulatory factors ever undertaken in the same study 
and is also the first to examine the role of these essential factors in the regulation of small 
ncRNAs in B. burgdorferi. I provide evidence in support of, and against, several important 
hypotheses: first that the essential regulatory factors in B. burgdorferi regulate some 
genes together and some genes separately; second, that genes essential for vertebrate 
infection are regulated independently of the alternative sigma factors RpoN and RpoS. I 
find it likely that the uniform effect is mediated, at least in part, by SpoVG. If this hypothesis 
were true, absent any other confounding variables and in the simplest case, I would expect 
the DE changes to be more apparent in the BadR mutant, as it had a larger fold increase 
in spoVG. While some transcripts follow this pattern (chbABC and murG), others do not. 
These findings suggest a more complicated scenario in which some of the effects of 
SpoVG are moderated or enhanced these two factors acting directly or indirectly, by other 
regulators acting at each specific locus.  
In general, these data are consistent with an increase in cellular growth 
necessitating an enhanced internalization of  nutrients and flux through carbon metabolism 
and an increase in production of peptidoglycan and its precursor metabolites. These 
findings are consistent with the previously described patterns of expression for CsrA and 
BadR as well as the well characterized defects in infectivity [165, 210, 233, 266, 307]. 
A significant limitation of this work is that the studies were performed on cultured 
bacteria at a single culture condition. As discussed in significant detail in previous 
chapters, B. burgdorferi is exquisitely sensitive to changes in environmental conditions 
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and alters gene regulatory networks in response to numerous, sometimes relatively 
innocuous, conditions. Additional conditions, be they growing bacteria at elevated 
temperatures, decreased pH, elevated or decreased osmolarity, or real-world 
environmental cues experienced during the enzootic cycle would all be informative. 
Currently, transcriptomics of in vivo derived spirochetes remains a challenge due to the 
extremely low burdens present in both tick and vertebrate hosts. Previous work has used 
a variety of approaches including whole transcriptome amplification [146] and the 
examination of spirochetes concentrated in dialysis membrane chambers (DMC’s) 
implanted in rat peritoneal cavities [50]. While both of these approaches have provided 
additional insight into the transcriptomes of bacteria during in vivo or in vivo-like conditions, 
they come with significant limitations. Whole transcriptome amplification can introduce 
biases in transcript abundance, particularly in poorly expressed transcripts [97]. While the 
only study describing such a procedure found generally good agreement between 
amplified and unamplified control samples, only 70% of transcripts encoding ORFs were 
measured as expressed above background in both condition [146]. DMCs allow the free 
exchange of small metabolites and signaling molecules (<5 KDa), but do not allow for the 
spirochetes to physically interact with their surroundings [7, 45]. Considering the large 
number of lipoproteins encoded in the B. burgdorferi genome and its well-established 
propensity to interact with host factors [35-37, 51, 53, 224, 323, 349], this condition does 
not fully replicate the true in vivo state within a vertebrate host.  
Considering all these limitations, I chose an approach that would provide insight in 
a method which could be quickly and reproducibly accomplished in standard conditions. 
While these conditions may not be fully representative of the enzootic cycle, gene 
regulatory networks can be dissected independently of the natural stimuli. My hope is that 
this work, along with other recent transcriptomic studies of B. burgdorferi [59] will provide 
the early foundational data for establishment of B. burgdorferi specific databases in the 
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same tradition as RegulonDB for E. coli, FlyBase for Drosophila melongaster, and 
WormBase for Caenorhabditis elegans. 
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Figure 6-1: Differentially expressed transcripts B. burgdorferi mutants examined in 
this study 
(A) csrA, (B) badR, (C) rpoS, and (D) rpoN mutants compared to the cognate wild-type 
strain. RNA was isolated, Illumina cDNA libraries were prepared, and sequenced [14] as 
described previously. Reads were mapped to the B. burgdorferi genome, counted using 
Salmon and tested for differential expression using DESeq2 [194] in R [1]. 
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Figure 6-2: Expression of select transcripts in ∆csrA mutant and wild-type B. 
burgdorferi 
Read counts for select transcripts were extracted from the library size normalized data 
set, log2 transformed, and plotted from wild-type and ∆csrA B. burgdorferi samples. 
Replicate samples are plotted together. 
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Figure 6-3: Expression of the glpFKD operon in a ∆badR mutant 
Read counts from the glpFKD operon and the anti-glpF small ncRNA (ncRNA0042) were 
extracted from the library size normalized data set, log2 transformed, and plotted in ∆badR 
mutant and wild-type B. burgdorferi. 
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Figure 6-4: Expression of select transcripts in ∆badR mutant and wild-type B. 
burgdorferi 
Read counts for select transcripts were extracted from the library size normalized data 
set, log2 transformed, and plotted from wild-type and ∆csrA B. burgdorferi samples. 
Replicate samples are plotted together. 
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Figure 6-5: Set analysis of differentially expressed gene sets  
The differentially expressed transcripts from each of the mutant to wild-type were 
compared for any overlap in identity using the UpsetR package [73]. Affected transcript 
sets were first filtered by higher or lower abundance to create 8 possible sets (four 
regulators, at higher or lower abundance). The lower left horizontal bars indicate the total 
size of a given set. The central, main bar plot indicates the size of the overlapping set, and 
the identity of the intersecting sets is indicated by the variously connected or separate dots 
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below. A line connecting darkened dots indicates the two sets of differentially expressed 
transcripts contain shared transcripts. Empty sets are not shown.  
  
  
 
101 
 
 
Figure 6-6: Expression of transcripts encoding proteins involved in chitobiose 
metabolism affected in ∆badR and ∆csrA mutants.  
Read counts for transcripts derived from the chitobiose operon were extracted from the 
library size normalized data sets, log2 transformed, and plotted from ∆csrA, ∆badR, and 
wild-type B. burgdorferi samples. Replicate samples are plotted together. 
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Figure 6-7: Promoter utilization of rpoS in an ∆rpoN mutant  
Read coverage histograms of rpoS locus and upstream genomic region in wild-type and 
∆rpoN strains. Abundance plots represent the merged normalized expression from three, 
independent biological replicates. Blue lines indicate relative transcript abundance from 
left to right (the coding strand of flgI, flgJ and rpoS) and red lines indicate relative transcript 
abundance from the opposite strand (right to left), and reside above (+) and below (-) the 
central axis. Open reading frames are indicated below coverage plots, and the direction 
of transcription is given by arrows at the ends of genes. Normalized read coverage of each 
strand is given as RPKMO (reads per kb of gene per million reads aligning to annotated 
ORFs) is given on Y-axis on the left. The RpoN- and RpoD-dependent transcriptional start 
sites were previously identified [3, 196, 265].  
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Chapter 7 Discussion 
 
Summary 
B. burgdorferi is the most common vector-borne pathogen in large swaths of the 
world and causes disease in both humans and animals of human concern [296]. The 
global distribution of disease is widespread and incidence continues to rise year over year 
[206]. B. burgdorferi was established early on as a model of vector borne disease, offering 
insight into other arthropod transmitted pathogens. Since then, it has also served well as 
a model of other pathogens and microbial physiology more generally [16, 75, 156, 254]. It 
has become evident that pathogenic bacteria, including B. burgdorferi, alter gene 
regulatory patterns during different stages of their life cycles. The Stevenson lab 
demonstrated in 2013 that some of these gene regulatory changes in B. burgdorferi are, 
in part, mediated by sensing changes in rates of cellular growth [157].  
Combined with this new perspective on previous data in the field, members of the 
Stevenson lab have become interested in investigating if B. burgdorferi directly senses its 
own growth rate and if so, defining the gene regulatory mechanisms that allow the cell to 
adapt to its changing environments. My studies investigate two general themes in this line 
of study. In Chapters 3 and 4, I better define the role of a metabolically entangled signaling 
molecule in vertebrate infection and test the hypothesis that a conserved nucleic-acid 
binding protein, BpuR, is directly controlled by cellular growth rates. In Chapter 5 and 6, I 
focused on a broader understanding of B. burgdorferi gene regulation as it relates to niche 
adaptation. I accomplish this by defining new potential gene regulatory mechanisms 
(sRNAs, extended 5’ UTRs, and intrinsic terminators) and testing hypotheses related to 
the complexity and connectivity of gene regulatory networks important for vertebrate 
adaptation. 
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Growth control 
All living things are defined by a drive to replicate and transmit their genetic 
information. At their very core, all living things do this through the increase in number and 
size of living units, i.e. individual cells. Bacterial cells have served to better understand 
basic cellular processes related to these drives. To quote the late Stanley Falkow, “‘the 
goal of a bacterium is to become bacteria” [219]. This goal is complicated by the fact that 
nutrients, and thus energy, available to a given cell are a finite resource, and so a cell 
must actively control how much energy it expends in order to survive. These decisions are 
at the very core of my studies in that I sought to better understand how B. burgdorferi 
makes the decision to grow or not grow, and how that decision is relayed into physiologic 
adaptation to environments it occupies.  
Nutritional control of cell size 
Sixty years ago, Schaechter, Maaløe and Kjeldgaard first observed a linear 
relationship between growth rate and cell size in Salmonella enterica Typhimirium [270] 
demonstrating that growth rate, rather than culture media composition, was responsible 
for differences in cell size. Since then, the study of cell size control and the so called 
“Growth Law” has remained active [65, 311, 319, 320, 328, 335, 337], yet conserved 
molecular mechanisms underlying this phenomenon are still not well understood. 
Furthermore, while some themes appear to be conserved across the bacterial kingdom, 
significant differences exist. In the case of E. coli and B. subtillis, two unique proteins, 
OpgH [131] and UgtP [66, 335], respectively, sense UDP-Glucose and tie it to the ability 
of the division ring protein FtsZ to oligomerize and function in cell division.  
To the best of my knowledge, no comprehensive study of B. burgdorferi’s 
adherence to the “growth law” has been undertaken, but anecdotal evidence in my own 
studies suggest that it does: rapidly growing cells in rich media are generally short, while 
those in in slow growth conditions, nutrient or temperature induced, are more extended in 
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physical length. Without quantitative, single-celled, phenotypic data from well-controlled 
studies, it is impossible to say at this time if the “growth law” is truly observed by B. 
burgdorferi. With that said, there is preliminary evidence that B. burgdorferi does 
coordinate cell size with division, with longer cells containing greater numbers division 
sites than shorter cells [159]. As noted above regarding glucose metabolism, while many 
bacteria appear to have a mechanism tying nutritional status to cell size, the exact 
molecular mechanisms appear to be more divergent. For example, B. burgdorferi does 
not encode recognizable homologues to either OpgH or UgtP; thus, if it ties cell size control 
to nutrient status, it does so in some other way.  
Nutritional control of DNA replication 
A key criterion for increases in cell size or increases in rates of division is the 
control of the rate of DNA synthesis. Any cell that divides without a complete complement 
of the genome is unlikely to survive to divide again. It should come as no surprise then, 
that the master regulator of DNA replication in most bacteria, DnaA, is often intimately tied 
to cell division and nutritional status of diverse bacterial species [114, 117, 181, 222]. 
Control of all aspects of growth and division must be intimately tied to available levels of 
nutrients. In conditions where nutrients are limiting, cells must actively adapt, often by 
slowing or ceasing growth in order to survive. In conditions where nutrients are abundant, 
it behooves the cell to grow and divide as rapidly as possible so as to best spread its 
genetic material. This is of critical importance in relation to the regulation of DNA synthesis. 
In most bacteria, initiation of chromosomal replication is a once per cell cycle event, and 
cells that commit to the initiation of DNA replication must complete synthesis and division 
or they may not survive. Cells have thus evolved elaborate mechanisms to ensure the 
process can actually be completed prior to initiation.  
DnaA is a DNA binding protein with a AAA+ ATPase domain and is the master 
regulator of DNA replication [162]. The function of DnaA is regulated at numerous steps, 
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including transcription and translation, and its activity is tightly coupled to cellular 
ATP/ADP ratios [64, 69, 71, 106, 113, 134, 152, 166, 168, 170, 179-181, 208, 248, 260, 
261, 282, 289]. DnaA levels are also controlled by proteolysis during adverse conditions. 
In Caulobacter crescentus, DnaA is a substrate for Lon protease, and, during periods of 
carbohydrate starvation, translation of DnaA is slowed while proteolysis remains steady. 
This results in an overall decrease in DnaA levels during adverse conditions and facilitates 
growth arrest during carbohydrate limitation. Recent work suggests that Lon does not 
target DnaA through the unfolded protein response, but instead recognizes native DnaA; 
this degradation is thought to potentially be dependent on the nucleotide bound state 
[188].  
Growth and virulence 
The key difference between pathogenic and commensal microbes is the causation 
of damage, which we call disease [55]. Commensal or mutualistic microorganisms have 
established a balance with their host, which allows them to grow, divide, and colonize new 
hosts without causing disease. Pathogenic bacteria, on the other hand, are those that 
occupy a host, or inappropriate part of an otherwise normal host, with which they have not 
evolved to appropriately coexist, or they may be an obligate parasite of that host organism. 
If a microbe is unable to grow, divide, and spread, generally, it cannot cause disease. 
Much work has focused on the regulation, mechanism, and effects of so called “virulence 
factors” without placing them in to the larger context of bacterial physiology. It should be 
clear by the end of this work that I feel a new paradigm is emerging. If bacteria intend to 
expand their numbers, and some bacteria do this through mechanisms which cause harm 
to other organisms, it would seem eminently reasonable that they may tie growth and 
division to the regulation of these virulence factors.  
Many bacteria have evolved mechanisms to persist when challenged with stressful 
conditions, such as starvation or host immune pressures [110, 130]. Most study in this 
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regard has focused on host factors or antimicrobial therapies as the cause of such 
conditions. There exist numerous examples of pathogenic bacteria which have evolved 
elaborate mechanisms to survive within their respective hosts. Mycobacterium 
tuberculosis [110] and S. enterica survive for extended periods within host macrophages 
[109]. Spore-forming pathogens, such as Bacillus anthracis and several species in the 
genus Clostridium, have evolved elaborate life stages that produce environmentally 
stable, metabolically inactive structures called endospores, which allow them to persist in 
extended, nutrient poor conditions [105, 130, 150]. When these spores enter a more 
favorable environment, they interconvert back into vegetative cells capable of division and 
growth. Similar processes are apparent in pathogenic Chlamydia, which survive through 
developmental interconversion between reticulate and elementary bodies, which are 
metabolically active and inactive forms, respectively [2].   
B. burgdorferi has also evolved mechanisms to survive extended periods of stress 
through apparent decreases in replicative or metabolic activity [38, 76, 242]. B. 
burgdorferi’s lifestyle has required the evolution of slow growth states outside of the 
vertebrate/tick host. I specifically choose to not refer to this adaptation as “persistence,”” 
as the term is closely associated with specific adaptations of certain bacterial species to 
stochastically enter a physiologic state resistant to antibiotic therapy [182]. To date, there 
exists no convincing data that B. burgdorferi enters such a state. During colonization of 
the tick midgut, B. burgdorferi transitions into a quiescent-like state, in which it does not 
undergo significant expansions in number and exhibits reduced motility [88, 242]. This is 
not surprising, given what is known regarding the nutrient content of Ixodes spp. tick 
midguts. Specifically, following digestion of the blood meal, the midgut is dominated by 
high levels of glycerol, an energy poor carbohydrate [111, 237]. As described in earlier 
chapters, concomitant with ticks’ ingestion of a blood meal, B. burgdorferi cells undergo a 
burst of replication, facilitating their transmission to and colonization of the vertebrate host. 
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Exact molecular mechanisms underlying this rapid and drastic alteration in behavior are 
not yet clear, but they are likely related to a combined increase in temperature, nutrient 
availability, and the presence or absence of specific vertebrate or tick factors. The 
mechanisms by which B. burgdorferi ties this enhancement of growth rate to the induction 
of vertebrate specific factors [157] and repression of tick-specific ones is still unclear, but 
the studies contained herein begin to shed some light on these processes. 
B. burgdorferi metabolism in context 
In these studies, with the support of my colleagues, I begin to elucidate how these 
processes are interconnected. I demonstrated that the metabolically intertwined signaling 
molecule AI-2 is essential for maximal fitness within the vertebrate host, and that the 
master regulator of DNA replication, DnaA, is associated with the expression of the nucleic 
acid binding protein BpuR. While they may appear disparate, these processes are 
intimately intertwined. During DNA replication, the newly synthesized strand of DNA must 
be methylated to ensure it is not cleaved by bacterial restriction systems [282, 338]. During 
periods of rapid DNA replication, flux through the LuxS enzyme would likely be increased 
due to this presumed elevated number of methylation reactions, and thus AI-2 abundance 
should be elevated. As previous work from the Stevenson lab has demonstrated, addition 
of AI-2 to B. burgdorferi cells results in enhanced production of several key vertebrate-
associated factors, and AI-2 reaches peak production during exponential growth [17, 253]. 
During these same periods of rapid DNA replication, I likewise expect there to be an 
increase in levels of cellular DnaA. These high levels of DnaA could result in a higher 
occupancy of the protein at its binding sites, including the bpuR promoter. While I have 
not provided evidence that the occupancy of DnaA at this location has an effect on 
transcription or gene expression, significant precedent exists for this hypothesis [133, 134, 
209, 285, 289, 306, 332]. 
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As with any academic work, much remains to be done to better understand these 
systems. As described in Chapter 3, AI-2 has significant impacts on the B. burgdorferi 
proteome and the expression of some important proteins (ErpA/I/N and VlsE) [17, 297]. 
No obvious homologues for the first discovered AI-2 sensing networks, such as those 
found in V. cholerae and Pseudomonas aeruginosa [259], are encoded by the B. 
burgdorferi genome. In Chapter 3, I elaborated upon some potential candidates for AI-2 
sensors. These included both a ribose ABC-type transporter system and a carbohydrate-
responsive DNA-binding protein. Ribose-importing ABC-type transporters have been 
previously shown to play a role in AI-2 intake in S. enterica Typhimurium and E. coli [310, 
341]. The ribose transporter RbsB has been experimentally demonstrated to bind AI-2 in 
Actinobacillus actinomycetemocomitans and has a role in the uptake of AI-2 and biofilm 
phenotypes of Haemophilus influenzae [12, 149]. B. burgdorferi encodes some 
components of a putative ribose ABC-transporter system (Rbs), but no identifiable 
homologues of the actual ribose binding protein, RbsB, are obvious. It is possible that this 
represents an orphan system that is in the process of being lost during evolution, or the 
ribose binding component of the system may be significantly divergent from established 
homologues. Studies using labeled ribose or AI-2 in the context of the deletion of 
components of these systems would provide insight into the activity of the Rbs system in 
B. burgdorferi. Follow-up experiments in the same vein as those described in Babb et al. 
[17] and Stevenson and Babb [297] in these newly constructed Rbs mutants would further 
test if the system is both active for AI-2 uptake and/or mediates the sensing of that AI-2.  
Even if an AI-2 binding or importing protein were to be identified, how AI-2 is then 
sensed is also an open question. One potential mechanism to explain the signal 
transduction is through the carbohydrate responsive DNA binding protein BadR. B. 
burgdorferi possess two proteins annotated as xylose responsive repressor type proteins, 
XylR-1 and XylR-2 [101]. Upon closer study it became apparent that B. burgdorferi cannot 
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metabolize xylose [326] raising questions about its true function. XylR-1 was eventually 
retitled BadR and found to play a significant role in B. burgdorferi gene regulation, 
including repressing the transcription of the alternative sigma factor rpoS. Intriguingly, 
coincubation of BadR with Ribose-5P blocked its ability to interact with rpoS DNA in 
EMSAs. In some model organisms, AI-2, once internalized, is phosphorylated [341]. 
Ribose-5-phosphate and AI-2 are structurally similar molecules, and detailed X-ray 
crystallographic studies show that one protein encoded in the LuxR-responsive lsr operon, 
LsrF, bind can bind ribose-5-phosphate in the same pocket as phospho-AI-2 [81]. 
Therefore, there exists precedent that proteins that can bind Ribose-5-phosphate can also 
bind phospho-AI-2 molecules.  
This model would be consistent with the observed data in B. burgdorferi: 
specifically, that AI-2 is produced most highly during periods of rapid growth. In this 
potential model, when AI-2 is produced at higher levels, it would increasingly bind BadR 
and inhibit its ability to bind target DNA sites to repress their transcription. In this scenario, 
the ability of BadR to repress rpoS transcription would be inhibited. rpoS is most highly 
transcribed during periods of transition to rapid growth. This coincides with the high-level 
production of AI-2 and the induction of the gene regulatory program utilized to transmit 
and colonize the vertebrate host, which is controlled partly by RpoS. Similarly, to the above 
described future experiments, one could test if labeled AI-2 is bound by BadR and if AI-2 
or phospho-AI-2 interferes with the ability of BadR to bind target DNA. A significant caveat 
to this model is that no obvious homologues to the LsrK kinase known to phosphorylate 
AI-2 are encoded in the B.  burgdorferi genome. 
As I hope I have made clear, physiologic processes are regulated by numerous 
inputs, and, while AI-2 signaling appears to play a significant role in adapting B. burgdorferi 
to its vertebrate host, it is only one component of this process. DNA replication is one of 
the points of signal integration in which bacteria make major physiologic decisions. As 
  
 
111 
described above, DnaA is the master regulator of DNA replication initiation in almost all 
bacteria [282]. DnaA is a multi-domain enzyme with and is composed of a DNA-binding 
domain, an oligomerization domain, a Walker-type ATPase domain, and a domain with a 
yet unknown role [107]. Prior to this work, the B. burgdorferi homologue of DnaA had not 
been directly studied beyond bioinformatic attempts to identify its potential binding sites 
within the origin of replication [239, 240].  
While the work described in the Chapter 4 provides substantial new data regarding 
DnaA’s potential role in B. burgdorferi gene regulation, the larger questions surrounding 
its biogenesis and activity during the course of the enzootic cycle remain completely 
unanswered. Intriguing questions exist regarding how DnaA is made, in what quantities, 
and in what form over the course of this bacterium’s life. As indicated earlier, the B. 
burgdorferi oriC had been previously investigated with the primary goal of understanding 
the location at which DNA begins replication. This location was identified experimentally 
for the main linear chromosome and computationally for the other genetic elements. At 
the location of initiation of the main linear chromosome no canonical DnaA binding sites 
(DnaA boxes, TTAT(C/A)CA(C/A)A)) were identified by sequence analysis but several 
degenerate repeated sequences ((A/T)A(A/C)(A/C)TACAA) were present [239, 240].  
While this degenerate site is present in numerous copies throughout the genome, 
it is not conserved at the DnaA binding region I identified in the bpuR promoter. I identified 
one additional binding site for DnaA in the B. burgdorferi genome by EMSA that includes 
the promoter elements for the dnaX gene. DnaX encodes the gamma and tau subunits of 
DNA polymerase [153]. Motif analysis of the sequences known validated B. burgdorferi 
DnaA binding sites (oriC, bpuRp, and dnaXp) do not share any obvious significant shared 
motifs. There are a number of potential explanations for this observation. As has been 
described previously, the binding site for DnaA differs depending upon its ATP versus 
ADP bound state [290]. Thus, DnaA can vary its DNA binding targets depending on both 
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cellular ATP/ADP ratios as well as the rate of replication, as DnaA-ATP is converted to 
DnaA-ADP following initiation of replication (regulatory inactivation of DnaA or RIDA) 
[166]. Considering our data demonstrating that bpuR expression is high during slow 
growth and very low during vertebrate infection, and previous data demonstrating the 
dnaX is most highly expressed during periods of rapid growth [153], it is possible that the 
DnaA binding site, and any outcome on gene expression, is different in these two 
locations. This biphasic model does not fully explain why neither of these sites share a 
motif with oriC. It is possible that difficulty in identifying these sites is compounded by the 
small sample size of known sites. It is worth noting that the previously mentioned 
sequence identified in the oriC is not present in potential replication origins on non-
chromosomal elements [239, 240]. 
In Chapter 4, I proposed a model wherein DnaA-ATP binds the bpuR promoter 
and interferes with productive transcription (Figure 4-8). This is premised on the idea that, 
during periods of rapid growth, DnaA-ATP levels are high, and, during slow growth, DnaA-
ATP levels are low. Data described in Chapter 5 provide some support for the above 
model, although with significant caveats. As B. burgdorferi transitions in to stationary 
phase, dnaA transcript abundance decreases and bpuR transcript becomes more 
abundant. The significant caveats are that both dnaA and bpuR are subject to multiple 
post-transcriptional controls, and thus their transcript levels may not reflect protein 
abundance or activity levels of either protein.  
DnaA is becoming increasingly known as a major regulator of transcription, in 
some cases acting through other DNA-binding proteins [285, 332]. EMSAs performed as 
described in Chapter 4 with alternative conditions or mutagenized DnaA could begin 
testing this model. Unfortunately, due to its key role in life of the cell, deletion, 
overexpression, or mutagenesis of the ATP- or DNA-binding domains of DnaA is either 
impossible or fraught with confounding variables. The use of uniformly ADP or ATP bound 
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DnaA in EMSAs could provide similar insight. If ATP/ADP binding does impact the results 
of the EMSAs, mutagenesis of the key residues of the nucleotide binding region could 
further test if ATP/ADP bound status impacts DNA binding specificity. Not only do we know 
little about the DNA-binding activity of DnaA, we know nothing regarding the expression 
and nucleotide bound state of DnaA during the natural enzootic cycle. Further 
complicating this model, we know very little about cellular levels of ATP at any stage of B. 
burgdorferi’s life cycle. Presumably, during tick colonization, when resources are less 
abundant, cellular ATP levels are lower than those during vertebrate colonization when 
glucose is abundant, but this remains unknown.  
If further experiments in B. burgdorferi can test whether DnaA does regulate the 
expression of bpuR, it would be the first such example in a pathogen utilizing DnaA in the 
regulation of genes involved in infection of the vertebrate host. ChIP-seq and in vitro 
transcription have both been used to test hypotheses regarding DnaA activity at specific 
loci [306, 332] and could provide insight in to this specific case. I hope that with additional 
study, we may be able to understand how B. burgdorferi uses the same information to 
make replication initiation decisions as it does host adaptation decisions. 
Input and output of gene regulatory networks (GRNs) 
As described in Chapter 1, many biological processes are commonly thought to be 
organized into tidy pathways, with a limited number of forks or alternative routes. Reality 
has proven to be far more complex. Regulatory factors are no exception to this, and when 
studied in detail, apparently linear pathways often emerge as highly interconnected 
networks with abundant crosstalk, feedback, feedforward, and control centers [23]. A large 
amount of work in the field of B. burgdorferi biology and gene regulation has focused on 
two separate regulatory cascades, HK2-Rrp2-RpoN-RpoS and HK-1-Rrp1-PlzA, thought 
to be important for vertebrate or tick colonization, respectively. 
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Testing specific hypotheses regarding function of gene regulatory networks 
requires knowledge of the network. Inference of existing networks based upon homology 
has significant limitations, and, in evolutionarily divergent organisms, the limitations are 
even more significant. This limitation is apparent in the field of B. burgdorferi biology, 
where only a small handful of canonical transcription factors and even fewer post-
transcriptional regulators were identified by genomic sequence similarity. Yet, additional 
factors have been discovered nearly every year since the original genomic annotation. 
Some of these are based upon the addition of new data to reference databases [155, 268, 
348], some following detailed experimentation on their regulatory targets [42, 156, 161, 
254], and others through the study of related processes or screens [169, 286]. These 
discoveries are often based upon the generation of new information or the implementation 
of new technologies.  
One such revolutionary technology is high-throughput RNA-Sequencing, which 
has provided the unprecedented ability to investigate transcript abundance at the single 
nucleotide level [281, 331]. Not only can RNA-Seq be used as the measurement for a 
variety of expression screens, it can also be used to interrogate transcriptome structure. 
Control of gene expression is well known to extend beyond simply proteins that induce or 
repress transcription, but includes RNA structure [119, 129], small non-coding RNAs [112, 
176, 228, 243, 302, 303, 321, 333], and the expression of alternative transcripts [4, 11, 
195], to name a few. 
With these possibilities in mind, and the dearth of literature regarding these 
mechanisms, in B. burgdorferi or any spirochete, I sought to test if any of these non-
proteinaceous mechanisms were at play. In performing whole transcriptome analysis, I 
was able to generate insight into transcriptome dynamics by examining these data in time-
series. I found that, similar to nearly every studied prokaryotic organism, B. burgdorferi 
expresses a large set of small RNAs, with both intergenic and antisense transcripts found 
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in abundance. I found small RNAs encoded across all seventeen replicons contained 
within the B31-A3 isolate sequenced. The only well studied sRNA known prior in B. 
burgdorferi, dsrA, plays a key role in the post-transcriptional regulation of RpoS [197], 
highlighting that sRNAs likely play an important role in gene regulation in this organism. 
dsrA works in concert with the RNA-binding protein, Hfq, to affect its function [195]. Hfq-
sRNA mediated control of expression is a well-known process in other bacteria [236], and 
likely mediates the effects of other sRNAs in B. burgdorferi. An additional study by 
Popitsch and colleagues further supported my findings using a sRNA-enriched 
sequencing strategy that identified many hundreds of small RNAs [243]. Newly identified 
antisense-RNAs are contained within genes encoding proteins of diverse biological 
function, including DNA replication, metabolism, and virulence. Small RNA’s often act as 
tuning switches for gene regulatory processes, similar to the role of AI-2 described earlier 
in my studies. 
Computational sequence analysis revolutionized the ability predict gene function 
in diverse organisms. Sequence analysis is not without limitations, and evolution 
introduces difficulty in making correct inferences on sequence alone. Identification of 
promoter elements controlling gene expression is also notoriously difficult based on solely 
on sequence. While well-defined promoters have been elucidated in several model 
organisms, the sequence of any individual promoter varies within and across organisms. 
Therefore, while the identification of putative protein coding genes is generally thought to 
be straightforward and relatively accurate, the prediction of non-coding portions of 
transcripts is significantly more challenging. RNA-sequencing allows for direct 
measurement of such features.  
My studies described in Chapter 5 present just such an experimental data set. I 
was able to unambiguously identify 5’ ends for up to ~700 transcripts, depending on time 
point, during in vitro growth. While I have not mined this data to identify the number of 
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unique operons represented, at minimum, it constitutes identification of 5’ ends for greater 
than 1/3 of all predicted protein coding genes. At this time, I have not extracted sequence 
information for the genomic regions immediately preceding these sites, and thus can 
provide no comprehensive statements regarding potential promoter sequences or 
alternative promoter utilization. I did compare previously identified transcriptional start 
sites to my data and found generally good agreement. I was also able to examine specific 
transcripts of known importance for B. burgdorferi’s enzootic cycle, including rpoS and 
glpFKD. Findings at both of these loci provided substantial insight in to their regulation, 
supporting previous and recently published hypotheses [120, 269]. A study by Adams et 
al. [4] recently undertook a comprehensive characterization of transcriptional start sites 
and, while, I have not completed a full comparison between our datasets, select transcripts 
were in good agreement. Riboswitches, which are important, non-coding, transcribed 
elements that may be responsive to diverse inputs including temperature, metabolites, 
and secondary messengers [22, 129, 278, 304], are not well studied in any spirochete, 
and none have been experimentally defined in B. burgdorferi. If riboswitches exist in the 
B. burgdorferi genome, and I suspect they do, then these 5’ UTR data could be readily 
mined for candidate identification. Non-coding elements are becoming increasingly well 
known to be major regulators of biological processes and my hope is that these datasets 
will serve as foundational resources for the field of B. burgdorferi biology. 
Topology of critical gene regulatory networks 
Finally, to begin providing insight in to critical protein-based gene regulatory 
networks in B. burgdorferi biology, I examined the transcriptomes of deletion mutants of 
four regulatory factors essential for completion of the enzootic cycle (CsrA, BadR, RpoS, 
and RpoN). While several of these factors have been examined in isolation previously, 
culture conditions, strain background, and technology have confounded the dissection of 
how these factors interact to generate the complex phenotype of vertebrate adaptation. I 
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found that none of the four regulatory factors examined regulate one another in the specific 
conditions examined. This means that all the transcripts that have been found to be 
regulated by two or more factors are likely the result of convergent regulation. This is in 
stark contrast to much of the current thought in the field that vertebrate adaptation is 
mediated largely through the HK2-Rrp2-RpoN-RpoS cascade. That being said, my data 
do not preclude a situation in which any of these given factors convergently regulate a 
third, which then goes on to regulate all the shared targets. As I said in Chapter 6, I 
consider a combination of both possibilities the most likely scenario.  
I found that of these factors, while RpoS and RpoN appear to not be activated in 
the examined conditions, CsrA and BadR regulate large numbers of genes. Not 
surprisingly, given their essentiality for vertebrate infection, the direction of differentially 
expressed transcripts, supported these observations. In general, the deletion of either 
factor lowered the expression of known vertebrate specific genes and enhanced the 
expression of known tick specific ones. The fact that these factors may coregulate an 
additional, third factor presents a potential opportunity, in that targeting the inputs of a 
single, key regulator may allow for interruption of the ability of pathogens to properly adapt. 
In the cases of the RpoN and RpoS deletion mutants, it may seem quite a surprise, 
given the current literature [47-49, 118, 127, 138, 230, 232, 343], that almost no transcripts 
were differentially expressed in my study. Upon careful consideration, the limitations of 
existing literature in that they often used specific rpoN and rpoS inducing culture 
conditions, these differences are less surprising. My data support a critical reevaluation of 
hypotheses surrounding vertebrate adaption in of B. burgdorferi. While RpoS certainly 
plays a significant role in host adaptation of the spirochete, it is apparent that additional 
factors also control this adaptation. BadR and CsrA have both been previously postulated 
to act through activity on rpoS, and this work provides substantial support that they drive 
vertebrate adaptive programs independently of the RpoS protein. What is still lacking is 
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an understanding of what gene regulatory effects are mediated directly versus those that 
are mediated indirectly. Both ChIP and RIP approaches were pioneered in the Stevenson 
lab for use in B. burgdorferi, and their application to these two proteins would provide 
substantial insight in to their place within the wider gene regulatory network. These and 
past studies highlight a significant limitation of such studies and most experiments in the 
life sciences, namely that a single snap shot of a single condition may not extrapolate to 
all processes. While my data provide substantial insight into the interactions between 
these four regulatory factors, time-series or multi-conditional comparisons would 
significant additional insight in to the dynamics between these and other factors. 
Biochemical evidence from multiple groups demonstrated that BadR binds rpoS 
promoter DNA and regulates its transcription, yet rpoS transcript was not impacted by 
deletion of badR in my study. This is almost certainly due to the use of non-rpoS inducing 
conditions, which would obscure any role for a negative regulator but does highlight tht 
BadR is not the only repressor of rpoS transcription. RpoN is a sigma-54 type factor and 
these typically require an enhancer binding protein (EBP) for their activity [44]. The 
proposed EBP in B. burgdorferi is the response regulator Rrp2, whose activity is 
phosphorylation dependent and thought to be activated the sensor histidine kinase HK2 
[118]. The histidine sensor-response regulator relay, HK2 nor Rrp2,  are not thought to be 
strongly activated during the culture conditions utilized in these studies and offer a 
potential explanation for the lack of effect by the deletion of rpoN.  
The obvious next step for further discerning critical B. burgdorferi gene regulatory 
networks is to perform transcriptome analysis on significantly larger numbers of mutants 
and culture conditions. Experiments such as these have provided substantial insight in a 
variety of prokaryotic organisms, including E. coli [201] and Halobacterium salinarum [78, 
79], which benefit from rapid doubling times and high-throughput culture methods. If high-
throughput methods could be combined with low input transcriptomics to account for the 
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comparably low bacterial densities achieved during B. burgdorferi in vitro cultivation, a 
more comprehensive view of important GRNs could be ascertained.  
Finally, the last, and likely most significant limitation of these studies is that they 
solely focus on regulation at the level of transcript abundance. While it is clear that RNA-
Seq does not measure transcription alone, but also transcript stability and structural 
dynamics, it still does not inform about protein levels or protein activity. This limitation is 
not newly recognized, but it should be reiterated: transcript abundance is only one fraction 
of the story. Combinations of genomic, transcriptomic, proteomic, and metabolomic tools 
will provide substantially more insight when combined than any single approach. In 
summary, the work described in Chapters 5 and 6, along with the recent work of Popitsch 
et al. and Adams et al., provide a firm foundation for -omics experiments to build data sets 
beyond the genomic sequence of this important human pathogen.  
Closing thoughts  
More than a handful of dissertations worth of work remain to be done before the 
growth-virulence connection in B. burgdorferi or the regulatory networks underlying it, let 
alone other pathogens, begins to be even partially elucidated. The work I have described 
here only begins to open that door and pose the earliest series of questions. This work, 
and that of innumerable others has also begun to provide opportunity for future study 
aimed at intervention in B. burgdorferi infections. If the signals that B. burgdorferi senses 
during the tick’s blood meal, and the mechanisms by which they convey that information 
are understood, they can be potentially targeted. 
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 Appendix 
 
The following chapter contains the differential expression testing tables generated in 
Chapter 5 and Chapter 6, and the coordinates of predicted terminators and non-coding 
RNAs from Chapter 5. These data have also been deposited as a static, citable repository 
of tables at Figshare (10.6084/m9.figshare.67390)
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Table 8-1 Differentially abundant transcripts when comparing early- to mid-exponential phase 
A) Decreased in abundance  
 
B) Increased in abundance 
Genetic Element Gene ID Early Expression Mid Expression Fold Change P-Value Adjusted P-Value 
Chromosome BB_0331_-_hypothetical_protein 6.74490 31.45814 4.66399 3.3494E-04 1.3563E-02 
lp28-4 BB_I19_-_hypothetical_protein 1335.20134 2769.22118 2.07401 7.4000E-09 4.7600E-06 
lp36 BB_K54_-_hypothetical_protein 25.51892 64.34795 2.52158 1.8231E-03 4.7642E-02 
cp32-7 BB_O38_bppC_protein_BppC 0.23055 8.00251 34.71043 1.4046E-03 3.9701E-02 
 
Those in (A) lower and (B) higher abundance in stationary phase compared to mid-exponential. Genes are listed which were identified 
by DEseq [9] as differentially expressed by meeting the criteria of >2X greater abundance and an adjusted P-value of <.05. In order 
from left to right columns list genetic element on which a given gene resides, the gene ID, the early-exponential expression, mid-
exponential expression, fold change, P-value, adjusted P-value. 
 
 
 
Genetic Element Gene ID Early Expression Mid Expression Fold Change P-Value Adjusted P-Value 
cp32-8 BB_L25_-_hypothetical_protein 198.58615 88.07865 0.44353 3.5299E-04 1.3563E-02 
cp32-8 BB_L26_-_hypothetical_protein 386.97847 122.60457 0.31683 8.7400E-08 3.0300E-05 
cp32-6 BB_M26_-_hypothetical_protein 282.77018 104.78590 0.37057 2.8300E-06 6.5298E-04 
cp32-4 BB_R26_-_hypothetical_protein 213.96985 81.55307 0.38114 2.9000E-05 2.6784E-03 
cp32-3 BB_S26_-_hypothetical_protein 186.38953 81.84602 0.43911 2.8986E-04 1.3482E-02 
1
2
1
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Table 8-2 Differentially abundant transcripts when comparing mid-exponential to stationary phase 
A) Decreased in abundance 
Genetic 
Element Gene ID 
Mid 
Expression 
Stat 
Expression 
Fold 
Change P-Value 
Adjusted P-
Value 
Chromosome BB_0450_rpoN_RNA_polymerase_sigma-54_factor 950.80453 296.76798 0.31212 3.5832E-04 1.0796E-02 
Chromosome BB_0641_-_spermidine/putrescine_transport_system_permease 847.29382 283.93297 0.33511 1.5453E-03 3.1041E-02 
Chromosome BB_0739_-_hypothetical_protein 1036.35817 338.83289 0.32695 7.3679E-04 1.8236E-02 
cp32-8 BB_L40_erpO_ErpB1_protein 8165.10277 3001.91488 0.36765 1.0128E-03 2.2845E-02 
cp32-9 BB_N39_erpQ_protein_ErpQ 2559.43425 988.26692 0.38613 2.7013E-03 4.3536E-02 
cp32-1 BB_P39_erpB_protein_ErpB 7775.79525 2923.42189 0.37596 1.1482E-03 2.4865E-02 
lp28-2 BB_G0036_-_hypothetical_protein 2.64349 0.00000 Inf 1.3894E-03 2.8320E-02 
 
A) Increased in abundance 
Genetic 
Element Gene ID 
Mid 
Expression 
Stat 
Expression Fold Change P-Value 
Adjusted P-
Value 
Chromosome BB_0007_-_hypothetical_protein 1656.65227 4198.01475 2.53403 1.2000E-05 1.2335E-03 
Chromosome 
BB_0026_-
_bifunctional_methylenetetrahydrofolate_dehydrogenase/methenyltetra
hydrofolate_cyclohydrolase 
1504.90269 3311.62556 2.20056 1.1184E-03 2.4605E-02 
Chromosome BB_0083_-_hypothetical_protein 986.21189 2256.34684 2.28789 4.3459E-04 1.2549E-02 
Chromosome BB_0133_-_hypothetical_protein 7487.80456 15694.90171 2.09606 1.2562E-03 2.6381E-02 
Chromosome BB_0153_-_superoxide_dismutase 1519.02890 3672.56311 2.41770 4.3500E-05 2.6213E-03 
Chromosome BB_0179_trmE_tRNA_modification_GTPase 3573.53902 8667.22088 2.42539 1.8574E-04 6.7746E-03 
Chromosome BB_0226_serS_serine--tRNA_ligase 2548.90331 5703.54381 2.23765 1.9275E-04 6.8501E-03 
Chromosome BB_0253_lon_ATP-dependent_protease_La 5332.42441 12739.31042 2.38903 8.7000E-05 4.3082E-03 
Chromosome BB_0269_-_ATP-binding_protein 5550.75274 15646.76500 2.81885 7.7600E-07 1.6501E-04 
Chromosome BB_0299_ftsZ_cell_division_protein_FtsZ 4093.50271 8514.43293 2.07999 1.2589E-04 5.4524E-03 
Chromosome BB_0300_ftsA_cell_division_protein_FtsA 7296.63800 17205.45614 2.35800 8.0800E-05 4.1467E-03 
Chromosome BB_0386_rpsG_30S_ribosomal_protein_S7 7173.63418 20533.28355 2.86233 8.3300E-07 1.6501E-04 
Chromosome BB_0394_nusG_transcription_termination/antitermination_factor 6957.34021 14665.18601 2.10787 5.0794E-04 1.3804E-02 
Chromosome BB_0402_proS_proline--tRNA_ligase 1399.15943 2826.33862 2.02003 6.3111E-04 1.6254E-02 
Chromosome BB_0478_rplC_50S_ribosomal_protein_L3 8474.90371 18778.14094 2.21574 3.0595E-04 9.4844E-03 
Chromosome BB_0485_rplP_50S_ribosomal_protein_L16 2423.20662 4864.16283 2.00732 9.5917E-04 2.2157E-02 
Chromosome BB_0488_rplN_50S_ribosomal_protein_L14 1226.44546 2766.39204 2.25562 2.1200E-05 1.3981E-03 
Chromosome BB_0493_-_50S_ribosomal_protein_L6 4471.77473 9773.26761 2.18555 1.0860E-04 5.0175E-03 
Chromosome BB_0495_rpsE_30S_ribosomal_protein_S5 1726.28274 5105.39817 2.95745 9.5700E-07 1.6587E-04 
Chromosome BB_0534_xth_exodeoxyribonuclease_III 583.24606 1266.35188 2.17121 2.2797E-04 7.7063E-03 
Chromosome BB_0536_-_zinc_protease 1124.25517 2645.00403 2.35267 7.0200E-05 3.7419E-03 
Chromosome BB_0599_cysS_cysteine--tRNA_ligase 2175.51971 5350.43395 2.45938 1.2500E-05 1.2335E-03 
1
2
2
 
  
 
123 
Chromosome 
BB_0621_-_4-methyl-5(b-hydroxyethyl)-
thiazole_monophosphate_biosynthesis_protein 
875.74098 2340.74643 2.67288 1.3936E-04 5.8531E-03 
Chromosome BB_0691_fusA_elongation_factor_G 10486.16082 21911.76904 2.08959 8.4073E-04 2.0091E-02 
Chromosome BB_0698_trmD_tRNA_(guanine-N(1)-)-methyltransferase 5066.43739 12046.84776 2.37777 4.4392E-04 1.2557E-02 
Chromosome BB_0704_acpP_acyl_carrier_protein 2485.23582 5748.97822 2.31325 1.5000E-05 1.3379E-03 
Chromosome BB_0705_rnc_ribonuclease_III 3558.39177 8195.16894 2.30305 6.1000E-05 3.3823E-03 
Chromosome BB_0738_valS_valine--tRNA_ligase 5016.83042 12754.13258 2.54227 2.0700E-05 1.3981E-03 
Chromosome BB_0749_-_hypothetical_protein 9901.65472 27334.62798 2.76061 2.5700E-05 1.6202E-03 
Chromosome BB_0804_rpsO_30S_ribosomal_protein_S15 1647.99931 3699.24376 2.24469 1.2291E-04 5.4524E-03 
Chromosome BB_0805_-_polyribonucleotide_nucleotidyltransferase 17634.94619 42138.86720 2.38951 3.0794E-04 9.4844E-03 
Chromosome BB_0816_-_hypothetical_protein 2653.08014 6860.36064 2.58581 1.5400E-05 1.3379E-03 
lp54 BB_A43_-_hypothetical_protein 528.52591 1201.42123 2.27315 7.7552E-04 1.8857E-02 
lp54 BB_A52_-_outer_membrane_protein 1308.79641 3123.81337 2.38678 1.3600E-06 1.9710E-04 
lp54 BB_A74_osm28_outer_membrane_porin_OMS28 10584.11040 23714.89375 2.24061 1.3019E-03 2.6931E-02 
lp17 BB_D21_-_hypothetical_protein 870.29195 2505.10897 2.87847 7.4400E-06 8.5965E-04 
lp28-1 BB_F06_-_hypothetical_protein 14.13518 68.14145 4.82070 9.4357E-04 2.2157E-02 
lp28-3 BB_H13_-_protein_RepU 784.17597 1824.34624 2.32645 1.8060E-03 3.3009E-02 
lp28-3 BB_H32_-_antigen_P35 147.63987 521.57508 3.53275 1.7200E-06 2.1710E-04 
lp28-3 BB_H37_-_lipoprotein 874.07528 2343.18493 2.68076 1.7300E-05 1.3981E-03 
lp28-3 BB_H40_-_transposase-like_protein 14.01908 57.17008 4.07802 2.6100E-03 4.2559E-02 
lp28-4 BB_I19_-_hypothetical_protein 2015.82056 6386.78179 3.16833 1.4200E-06 1.9710E-04 
lp28-4 BB_I20_-_hypothetical_protein 401.04241 1635.60630 4.07839 2.2200E-08 6.1400E-06 
lp28-4 BB_I21_-_PF-32_protein 622.28578 4496.09463 7.22513 9.5600E-20 6.6200E-17 
lp28-4 BB_I22_-_PF-49_protein 331.29853 949.26210 2.86528 2.5947E-04 8.3634E-03 
lp38 BB_J48_-_hypothetical_protein 161.21439 434.92115 2.69778 1.6912E-03 3.3009E-02 
lp36 BB_K13_-_hypothetical_protein 3248.70637 7429.79420 2.28700 6.3326E-04 1.6254E-02 
lp36 BB_K40_-_hypothetical_protein 1922.08954 4013.33616 2.08801 1.5098E-04 6.0535E-03 
lp36 BB_K45_-_immunogenic_protein_P37 3927.66165 9863.14469 2.51120 2.0100E-05 1.3981E-03 
cp32-8 BB_L31_-_hypothetical_protein 236.51806 634.63648 2.68325 9.2300E-05 4.4105E-03 
cp32-9 BB_N28_mlpI_lipoprotein 136.39036 432.80008 3.17325 1.9300E-05 1.3981E-03 
cp32-9 BB_N30_-_hypothetical_protein 1117.38096 2464.88361 2.20595 4.6832E-04 1.2982E-02 
cp32-9 BB_N31_-_hypothetical_protein 124.10864 316.78842 2.55251 2.3428E-04 7.7313E-03 
lp56 BB_Q07_-_plasmid_partition_protein 181.98173 482.59448 2.65188 1.0219E-03 2.2845E-02 
lp56 BB_Q34_bdrW_protein_BdrW_protein 326.69158 982.69060 3.00801 5.6800E-05 3.2792E-03 
lp56 BB_Q38_-_hypothetical_protein 2587.77422 6218.11924 2.40288 5.5639E-04 1.4830E-02 
lp56 BB_Q39_-_hypothetical_protein 163.86638 758.91934 4.63133 1.1400E-08 3.9400E-06 
lp56 BB_Q40_-_PF-32_protein 416.10624 1202.49810 2.88988 1.5287E-04 6.0535E-03 
cp32-4 BB_R31_-_hypothetical_protein 916.15127 1943.84927 2.12176 6.8008E-04 1.7138E-02 
cp32-4 BB_R32_-_hypothetical_protein 149.36200 772.42758 5.17151 1.6000E-11 7.3900E-09 
cp32-4 BB_R33_-_plasmid_partition_protein,_putative 182.31441 508.89515 2.79131 1.8537E-04 6.7746E-03 
cp32-4 BB_R34_-_hypothetical_protein 107.29289 285.91129 2.66477 1.7869E-03 3.3009E-02 
cp32-4 BB_R44_-_hypothetical_protein 49.78824 144.35307 2.89934 2.2068E-04 7.6465E-03 
cp32-3 BB_S34_-_hypothetical_protein 173.16988 436.01624 2.51785 1.5775E-04 6.0735E-03 
Chromosome Rfam_ncRNA1_NC_001318_SRP_bact_Rfam_annotation 2827.60605 40168.05042 14.20567 4.6500E-28 6.4500E-25 
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Those in (A) lower and (B) higher abundance in stationary phase compared to mid-exponential. Genes are listed which were identified 
by DEseq [9] as differentially expressed by meeting the criteria of >2X greater abundance and an adjusted P-value of <.05. In order 
from left to right columns list genetic element on which a given gene resides, the gene ID, the mid-log expression, stationary expression, 
fold change, P-value, adjusted P-value. 
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Table 8-3 Transcripts that were differentially abundant between early-exponential and stationary phase 
A) Decreased in abundance 
Genetic 
Element Gene ID 
Early 
Expression 
Stat 
Expression 
Fold 
Change P-Value Adjusted P-Value 
Chromosome BB_0009_-_hypothetical_protein 337.08924 150.88217 0.44760 6.8815E-04 3.1830E-03 
Chromosome BB_0012_truA_tRNA_pseudouridine_synthase_A 625.60812 299.79831 0.47921 1.1600E-04 6.9752E-04 
Chromosome BB_0013_-_hypothetical_protein 406.49089 155.23899 0.38190 5.5400E-06 5.3500E-05 
Chromosome BB_0014_priA_primosomal_protein_N 723.03223 294.68038 0.40756 6.6500E-07 8.5900E-06 
Chromosome BB_0040_cheR_chemotaxis_protein_methyltransferase 125.79145 51.41407 0.40872 2.3285E-03 8.6106E-03 
Chromosome BB_0077_-_hypothetical_protein 561.48651 259.26760 0.46175 2.6900E-05 2.0129E-04 
Chromosome BB_0196_prfA_peptide_chain_release_factor_1 717.68996 325.95274 0.45417 5.5400E-05 3.6993E-04 
Chromosome BB_0199_-_hypothetical_protein 871.84979 313.57160 0.35966 2.5600E-08 4.7800E-07 
Chromosome BB_0208_-_hypothetical_protein 622.47938 242.64847 0.38981 3.1200E-07 4.3600E-06 
Chromosome BB_0211_-_DNA_mismatch_repair_protein 1858.15944 909.06258 0.48923 6.5400E-06 6.0300E-05 
Chromosome BB_0218_pstB_phosphate_ABC_transporter_ATP-binding_protein 585.13237 240.94437 0.41178 1.9200E-05 1.4941E-04 
Chromosome BB_0237_lnt_apolipoprotein_N-acyltransferase 491.11309 228.08342 0.46442 4.2133E-04 2.0987E-03 
Chromosome BB_0251_leuS_leucine--tRNA_ligase 5802.43846 2344.75863 0.40410 3.3700E-08 6.0500E-07 
Chromosome BB_0252_-_hypothetical_protein 2401.84986 742.90570 0.30931 1.7100E-11 6.2300E-10 
Chromosome BB_0255_-_M23_peptidase_domain-containing_protein 815.06549 382.52021 0.46931 7.8000E-06 6.9700E-05 
Chromosome BB_0317_-_integral_membrane_protein 1815.65389 836.57266 0.46076 1.5900E-06 1.8300E-05 
Chromosome BB_0363_-_hypothetical_protein 1609.28100 548.46694 0.34081 1.4800E-09 4.0800E-08 
Chromosome BB_0375_pfs_nucleosidase 1772.01181 821.36958 0.46352 1.8600E-06 2.1000E-05 
Chromosome BB_0376_metK_S-adenosylmethionine_synthetase 2811.93420 1091.18557 0.38806 1.1300E-07 1.7400E-06 
Chromosome BB_0399_-_hypothetical_protein 71.32611 28.95200 0.40591 9.7023E-03 2.8540E-02 
Chromosome BB_0404_-_hypothetical_protein 131.72712 54.01437 0.41005 9.6688E-03 2.8512E-02 
Chromosome BB_0406_-_hypothetical_protein 421.82995 200.49637 0.47530 5.1824E-04 2.4973E-03 
Chromosome BB_0409_-_hypothetical_protein 207.57895 96.18330 0.46336 1.1848E-03 4.9655E-03 
Chromosome BB_0437_dnaA_chromosomal_replication_initiation_protein 1373.78280 523.57494 0.38112 7.2300E-08 1.1500E-06 
Chromosome BB_0450_rpoN_RNA_polymerase_sigma-54_factor 1145.83220 276.95471 0.24171 1.9600E-13 9.0400E-12 
Chromosome BB_0507_-_hypothetical_protein 804.03291 322.03239 0.40052 5.7700E-06 5.4900E-05 
Chromosome BB_0547_coaE_dephospho-CoA_kinase 378.51301 167.43961 0.44236 5.1520E-04 2.4913E-03 
Chromosome BB_0548_polA_DNA_polymerase_I 3157.34653 1120.83088 0.35499 1.1300E-09 3.1800E-08 
Chromosome BB_0554_-_hypothetical_protein 2883.92539 1345.07556 0.46640 1.5300E-05 1.2340E-04 
Chromosome BB_0555_-_hypothetical_protein 791.74640 292.90027 0.36994 2.0200E-06 2.2300E-05 
Chromosome BB_0586_-_FemA_protein 792.61480 251.61185 0.31745 4.8500E-09 1.1800E-07 
Chromosome BB_0603_p66_integral_outer_membrane_protein_p66 7477.75660 3576.49441 0.47828 4.2900E-06 4.2700E-05 
Chromosome BB_0620_-_beta-glucosidase 324.31878 131.55377 0.40563 3.9600E-05 2.7680E-04 
Chromosome BB_0632_recD_exodeoxyribonuclease_V_subunit_alpha 373.48624 99.96354 0.26765 4.4200E-08 7.4600E-07 
Chromosome BB_0633_recB_exodeoxyribonuclease_V_subunit_beta 932.89827 323.50216 0.34677 1.6500E-08 3.2300E-07 
Chromosome 
BB_0639_-_spermidine/putrescine_ABC_transporter_substrate-
binding_protein 
1106.98110 309.87719 0.27993 1.1700E-10 3.8500E-09 
Chromosome BB_0640_-_spermidine/putrescine_ABC_transporter_permease 562.98794 154.44527 0.27433 1.7000E-09 4.5800E-08 
Chromosome BB_0641_-_spermidine/putrescine_transport_system_permease 934.56747 264.56098 0.28308 1.1600E-10 3.8500E-09 
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Chromosome 
BB_0642_-_spermidine/putrescine_ABC_transporter_ATP-
binding_protein 
2194.65581 881.46085 0.40164 8.8500E-08 1.3900E-06 
Chromosome BB_0713_-_hypothetical_protein 3165.93427 1301.43863 0.41108 4.6600E-07 6.3800E-06 
Chromosome BB_0739_-_hypothetical_protein 936.79632 315.79479 0.33710 1.3200E-07 1.9800E-06 
Chromosome BB_0751_-_hypothetical_protein 683.51486 322.81327 0.47228 9.4400E-06 8.0600E-05 
Chromosome BB_0752_-_hypothetical_protein 2228.79764 792.16348 0.35542 4.4200E-10 1.3300E-08 
Chromosome BB_0753_-_hypothetical_protein 1744.07574 657.51209 0.37700 2.6300E-08 4.8400E-07 
Chromosome BB_0754_-_ABC_transporter_ATP-binding_protein 1427.96204 568.14917 0.39787 3.8800E-08 6.8700E-07 
Chromosome BB_0755_rnz_ribonuclease_Z 865.14974 420.87390 0.48648 2.0000E-05 1.5453E-04 
Chromosome BB_0764_-_sensory_transduction_histidine_kinase 485.66170 217.35069 0.44754 6.8600E-05 4.4542E-04 
Chromosome BB_0765_-_hypothetical_protein 403.90329 130.60350 0.32335 5.1000E-07 6.8500E-06 
Chromosome BB_0766_cvpA_colicin_V_production_protein 394.90518 181.60382 0.45987 2.8107E-04 1.4837E-03 
Chromosome BB_0769_-_tRNA_N6-adenosine_threonylcarbamoyltransferase 1190.91121 567.50638 0.47653 1.5300E-05 1.2340E-04 
Chromosome BB_0771a_-_hypothetical_protein 270.00690 129.40850 0.47928 2.3545E-03 8.6835E-03 
Chromosome BB_0773_-_hypothetical_protein 322.97503 94.00100 0.29105 1.4800E-07 2.1800E-06 
Chromosome BB_0782_nadD_nicotinate-nucleotide_adenylyltransferase 620.89236 274.14473 0.44153 1.3500E-05 1.1157E-04 
Chromosome BB_0834_-_ATP-dependent_Clp_protease_subunit_C 5166.90380 2467.97020 0.47765 4.0800E-06 4.1000E-05 
Chromosome BB_0835_-_phosphomannomutase 411.99700 164.89674 0.40024 8.3300E-06 7.2900E-05 
Chromosome BB_0838_-_hypothetical_protein 2676.73652 1189.67028 0.44445 2.5300E-06 2.7400E-05 
lp54 BB_A10_-_hypothetical_protein 115.20935 56.97838 0.49456 9.1240E-03 2.7137E-02 
lp54 BB_A11_-_hypothetical_protein 79.85892 37.67239 0.47174 1.0732E-02 3.0985E-02 
lp54 BB_A13_-_hypothetical_protein 111.97512 45.39231 0.40538 2.6730E-03 9.5524E-03 
lp54 BB_A20_-_PF-32_protein 973.18094 436.40522 0.44843 9.6900E-07 1.2200E-05 
lp54 BB_A31_-_pbsx_family_phage_terminase 590.88121 265.67377 0.44962 5.2400E-05 3.5211E-04 
lp54 BB_A32_-_hypothetical_protein 64.73942 27.81277 0.42961 1.1554E-02 3.3016E-02 
lp54 BB_A41_-_hypothetical_protein 366.14853 142.24488 0.38849 1.2100E-05 1.0067E-04 
lp54 BB_A46_-_hypothetical_protein 446.41579 219.88100 0.49255 1.1452E-04 6.9163E-04 
lp54 BB_A64_-_P35_antigen 26.41418 6.92210 0.26206 1.6519E-02 4.4447E-02 
cp26 BB_B06_-_chitibiose_transporter_protein_ChbB 137.21042 52.32826 0.38137 5.6765E-04 2.7165E-03 
cp26 BB_B07_-_alpha3-beta1_integrin-binding_protein 533.88248 187.91672 0.35198 1.3400E-06 1.6300E-05 
cp26 BB_B12_-_PF-32_protein 735.94124 321.50005 0.43686 4.0900E-06 4.1000E-05 
cp26 BB_B13_-_plasmid_partition_protein 293.15407 116.73775 0.39821 3.1500E-05 2.2688E-04 
lp28-1 BB_F25_-_hypothetical_protein 183.24629 77.11307 0.42082 2.0269E-04 1.1258E-03 
cp32-8 BB_L08_-_hypothetical_protein 14.67914 2.80349 0.19098 5.1263E-03 1.7002E-02 
cp32-8 BB_L21_-_hypothetical_protein 48.57141 17.94922 0.36954 7.7824E-03 2.3759E-02 
cp32-8 BB_L24_blyB_holin_protein 94.71962 42.78236 0.45167 5.5227E-03 1.8029E-02 
cp32-8 BB_L25_-_hypothetical_protein 134.20654 60.66260 0.45201 2.6842E-03 9.5676E-03 
cp32-8 BB_L26_-_hypothetical_protein 262.15074 97.92359 0.37354 9.8600E-05 6.0904E-04 
cp32-8 BB_L40_erpO_ErpB1_protein 6458.99004 2796.61255 0.43298 9.1500E-06 7.8700E-05 
cp32-6 BB_M25_-_hypothetical_protein 97.15662 27.32484 0.28125 1.0210E-04 6.2756E-04 
cp32-6 BB_M26_-_hypothetical_protein 191.11242 48.68464 0.25474 2.8300E-06 3.0100E-05 
cp32-6 BB_M33_-_PF-49_protein 244.75884 106.61657 0.43560 2.9445E-04 1.5425E-03 
cp32-6 BB_M34_bdrK_BdrK 368.20418 148.20456 0.40251 1.3600E-06 1.6300E-05 
cp32-9 BB_N25_-_hypothetical_protein 71.33098 29.53064 0.41399 7.2777E-03 2.2618E-02 
cp32-9 BB_N39_erpQ_protein_ErpQ 1863.00605 920.29945 0.49399 1.4365E-04 8.4180E-04 
cp32-7 BB_O02_-_hypothetical_protein 34.07245 13.97117 0.41004 1.4961E-02 4.1134E-02 
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cp32-7 BB_O21_-_hypothetical_protein 38.03625 15.17437 0.39894 1.4999E-02 4.1158E-02 
cp32-7 BB_O33_-_plasmid_partition_protein 287.78902 117.83565 0.40945 1.4318E-04 8.4180E-04 
cp32-7 BB_O34_bdrM_protein_BdrM 313.77346 149.13921 0.47531 1.9612E-04 1.0981E-03 
cp32-1 BB_P21_-_hypothetical_protein 46.56013 16.61645 0.35688 2.5186E-03 9.1183E-03 
cp32-1 BB_P25_-_hypothetical_protein 95.28585 34.88293 0.36609 1.2487E-03 5.2015E-03 
cp32-1 BB_P26_-_hypothetical_protein 237.12128 90.52797 0.38178 1.0256E-04 6.2761E-04 
cp32-1 BB_P33_-_PF-49_protein 1040.44099 408.85645 0.39296 1.7700E-07 2.5500E-06 
cp32-1 BB_P34_bdrA_protein_BdrA 1164.18747 542.00474 0.46556 7.8200E-06 6.9700E-05 
cp32-1 BB_P39_erpB_protein_ErpB 6107.20153 2723.34364 0.44592 1.5800E-05 1.2540E-04 
cp32-4 BB_R25_-_hypothetical_protein 94.59779 29.99717 0.31710 6.2595E-04 2.9246E-03 
cp32-3 BB_R26_-_hypothetical_protein 144.79968 66.60394 0.45997 5.0913E-03 1.6926E-02 
cp32-3 BB_S21_-_hypothetical_protein 38.14528 14.69844 0.38533 1.4420E-02 4.0369E-02 
cp32-3 BB_S25_-_hypothetical_protein 94.84991 33.11997 0.34918 8.1493E-04 3.6952E-03 
lp21 BB_U07_-_protein_BBC01 140.86599 45.65445 0.32410 6.5700E-05 4.2866E-04 
lp21 BB_U08_-_SUA5_subfamily_protein 24.96945 5.60438 0.22445 4.9047E-03 1.6464E-02 
 
B) Increased in abundance 
Genetic 
Element Gene ID 
Early 
Expression 
Stat 
Expression 
Fold 
Change P-Value 
Adjusted P-
Value 
Chromosome BB_0007_-_hypothetical_protein 1381.46976 3892.47953 2.81764 3.1600E-15 2.1900E-13 
Chromosome BB_0016_-_GlpE_protein 1962.61099 4064.61718 2.07103 1.1100E-07 1.7200E-06 
Chromosome 
BB_0026_-
_bifunctional_methylenetetrahydrofolate_dehydrogenase/methenyltetrahydrofol
ate_cyclohydrolase 
1377.07854 3067.06873 2.22723 1.5600E-10 5.0000E-09 
Chromosome BB_0061_trx_thioredoxin 2008.18083 5336.51539 2.65739 4.9000E-13 2.1900E-11 
Chromosome BB_0083_-_hypothetical_protein 741.14672 2090.29269 2.82035 7.0400E-14 3.8900E-12 
Chromosome BB_0135_hisS_histidine--tRNA_ligase 2064.72124 4490.32409 2.17478 7.9900E-09 1.7500E-07 
Chromosome BB_0137_-_long-chain-fatty-acid_CoA_ligase 7632.80029 16615.00048 2.17679 1.2800E-08 2.6000E-07 
Chromosome BB_0138_-_hypothetical_protein 423.53765 1082.79183 2.55654 4.1300E-12 1.6300E-10 
Chromosome BB_0153_-_superoxide_dismutase 1511.59366 3402.07571 2.25065 5.1900E-09 1.2400E-07 
Chromosome BB_0166_malQ_4-alpha-glucanotransferase 229.39227 485.04807 2.11449 7.4000E-07 9.3800E-06 
Chromosome BB_0179_trmE_tRNA_modification_GTPase 2857.19576 8041.07702 2.81432 8.7200E-15 5.2400E-13 
Chromosome BB_0253_lon_ATP-dependent_protease_La 5516.55150 11797.16013 2.13850 1.3100E-08 2.6200E-07 
Chromosome BB_0269_-_ATP-binding_protein 5744.33527 14478.56719 2.52049 1.8500E-12 7.5300E-11 
Chromosome BB_0300_ftsA_cell_division_protein_FtsA 7237.88877 15937.18515 2.20191 6.0800E-09 1.4000E-07 
Chromosome BB_0331_-_hypothetical_protein 4.54742 18.30338 4.02500 1.6564E-03 6.6016E-03 
Chromosome BB_0386_rpsG_30S_ribosomal_protein_S7 7631.36854 19017.66197 2.49204 1.0400E-10 3.6000E-09 
Chromosome BB_0394_nusG_transcription_termination/antitermination_factor 6477.82807 13583.17028 2.09687 2.0200E-08 3.8800E-07 
Chromosome BB_0395_secE_protein_translocase_subunit_SecE 3199.82428 6400.93660 2.00040 7.2000E-08 1.1500E-06 
Chromosome BB_0488_rplN_50S_ribosomal_protein_L14 1247.84666 2563.43842 2.05429 4.3900E-08 7.4600E-07 
Chromosome BB_0495_rpsE_30S_ribosomal_protein_S5 1597.59368 4734.25824 2.96337 5.4100E-17 4.9900E-15 
Chromosome BB_0508_engA_GTPase_Der 5651.57997 11779.82218 2.08434 2.2400E-08 4.2400E-07 
Chromosome BB_0534_xth_exodeoxyribonuclease_III 552.89536 1174.57073 2.12440 4.4100E-08 7.4600E-07 
1
2
7
 
  
 
128 
Chromosome BB_0536_-_zinc_protease 1227.42056 2456.03130 2.00097 6.5000E-07 8.4800E-06 
Chromosome BB_0578_-_methyl-accepting_chemotaxis_protein 2190.56338 4647.03461 2.12139 1.6600E-08 3.2300E-07 
Chromosome BB_0599_cysS_cysteine--tRNA_ligase 2135.90410 4959.49925 2.32197 5.4500E-10 1.6000E-08 
Chromosome 
BB_0621_-_4-methyl-5(b-hydroxyethyl)-
thiazole_monophosphate_biosynthesis_protein 
802.37582 2165.33960 2.69866 1.7700E-13 8.4400E-12 
Chromosome BB_0628_-_lipoprotein 2088.85745 5614.38058 2.68778 8.1900E-14 4.2000E-12 
Chromosome BB_0656_-_oxygen-independent_coproporphyrinogen_III_oxidase 600.55210 1361.98616 2.26789 3.0900E-09 7.9200E-08 
Chromosome BB_0698_trmD_tRNA_(guanine-N(1)-)-methyltransferase 3795.95530 11188.36815 2.94744 9.6700E-16 7.8700E-14 
Chromosome BB_0705_rnc_ribonuclease_III 3742.85235 7592.74748 2.02860 4.6400E-08 7.7300E-07 
Chromosome BB_0714_-_hypothetical_protein 2568.07292 5458.77495 2.12563 4.8100E-09 1.1800E-07 
Chromosome BB_0715_-_cell_division_protein_FtsA 5216.03512 11700.12540 2.24311 1.7200E-09 4.5800E-08 
Chromosome BB_0723_-_adenylyl_cyclase 36.85845 79.91207 2.16808 2.6209E-03 9.4149E-03 
Chromosome BB_0738_valS_valine--tRNA_ligase 4467.52613 11822.67135 2.64636 6.3500E-13 2.7400E-11 
Chromosome BB_0745_-_endonuclease_III 95.61633 263.42921 2.75506 4.7000E-09 1.1800E-07 
Chromosome BB_0749_-_hypothetical_protein 7742.32859 25299.29858 3.26766 1.5400E-19 2.1200E-17 
Chromosome BB_0760_-_protein_Gp37 291.22766 598.01648 2.05343 9.8400E-06 8.3500E-05 
Chromosome BB_0761_-_peptidoglycan-binding_protein 330.79366 770.80486 2.33017 1.8600E-09 4.8500E-08 
Chromosome BB_0804_rpsO_30S_ribosomal_protein_S15 1497.35030 3426.07706 2.28809 2.7200E-10 8.3500E-09 
Chromosome BB_0805_-_polyribonucleotide_nucleotidyltransferase 15942.12190 39010.65242 2.44702 3.3100E-11 1.1700E-09 
Chromosome BB_0816_-_hypothetical_protein 2894.45759 6358.50548 2.19679 7.4100E-09 1.6500E-07 
Chromosome BB_0824_-_hypothetical_protein 2919.25038 6057.87705 2.07515 1.3500E-07 2.0100E-06 
lp54 BB_A24_dbpA_decorin-binding_protein_A 34.93355 84.50144 2.41892 4.4707E-04 2.2004E-03 
lp54 BB_A25_dbpB_decorin-binding_protein_B 6.89777 31.30814 4.53888 3.0600E-05 2.2191E-04 
lp54 BB_A36_-_lipoprotein 12.88527 36.93724 2.86663 4.1827E-04 2.0959E-03 
lp54 BB_A43_-_hypothetical_protein 439.52643 1112.01975 2.53004 9.7800E-14 4.8300E-12 
lp54 BB_A52_-_outer_membrane_protein 1295.37613 2897.55834 2.23685 7.8500E-10 2.2600E-08 
lp54 BB_A54_-_hypothetical_protein 477.31298 954.64336 2.00004 1.0800E-06 1.3300E-05 
lp54 BB_A57_-_P45-13 332.67601 698.66503 2.10014 6.4800E-08 1.0500E-06 
lp17 BB_D10_-_lipoprotein 272.05032 739.97786 2.72000 8.4800E-12 3.2600E-10 
lp17 BB_D21_-_hypothetical_protein 611.29346 2321.63739 3.79791 8.0200E-25 1.8500E-22 
lp17 BB_D22_-_hypothetical_protein 146.99470 333.54339 2.26908 4.5100E-06 4.4600E-05 
lp28-1 BB_F0034_-_hypothetical_protein 27.73222 57.76731 2.08304 7.9137E-03 2.4002E-02 
lp28-1 BB_F06_-_hypothetical_protein 13.53798 63.25921 4.67272 1.6600E-07 2.4100E-06 
lp28-1 BB_F17_-_putative_transmembrane_protein 17.69075 50.06402 2.82995 1.0180E-03 4.3762E-03 
lp28-1 BB_F20_-_BBF20 77.05580 205.57919 2.66793 5.9800E-06 5.5800E-05 
lp28-2 BB_G07_-_hypothetical_protein 416.25459 893.57216 2.14670 1.4500E-06 1.6900E-05 
lp28-3 BB_H13_-_protein_RepU 540.60961 1702.16932 3.14861 1.0900E-15 8.3700E-14 
lp28-3 BB_H25_-_hypothetical_protein 6.42698 17.48243 2.72016 2.5555E-03 9.2039E-03 
lp28-3 BB_H26_-_hypothetical_protein 155.23930 527.97732 3.40105 4.5900E-15 3.0300E-13 
lp28-3 BB_H28_-_PF-32_protein 110.03583 234.47743 2.13092 4.0947E-04 2.0668E-03 
lp28-3 BB_H32_-_antigen_P35 111.14145 483.05343 4.34629 2.9400E-20 4.5200E-18 
lp28-3 BB_H33_-_adenine_deaminase 32.94565 86.52038 2.62615 1.6818E-04 9.6112E-04 
lp28-3 BB_H37_-_lipoprotein 750.52454 2173.11902 2.89547 4.2800E-16 3.7000E-14 
lp28-3 BB_H40_-_transposase-like_protein 7.95332 53.29080 6.70045 6.0100E-09 1.4000E-07 
lp28-4 BB_I19_-_hypothetical_protein 903.89487 5957.28429 6.59068 8.0200E-45 2.7700E-42 
lp28-4 BB_I20_-_hypothetical_protein 222.99870 1523.06568 6.82993 1.2200E-45 5.6200E-43 
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lp28-4 BB_I21_-_PF-32_protein 380.95382 4168.23442 10.94157 1.7100E-72 1.1800E-69 
lp28-4 BB_I22_-_PF-49_protein 222.11828 883.32536 3.97682 2.1900E-21 4.3300E-19 
lp28-4 BB_I42_-_outer_membrane_protein 217.53874 442.80318 2.03551 4.5500E-07 6.2900E-06 
lp38 BB_J11_-_hypothetical_protein 6.43141 23.32932 3.62741 9.4475E-04 4.1348E-03 
lp38 BB_J46_-_hypothetical_protein 28.86918 60.42085 2.09292 2.2230E-03 8.3773E-03 
lp38 BB_J47_-_hypothetical_protein 72.88274 183.65030 2.51981 9.2400E-05 5.7545E-04 
lp38 BB_J48_-_hypothetical_protein 80.62931 403.35617 5.00260 5.2800E-21 9.1300E-19 
lp36 BB_K07_-_lipoprotein 48.50724 118.73249 2.44773 3.7100E-06 3.8000E-05 
lp36 BB_K13_-_hypothetical_protein 2291.81895 6905.16629 3.01296 1.1500E-15 8.3700E-14 
lp36 BB_K24_-_PF-49_protein 153.98267 348.32647 2.26211 1.4500E-06 1.6900E-05 
lp36 BB_K32_-_fibronectin-binding_protein 68.00955 193.15493 2.84011 5.5400E-07 7.3700E-06 
lp36 BB_K34_-_hypothetical_protein 70.28427 141.55291 2.01401 2.1375E-03 8.1213E-03 
lp36 BB_K35_-_hypothetical_protein 136.74791 447.24776 3.27060 7.9900E-14 4.2000E-12 
lp36 BB_K40_-_hypothetical_protein 1747.02318 3720.91095 2.12986 1.0900E-08 2.3500E-07 
lp36 BB_K45_-_immunogenic_protein_P37 3440.66137 9172.16224 2.66581 1.5100E-12 6.3200E-11 
lp36 BB_K49_-_hypothetical_protein 710.38768 1428.96830 2.01153 1.2700E-07 1.9400E-06 
lp36 BB_K54_-_hypothetical_protein 17.33747 58.54895 3.37702 4.7400E-05 3.2148E-04 
lp36 BB_L27_bdrP_protein_BdrP 505.53991 1035.08303 2.04748 4.0500E-08 7.0900E-07 
cp32-8 BB_L30_-_hypothetical_protein 1070.05088 2578.75476 2.40994 1.2700E-11 4.7300E-10 
cp32-6 BB_M35_bppA_BppA 20.68947 55.37801 2.67663 1.9263E-04 1.0830E-03 
cp32-6 BB_M36_bppB_BppB 5.56634 17.32319 3.11213 5.2847E-03 1.7360E-02 
cp32-6 BB_M41_-_hypothetical_protein 20.71621 57.66656 2.78364 4.7400E-05 3.2148E-04 
cp32-9 BB_N03_-_hypothetical_protein 14.23059 28.89235 2.03030 1.0977E-02 3.1628E-02 
cp32-9 BB_N27_bdrR_BdrR_protein 246.86230 596.04810 2.41450 1.1200E-08 2.3800E-07 
cp32-9 BB_N28_mlpI_lipoprotein 170.03849 403.07595 2.37050 6.7100E-09 1.5200E-07 
cp32-9 BB_N30_-_hypothetical_protein 709.22242 2301.03966 3.24445 5.5800E-19 6.4400E-17 
cp32-9 BB_N31_-_hypothetical_protein 133.97155 294.35934 2.19718 8.8500E-05 5.5622E-04 
cp32-9 BB_N36_bppB_protein_BppB 7.95341 21.45583 2.69769 1.0862E-03 4.6078E-03 
cp32-9 BB_N42_-_hypothetical_protein 7.79016 34.26490 4.39848 7.8600E-06 6.9700E-05 
cp32-7 BB_O30_-_hypothetical_protein 765.29336 1564.16760 2.04388 3.3400E-08 6.0500E-07 
cp32-7 BB_O36_bppA_protein_BppA 15.49878 48.36667 3.12068 1.6431E-04 9.4289E-04 
cp32-1 BB_P29_-_hypothetical_protein 18.14399 37.75820 2.08103 5.1460E-03 1.7026E-02 
cp32-1 BB_P35_bppA_protein_BppA 21.08284 43.82085 2.07851 1.1526E-02 3.3004E-02 
lp56 BB_Q03_-_outer_membrane_protein 47.78358 114.04540 2.38671 6.7989E-04 3.1553E-03 
lp56 BB_Q05_-_antigen,_P35 16.94388 39.07172 2.30595 8.0483E-03 2.4303E-02 
lp56 BB_Q06_-_membrane_protein 661.17979 1333.83297 2.01735 2.1300E-06 2.3200E-05 
lp56 BB_Q07_-_plasmid_partition_protein 100.54913 449.64366 4.47188 3.9900E-19 5.0200E-17 
lp56 BB_Q22_-_hypothetical_protein 13.10315 39.07406 2.98204 3.2044E-03 1.1135E-02 
lp56 BB_Q34_bdrW_protein_BdrW_protein 288.84376 911.49132 3.15566 5.5000E-15 3.4600E-13 
lp56 BB_Q37_-_hypothetical_protein 13.89577 42.82579 3.08193 2.9993E-04 1.5653E-03 
lp56 BB_Q38_-_hypothetical_protein 1248.46277 5800.00611 4.64572 9.0700E-32 2.5100E-29 
lp56 BB_Q39_-_hypothetical_protein 183.88882 702.51359 3.82032 7.4400E-19 7.9200E-17 
lp56 BB_Q40_-_PF-32_protein 492.53750 1117.06114 2.26797 5.5000E-08 9.0500E-07 
lp56 BB_Q43_bppA_protein_BppA 10.20867 39.99468 3.91772 1.3400E-04 7.9882E-04 
lp56 BB_Q45_bppC_protein_BppC 1.15948 10.99358 9.48150 1.0567E-04 6.4378E-04 
lp56 BB_Q54_-_hypothetical_protein 4.66050 18.94375 4.06474 1.5590E-03 6.2677E-03 
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cp32-4 BB_R27_bdrH_BdrH 180.60636 463.01786 2.56369 1.2300E-08 2.5300E-07 
cp32-4 BB_R31_-_hypothetical_protein 646.72266 1811.64243 2.80127 1.4000E-14 8.0500E-13 
cp32-4 BB_R32_-_hypothetical_protein 195.31099 714.08627 3.65615 1.2400E-18 1.2300E-16 
cp32-4 BB_R33_-_plasmid_partition_protein,_putative 224.08252 472.30089 2.10771 4.9800E-06 4.8600E-05 
cp32-4 BB_R36_bppA_BppA 14.47084 43.04487 2.97459 2.0997E-03 8.0218E-03 
cp32-4 BB_R44_-_hypothetical_protein 30.57151 133.75231 4.37506 1.5900E-10 5.0000E-09 
cp32-4 BB_R45_-_phage_terminase_large_subunit 21.03824 52.22975 2.48261 9.4196E-04 4.1348E-03 
cp32-3 BB_S31_-_hypothetical_protein 12.49136 34.58624 2.76881 4.9315E-03 1.6514E-02 
cp32-3 BB_S33_-_hypothetical_protein 1198.02898 2602.04408 2.17194 1.1500E-08 2.4000E-07 
cp32-3 BB_S34_-_hypothetical_protein 195.50969 404.33451 2.06810 4.7100E-05 3.2148E-04 
cp32-3 BB_S38_bppA_protein_BppA 13.51524 36.66507 2.71287 5.5863E-04 2.6826E-03 
cp32-3 BB_S44_-_hypothetical_protein 46.26957 93.94267 2.03033 2.2390E-03 8.4146E-03 
lp5 BB_T04_-_hypothetical_protein 17.80917 58.02374 3.25808 4.6000E-05 3.1627E-04 
lp21 BB_U05_-_PF-32_protein 144.17353 327.57493 2.27209 1.8700E-06 2.1000E-05 
lp28-2 frameshift_BB_G03_BB_G03 30.61363 67.35336 2.20011 6.3023E-03 2.0242E-02 
Chromosome Rfam_ncRNA1_NC_001318_SRP_bact_Rfam_annotation 3242.23709 37127.73015 11.45127 3.9000E-73 5.4000E-70       
Those in (A) lower and (B) higher abundance in early-exponential compared to stationary phase. Genes are listed which were 
identified by DEseq [9] as differentially expressed by meeting the criteria of >2X greater abundance and an adjusted P-value of <.05. 
In order from left to right columns list genetic element on which a given gene resides, the gene ID, the early-log expression, 
stationary expression, fold change, P-value, adjusted P-value. 
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Table 8-4 Identified Intrinsic Terminators 
 
Genetic Element Start Location Strand Length Program Predicted Score Relative Location 
Chromosome 18193 - 40 T |T90 5' 
Chromosome 60406 - 36 R |R-10.80 5' 
Chromosome 80830 + 34 T |T100 3' 
Chromosome 82961 + 22 T |T90 3' 
Chromosome 82961 - 22 T |T93 3' 
Chromosome 101510 - 28 B |T100|R-10.20 3' 
Chromosome 147616 - 31 T |T100 3' 
Chromosome 174407 - 19 T |T91 Internal   
Chromosome 250131 + 24 B |T93|R-9.40 3' 
Chromosome 318984 - 25 T |T100 5' 
Chromosome 329204 + 27 B |T100|R-9.50 Intergenic 
Chromosome 346385 + 20 T |T90 3' 
Chromosome 373548 - 31 T |T100 3' 
Chromosome 374673 + 33 X |F-14.1|F-14.1|R-12.30 Internal   
Chromosome 375954 + 19 T |T91 3' 
Chromosome 375958 - 27 T |T100 3' 
Chromosome 395347 - 28 T |T89 Intergenic 
Chromosome 396600 - 24 T |T100 3' 
Chromosome 401007 + 31 R |R-9.20 Intergenic 
Chromosome 418385 - 29 T |T100 3' 
Chromosome 438133 - 22 T |T90 5' 
Chromosome 441378 - 22 T |T90 5' 
Chromosome 442676 - 39 T |T95 3' 
Chromosome 443427 - 30 T |T95 Intergenic 
Chromosome 443570 - 38 T |T100 Intergenic 
Chromosome 450538 - 39 R |R-10.30 Internal AS 
Chromosome 450929 + 30 T |T95 3' 
Chromosome 452017 - 27 T |T100 3' 
Chromosome 465177 + 22 T |T90 3' 
Chromosome 467880 + 35 R |R-10.30 Internal AS 
Chromosome 474740 + 38 R |R-9.50 5' 
Chromosome 492515 + 45 T |T95 5' 
Chromosome 526296 + 44 T |T93 5' 
Chromosome 526427 + 34 R |R-11.40 5' 
Chromosome 547443 + 42 T |T100 3' 
Chromosome 552277 + 37 R |R-9.10 Intergenic 
Chromosome 552301 + 32 T |T100 Intergenic 
Chromosome 571876 - 26 B |T100|R-11.00 3' 
Chromosome 571876 + 26 T |T95 3' 
Chromosome 571889 + 52 T |T100 3' 
Chromosome 614014 + 35 T |T100 3' 
Chromosome 614014 - 35 T |T100 3' 
Chromosome 627083 + 23 B |T100|R-10.80 3' 
Chromosome 627085 - 26 Z |F-13.2|T100|R-11.60|T100|R-11.60|F-13.2 3' 
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Chromosome 636072 + 31 T |T100 Intergenic 
Chromosome 642464 - 23 T |T95 3' 
Chromosome 642464 + 23 T |T100 3' 
Chromosome 656159 + 34 T |T100 Internal   
Chromosome 659662 + 37 T |T100 3' 
Chromosome 662592 + 31 T |T100 3' 
Chromosome 676381 + 32 T |T93 3' 
Chromosome 677871 + 37 T |T100 3' 
Chromosome 677871 - 37 T |T100 3' 
Chromosome 685007 + 40 T |T100 3' 
Chromosome 690167 + 37 T |T100 5' 
Chromosome 698379 + 27 T |T100 3' 
Chromosome 699222 + 29 F |F-13.5 Internal AS 
Chromosome 717948 + 33 R |R-9.40 Internal AS 
Chromosome 726570 + 16 T |T91 5' 
Chromosome 726722 + 26 T |T100 Internal   
Chromosome 745262 + 44 T |T91 5' 
Chromosome 789031 + 27 T |T100 3' 
Chromosome 829116 + 29 T |T95 3' 
Chromosome 855659 + 30 T |T100 Internal   
Chromosome 856869 + 40 T |T100 Internal   
Chromosome 868783 - 33 R |R-10.90 3' 
Chromosome 897051 - 45 T |T100 5' 
cp26 2425 - 25 T |T100 3' 
cp26 10071 + 44 T |T100 3' 
cp26 10078 + 58 T |T100 3' 
cp26 10808 + 23 T |T93 Intergenic 
cp26 13689 + 28 T |T95 Intergenic 
cp26 13693 - 36 T |T100 Intergenic 
cp26 17625 + 35 T |T95 3' 
cp32-1 11976 - 37 R |R-10.40 3' 
cp32-1 16546 - 41 T |T91 3' 
cp32-1 16546 + 41 T |T89 5' 
cp32-1 17704 - 22 T |T100 3' 
cp32-1 17704 + 22 B |T100|R-9.10 3' Antisense 
cp32-1 23141 + 47 T |T100 5' 
cp32-1 27996 + 36 T |T100 Intergenic 
cp32-3 11976 - 37 R |R-10.40 5' Antisense 
cp32-3 18276 + 22 B |T91|R-9.60 3' 
cp32-3 23322 + 47 T |T93 Intergenic 
cp32-3 23600 + 57 T |T89 5' 
cp32-3 28045 + 32 T |T100 Intergenic 
cp32-4 11920 - 37 R |R-10.40 5' Antisense 
cp32-4 22452 + 47 T |T90 3' 
cp32-4 22747 + 59 T |T95 5' 
cp32-6 11986 - 37 R |R-10.40 5' Antisense 
cp32-6 16561 - 41 T |T100 3' 
cp32-6 17722 + 22 B |T95|R-9.60 3' 
cp32-6 23154 + 53 T |T93 5' 
cp32-6 27051 + 33 R |R-10.10 3' Antisense 
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cp32-6 27076 - 36 B |T100|T100|T100|R-9.70 3' 
cp32-6 27076 + 36 T |T100 3' 
cp32-7 17691 + 22 T |T100 3' 
cp32-7 21524 - 35 R |R-11.10 3' Antisense 
cp32-8 11976 - 37 R |R-10.40 5' Antisense 
cp32-8 17677 + 22 B |T95|R-9.60 3' 
cp32-8 22703 + 34 T |T93 3' 
cp32-8 22973 + 43 T |T100 Intergenic 
cp32-8 23120 + 47 T |T100 Intergenic 
cp32-8 28131 + 36 T |T100 3' 
cp32-9 12065 - 37 R |R-10.40 5' Antisense 
cp32-9 18918 + 47 T |T93 Intergenic 
cp32-9 22815 + 47 T |T95 3' 
cp32-9 27906 + 37 T |T100 3' 
lp17 1820 + 30 T |T93 3' 
lp17 1828 + 46 T |T88 3' 
lp17 2893 + 46 T |T89 5' 
lp17 4289 - 23 T |T89 Intergenic 
lp17 15920 + 60 T |T100 Internal AS 
lp21 1296 - 50 T |T100 Intergenic 
lp21 16221 + 26 T |T91 3' Antisense 
lp21 16230 + 44 T |T100 3' Antisense 
lp21 16231 - 46 T |T100 3' 
lp25 2308 + 28 R |R-9.20 Internal   
lp25 4262 - 29 T |T100 3' Antisense 
lp25 8042 - 42 T |T100 Intergenic 
lp25 14992 - 22 T |T90 3' 
lp25 18583 + 36 T |T100 Intergenic 
lp25 21876 + 41 B |T95|T100|R-10.30 3' Antisense 
lp25 21912 - 29 T |T100 3' 
lp25 21912 + 29 T |T100 3' Antisense 
lp28-1 5051 + 50 T |T95 3' 
lp28-1 5863 - 17 T |T100 3' 
lp28-1 12235 - 60 T |T100 3' 
lp28-2 2127 - 36 T |T88 5' Antisense 
lp28-2 2130 + 42 T |T93 5' 
lp28-2 6713 + 20 T |T100 3' 
lp28-2 7374 - 29 T |T100 3' 
lp28-2 7374 + 29 T |T90 3' 
lp28-2 27059 + 33 R |R-9.90 3' 
lp28-3 7820 - 49 T |T100 5' 
lp28-3 8250 - 26 T |T100 Internal AS 
lp28-3 9507 - 26 R |R-9.50 Intergenic 
lp28-3 11471 - 34 F |F-14.2 Intergenic 
lp28-3 19697 + 36 T |T100 Intergenic 
lp28-3 24459 - 37 T |T100 Intergenic 
lp28-3 25391 - 28 B |T100|T95|R-10.30 3' 
lp28-4 1414 - 51 T |T100 Intergenic 
lp28-4 1573 + 35 T |T100 5' 
lp28-4 1573 - 35 T |T88 5' Antisense 
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lp28-4 1579 + 47 T |T100 5' 
lp28-4 3361 + 34 T |T100 3' 
lp28-4 3361 - 34 T |T100 3' Antisense 
lp28-4 6892 - 37 R |R-10.60 3' Antisense 
lp28-4 7122 + 48 T |T100 5' 
lp28-4 10568 - 55 T |T100 3' 
lp28-4 13241 + 21 T |T88 3' 
lp28-4 16687 + 39 T |T100 3' 
lp28-4 20741 + 32 T |T100 3' Antisense 
lp28-4 24085 - 39 T |T100 3' 
lp28-4 24180 - 23 T |T93 5' 
lp36 11104 + 34 F |F-13.1 Internal   
lp36 13271 + 30 R |R-11.40 3' Antisense 
lp36 13288 - 30 R |R-12.20 3' 
lp36 17353 + 26 T |T100 5' 
lp36 17815 + 57 T |T100 5' 
lp36 23749 - 31 T |T91 5' 
lp36 24698 + 24 T |T93 3' 
lp36 24785 + 26 T |T90 3' 
lp36 25791 - 50 T |T91 3' 
lp36 34370 + 26 T |T91 3' Antisense 
lp54 1167 + 47 T |T100 3' 
lp54 1943 + 35 R |R-9.20 3' 
lp54 1973 + 44 T |T100 3' 
lp54 9211 + 21 T |T100 3' 
lp54 11238 + 31 T |T95 3' 
lp54 14964 + 57 T |T100 3' 
lp54 15880 + 35 R |R-9.40 3' 
lp54 15897 - 38 R |R-9.60 3' 
lp54 15902 + 29 T |T100 3' 
lp54 21595 + 27 T |T100 3' 
lp54 21605 - 47 T |T100 3' 
lp54 21606 + 49 T |T100 3' 
lp54 24397 + 29 T |T100 3' 
lp54 25094 - 34 R |R-10.20 3' 
lp54 25094 + 27 B |T89|R-10.90 3' Antisense 
lp54 42536 - 34 X |F-15.2|R-9.70 3' 
lp54 43598 - 21 T |T100 3' 
lp54 44590 - 24 T |T89 3' 
lp54 46365 - 23 T |T91 3' 
lp54 48375 - 23 T |T100 5' 
lp54 49326 - 23 T |T91 Intergenic 
lp56 658 + 41 T |T100 Intergenic 
lp56 15466 - 37 R |R-10.40 5' 
lp56 21521 + 22 B |T95|R-9.10 3' 
lp56 25293 - 31 R |R-9.70 3' Antisense 
lp56 25294 + 25 T |T91 3' 
lp56 26565 + 47 T |T100 Intergenic 
lp56 31052 + 37 T |T100 3' 
lp56 37706 + 29 T |T100 3' 
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lp56 37706 - 29 T |T100 3' Antisense 
lp56 44259 - 31 T |T100 Internal   
lp56 45722 + 33 T |T100 3' Antisense 
lp56 45748 + 33 T |T100 3' Antisense 
lp56 47723 + 37 R |R-10.40 3' Antisense 
lp56 47747 + 31 T |T100 3' Antisense 
lp56 51144 - 30 T |T100 3' 
 
 
The full list of predicted intrinsic terminators predicted by the SIPHT pipeline [190]. Included is are the genetic element, start location, 
strand, length, program predicted (T: TransTerm, R: RNAMotif, F: FindTerm, B: RNAMotif and TransTerm, X: RNAMotif and FindTerm, 
Z: RNAMotif, FindTerm, and TransTerm), score as described in materials and methods, and relative location compared to nearby 
genes. 
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Table 8-5 Putative non-coding RNAs 
Genetic 
Element Start End Strand 
Relative 
Location Length Flanking Genes 
Chromosome 3138 3343 - PI 205 (BB_0003,BB_0003/BB_0004) 
Chromosome 4958 5220 - AI 262 (BB_0004,BB_0004/BB_0005) 
Chromosome 10770 11082 - A 312 (BB_0011) 
Chromosome 12221 12447 - A 226 (BB_0013) 
Chromosome 13593 13767 - A 174 (BB_0014) 
Chromosome 45459 45739 - A 280 (BB_0046) 
Chromosome 46621 46688 - I 67 (BB_t25/BB_0050) 
Chromosome 46721 47049 - I 328 (BB_t25/BB_0050) 
Chromosome 65600 65790 - AIA 190 (BB_0070,BB_0070/BB_0071,BB_0071) 
Chromosome 68049 68243 - A 194 (BB_0072) 
Chromosome 73802 74090 - A 288 (BB_0077) 
Chromosome 80390 80539 - A 149 (BB_0084) 
Chromosome 151461 151753 - A 292 (BB_0151) 
Chromosome 170239 170515 - A 276 (BB_0167) 
Chromosome 182989 183252 - A 263 (BB_0180) 
Chromosome 184976 185175 - A 199 (BB_0181) 
Chromosome 185214 185535 - AA 321 (BB_0181,BB_0182) 
Chromosome 188516 188703 - I 187 (BB_0187/BB_0188) 
Chromosome 194536 194807 - A 271 (BB_0196) 
Chromosome 196949 197248 - A 299 (BB_0198) 
Chromosome 197645 197876 - AA 231 (BB_0198,BB_0199) 
Chromosome 204521 204670 - A 149 (BB_0203) 
Chromosome 204756 205105 - AI 349 (BB_0203,BB_0203/BB_0204) 
Chromosome 207622 207750 - A 128 (BB_0205) 
Chromosome 209719 209942 - A 223 (BB_0208) 
Chromosome 214966 215257 - A 291 (BB_0210) 
Chromosome 216412 216605 - A 193 (BB_0211) 
Chromosome 221798 222147 - A 349 (BB_0217) 
Chromosome 233386 233669 - A 283 (BB_0228) 
Chromosome 245893 246071 - A 178 (BB_0240) 
Chromosome 253173 253408 - A 235 (BB_0248) 
Chromosome 255770 255850 - A 80 (BB_0250) 
Chromosome 255889 256097 - A 208 (BB_0250) 
Chromosome 256196 256297 - AI 101 (BB_0250,BB_0250/BB_0251) 
Chromosome 340422 340650 - A 228 (BB_0332) 
Chromosome 343370 343557 - A 187 (BB_0335) 
Chromosome 355816 356079 - A 263 (BB_0347) 
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Chromosome 356096 356234 - A 138 (BB_0347) 
Chromosome 369356 369471 - A 115 (BB_0361) 
Chromosome 369531 369724 - A 193 (BB_0361) 
Chromosome 384357 384598 - A 241 (BB_0374) 
Chromosome 416715 416960 - A 245 (BB_0404) 
Chromosome 422883 423198 - pA 315 (BB_0411,BB_0412) 
Chromosome 457756 458089 - AI 333 (BB_0437,BB_0437/BB_0438) 
Chromosome 458090 458187 - I 97 (BB_0437/BB_0438) 
Chromosome 483157 483283 - A 126 (BB_0461) 
Chromosome 486699 486997 - AA 298 (BB_0465,BB_0466) 
Chromosome 505982 506228 - A 246 (BB_0498) 
Chromosome 507282 507483 - AIA 201 (BB_0500,BB_0500/BB_0501,BB_0501) 
Chromosome 514725 514976 - A 251 (BB_0509) 
Chromosome 532104 532282 - p 178 (BB_0522) 
Chromosome 568895 569212 - AI 317 (BB_0556,BB_0556/BB_0557) 
Chromosome 596657 596815 - A 158 (BB_0581) 
Chromosome 600533 600717 - A 184 (BB_0583) 
Chromosome 607274 607419 - A 145 (BB_0588) 
Chromosome 607443 607706 - A 263 (BB_0588) 
Chromosome 631847 631985 - A 138 (BB_0605) 
Chromosome 633675 633894 - A 219 (BB_0607) 
Chromosome 634228 634508 - AI 280 (BB_0607,BB_0607/BB_0608) 
Chromosome 638554 638848 - AIA 294 (BB_0611,BB_0611/BB_0612,BB_0612) 
Chromosome 639730 640018 - AA 288 (BB_0612,BB_0613) 
Chromosome 640045 640384 - A 339 (BB_0613) 
Chromosome 642343 642433 - A 90 (BB_0614) 
Chromosome 644836 644890 - A 54 (BB_0617) 
Chromosome 662384 662550 - AI 166 (BB_0630,BB_0630/BB_0631) 
Chromosome 688561 688679 - A 118 (BB_0649) 
Chromosome 688729 688888 - A 159 (BB_0649) 
Chromosome 690193 690481 - A 288 (BB_0650) 
Chromosome 696333 696589 - A 256 (BB_0656) 
Chromosome 702007 702116 - A 109 (BB_0663) 
Chromosome 719746 719903 - A 157 (BB_0680) 
Chromosome 730109 730199 - A 90 (BB_0688) 
Chromosome 737294 737634 - A 340 (BB_0697) 
Chromosome 745726 745823 - A 97 (BB_0709) 
Chromosome 751060 751257 - IA 197 (BB_0713/BB_0714,BB_0714) 
Chromosome 758380 758598 - A 218 (BB_0720) 
Chromosome 819269 819400 - A 131 (BB_0780) 
Chromosome 831811 831882 - A 71 (BB_0794) 
Chromosome 831883 832089 - A 206 (BB_0794) 
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Chromosome 836043 836345 - AIA 302 (BB_0794,BB_0794/BB_0795,BB_0795) 
Chromosome 839756 840096 - A 340 (BB_0797) 
Chromosome 841129 841360 - A 231 (BB_0797) 
Chromosome 844393 844581 - AA 188 (BB_0800,BB_0801) 
Chromosome 855692 855935 - A 243 (BB_0809) 
cp26 7474 7782 - AI 308 (BB_B09,BB_B09/BB_B10) 
cp32-1 49 327 - IA 278 (ORIG/BB_P01,BB_P01) 
cp32-1 1250 1340 - AIA 90 (BB_P01,BB_P01/BB_P02,BB_P02) 
cp32-1 1341 1590 - A 249 (BB_P02) 
cp32-1 11284 11597 - A 313 (BB_P17) 
cp32-1 13522 13823 - AIA 301 (BB_P20,BB_P20/BB_P21,BB_P21) 
cp32-1 14010 14287 - A 277 (BB_P21) 
cp32-1 18857 18932 - I 75 (BB_P29/BB_P30) 
cp32-1 19138 19264 - A 126 (BB_P30) 
cp32-1 21537 21716 - IA 179 (BB_P32/BB_P33,BB_P33) 
cp32-1 24537 24688 - AIA 151 (BB_P35,BB_P35/BB_P36,BB_P36) 
cp32-3 7415 7729 - A 314 (BB_S11) 
cp32-3 19351 19491 - I 140 (BB_S31/BB_S33) 
cp32-3 19564 19879 - IA 315 (BB_S31/BB_S33,BB_S33) 
cp32-3 24999 25148 - AIA 149 (BB_S38,BB_S38/BB_S39,BB_S39) 
cp32-5 30 266 - IA 236 (ORIG/BB_R01,BB_R01) 
cp32-5 1275 1590 - AIp 315 (BB_R01,BB_R01/BB_R02,BB_R02) 
cp32-5 3569 3690 - A 121 (BB_R05) 
cp32-5 11273 11539 - A 266 (BB_R17) 
cp32-5 13475 13776 - AIA 301 (BB_R20,BB_R20/BB_R21,BB_R21) 
cp32-5 13989 14240 - A 251 (BB_R21) 
cp32-5 18707 18773 - I 66 (BB_R29/BB_R31) 
cp32-5 22102 22331 - p 229 (BB_R35) 
cp32-5 24136 24289 - AIA 153 (BB_R36,BB_R36/BB_R37,BB_R37) 
cp32-5 25969 26191 - IA 222 (BB_R38/BB_R41,BB_R41) 
cp32-5 27950 28167 - A 217 (BB_R43) 
cp32-5 28990 29272 - A 282 (BB_R45) 
cp32-6 41 266 - IA 225 (ORIG/BB_M01,BB_M01) 
cp32-6 1221 1283 - A 62 (BB_M01) 
cp32-6 1284 1587 - AIA 303 (BB_M01,BB_M01/BB_M02,BB_M02) 
cp32-6 6854 7140 - A 286 (BB_M11) 
cp32-6 15927 16126 - AA 199 (BB_M25,BB_M26) 
cp32-6 18799 18884 - I 85 (BB_M29/BB_M30) 
cp32-6 19051 19341 - IA 290 (BB_M29/BB_M30,BB_M30) 
cp32-6 24567 24698 - IA 131 (BB_M35/BB_M36,BB_M36) 
cp32-7 34 265 - IA 231 (ORIG/BB_O01,BB_O01) 
cp32-7 1247 1586 - AIA 339 (BB_O01,BB_O01/BB_O02,BB_O02) 
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cp32-7 10840 11094 - AA 254 (BB_O16,BB_O17) 
cp32-7 12523 12723 - A 200 (BB_O19) 
cp32-7 16855 17185 - AI 330 (BB_O27,BB_O27/BB_O28) 
cp32-7 18851 18934 - I 83 (BB_O29/BB_O30) 
cp32-7 21498 21704 - AIA 206 (BB_O32,BB_O32/BB_O33,BB_O33) 
cp32-7 23214 23460 - A 246 (BB_O36) 
cp32-7 23461 23718 - A 257 (BB_O36) 
cp32-7 24440 24664 - AIA 224 (BB_O36,BB_O36/BB_O37,BB_O37) 
cp32-7 26199 26459 - A 260 (BB_O39) 
cp32-7 29877 30102 - A 225 (BB_O44) 
cp32-8 34 266 - IA 232 (ORIG/BB_L01,BB_L01) 
cp32-8 822 1071 - A 249 (BB_L01) 
cp32-8 1275 1595 - AIA 320 (BB_L01,BB_L01/BB_L02,BB_L02) 
cp32-8 7106 7351 - A 245 (BB_L11) 
cp32-8 7384 7729 - A 345 (BB_L11) 
cp32-8 8850 9091 - AIA 241 (BB_L14,BB_L14/BB_L15,BB_L15) 
cp32-8 13521 13805 - AIA 284 (BB_L20,BB_L20/BB_L21,BB_L21) 
cp32-8 18832 18915 - I 83 (BB_L29/BB_L30) 
cp32-8 18916 19180 - IA 264 (BB_L29/BB_L30,BB_L30) 
cp32-8 19437 19601 - A 164 (BB_L30) 
cp32-8 22038 22356 - pIA 318 (BB_L34,BB_L34/BB_L35,BB_L35) 
cp32-8 22390 22605 - A 215 (BB_L35) 
cp32-8 22607 22659 - A 52 (BB_L35) 
cp32-8 23515 23714 - A 199 (BB_L36) 
cp32-8 24709 24823 - IA 114 (BB_L36/BB_L37,BB_L37) 
cp32-8 29614 29826 - A 212 (BB_L43) 
cp32-9 36 383 - IA 347 (ORIG/BB_N01,BB_N01) 
cp32-9 910 1155 - A 245 (BB_N01) 
cp32-9 2841 3089 - A 248 (BB_N04) 
cp32-9 3090 3146 - A 56 (BB_N04) 
cp32-9 3556 3695 - p 139 (BB_N05) 
cp32-9 11418 11684 - A 266 (BB_N17) 
cp32-9 13620 13919 - AI 299 (BB_N20,BB_N20/BB_N23) 
cp32-9 14509 14771 - I 262 (BB_N20/BB_N23) 
cp32-9 18910 18980 - I 70 (BB_N29/BB_N30) 
cp32-9 20362 20577 - A 215 (BB_N31) 
cp32-9 21585 21762 - IA 177 (BB_N32/BB_N33,BB_N33) 
cp32-9 22491 22727 - AI 236 (BB_N34,BB_N34/BB_N35) 
cp32-9 24150 24494 - A 344 (BB_N35) 
cp32-9 24501 24651 - AIA 150 (BB_N35,BB_N35/BB_N36,BB_N36) 
cp32-9 25613 25814 - PI 201 (BB_N37,BB_N37/BB_N38) 
cp32-9 27124 27222 - A 98 (BB_N39) 
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cp32-9 27250 27434 - A 184 (BB_N39) 
lp17 3621 3926 - IAI 305 (BB_D05a/BB_D0027,BB_D0027,BB_D0027/BB_D09) 
lp17 7977 8261 - AI 284 (BB_D13,BB_D13/BB_D14) 
lp17 11859 12179 - I 320 (BB_D18/BB_D20) 
lp17 12393 12594 - p 201 (BB_D20) 
lp17 14378 14580 - I 202 (BB_D22/BB_D23) 
lp17 15329 15576 - p 247 (BB_D23) 
lp21 1281 1340 - I 59 (BB_U02/BB_U04) 
lp21 3250 3464 - A 214 (BB_U05) 
lp25 4719 4998 - I 279 (BB_E02/BB_E05) 
lp25 6929 7014 - A 85 (BB_E09) 
lp25 7048 7300 - A 252 (BB_E09) 
lp25 7339 7559 - A 220 (BB_E09) 
lp25 18592 18830 - I 238 (BB_E23b/BB_E29a) 
lp28-1 2896 3098 - pI 202 (BB_F05,BB_F05/BB_F06) 
lp28-1 5538 5644 - PI 106 (BB_F11a,BB_F11a/BB_F12) 
lp28-1 5717 5904 - I 187 (BB_F11a/BB_F12) 
lp28-1 7968 8218 - Ip 250 (BB_F14/BB_F14a,BB_F14a) 
lp28-1 8230 8462 - pIp 232 (BB_F14a,BB_F14a/BB_F16,BB_F16) 
lp28-2 2703 2761 - I 58 (BB_G02/BB_G05) 
lp28-2 3997 4057 - PI 60 (BB_G05,BB_G05/BB_G06) 
lp28-2 4836 5053 - p 217 (BB_G06) 
lp28-2 5846 6131 - AA 285 (BB_G07,BB_G08) 
lp28-2 7147 7360 - AI 213 (BB_G09,BB_G09/BB_G10) 
lp28-2 24365 24490 - IA 125 (BB_G28/BB_G29,BB_G29) 
lp28-2 26781 26974 - A 193 (BB_G31) 
lp28-3 567 865 - AI 298 (BB_H02,BB_H02/BB_H04) 
lp28-3 12492 12734 - p 242 (BB_H18) 
lp28-3 17744 18093 - AA 349 (BB_H27,BB_H28) 
lp28-3 20533 20795 - P 262 (BB_H30) 
lp28-4 2676 2939 - A 263 (BB_I06) 
lp28-4 9653 9828 - I 175 (BB_I16/BB_I18) 
lp28-4 16650 16806 - I 156 (BB_I26/BB_I28) 
lp36 4408 4509 - I 101 (BB_K02a/BB_K07) 
lp36 11123 11338 - A 215 (BB_K17) 
lp36 13006 13099 - A 93 (BB_K19) 
lp36 13100 13235 - A 135 (BB_K19) 
lp36 18451 18615 - I 164 (BB_K55/BB_K56) 
lp36 20890 21158 - A 268 (BB_K32) 
lp36 21748 21985 - AIA 237 (BB_K33,BB_K33/BB_K34,BB_K34) 
lp38 4651 4887 - A 236 (BB_J08) 
lp38 7242 7498 - IpI 256 (BB_J09/BB_J10,BB_J10,BB_J10/BB_J11) 
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lp38 24304 24559 - I 255 (BB_J31/BB_J34) 
lp54 5792 5997 - A 205 (BB_A09) 
lp54 5998 6196 - A 198 (BB_A09) 
lp54 6826 7065 - A 239 (BB_A10) 
lp54 8332 8588 - AA 256 (BB_A12,BB_A13) 
lp54 11291 11411 - I 120 (BB_A16/BB_A18) 
lp54 11429 11584 - I 155 (BB_A16/BB_A18) 
lp54 17615 17934 - I 319 (BB_A25/BB_A30) 
lp54 18551 18781 - AA 230 (BB_A30,BB_A31) 
lp54 25129 25436 - I 307 (BB_A37/BB_A38) 
lp54 41157 41315 - I 158 (BB_A60/BB_A61) 
lp54 46069 46402 - I 333 (BB_A66/BB_A68) 
lp56 209 462 - Ip 253 (ORIG/BB_Q01,BB_Q01) 
lp56 1555 1808 - p 253 (BB_Q04) 
lp56 1809 2066 - p 257 (BB_Q04) 
lp56 10965 11199 - A 234 (BB_Q18) 
lp56 17021 17322 - AIA 301 (BB_Q27,BB_Q27/BB_Q28,BB_Q28) 
lp56 22607 22685 - I 78 (BB_Q37/BB_Q38) 
lp56 23213 23378 - A 165 (BB_Q38) 
lp56 26125 26421 - A 296 (BB_Q42) 
lp56 28226 28487 - AIA 261 (BB_Q43,BB_Q43/BB_Q44,BB_Q44) 
lp56 30445 30657 - A 212 (BB_Q47) 
lp56 33856 34073 - Ip 217 (BB_Q50/BB_Q51,BB_Q51) 
lp56 35061 35151 - pIA 90 (BB_Q51,BB_Q51/BB_Q52,BB_Q52) 
lp56 35152 35396 - A 244 (BB_Q52) 
lp56 46941 47073 - I 132 (BB_Q74/BB_Q79) 
lp56 47245 47448 - Ip 203 (BB_Q74/BB_Q79,BB_Q79) 
Chromosome 6195 6515 + AA 320 (BB_0005,BB_0006) 
Chromosome 7248 7531 + AIA 283 (BB_0006,BB_0006/BB_0007,BB_0007) 
Chromosome 120029 120216 + A 187 (BB_0123) 
Chromosome 120217 120446 + A 229 (BB_0123) 
Chromosome 124199 124455 + A 256 (BB_0128) 
Chromosome 141334 141680 + p 346 (BB_0140) 
Chromosome 141689 141950 + p 261 (BB_0140) 
Chromosome 177495 177787 + A 292 (BB_0175) 
Chromosome 188410 188590 + AI 180 (BB_0187,BB_0187/BB_0188) 
Chromosome 191997 192165 + A 168 (BB_0194) 
Chromosome 227226 227555 + A 329 (BB_0221) 
Chromosome 230783 231006 + A 223 (BB_0226) 
Chromosome 250385 250588 + A 203 (BB_0244) 
Chromosome 267323 267566 + A 243 (BB_0257) 
Chromosome 270114 270374 + A 260 (BB_0258) 
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Chromosome 282439 282700 + AIA 261 (BB_0269,BB_0269/BB_0270,BB_0270) 
Chromosome 297224 297529 + AA 305 (BB_0287,BB_0288) 
Chromosome 299202 299426 + A 224 (BB_0289) 
Chromosome 324866 325152 + A 286 (BB_0318) 
Chromosome 367322 367588 + A 266 (BB_0359) 
Chromosome 388221 388453 + A 232 (BB_0378) 
Chromosome 390486 390673 + A 187 (BB_0381) 
Chromosome 406812 407029 + AA 217 (BB_0392,BB_0393) 
Chromosome 410470 410691 + I 221 (BB_0398/BB_0399) 
Chromosome 466326 466588 + A 262 (BB_0446) 
Chromosome 470513 470715 + A 202 (BB_0450) 
Chromosome 473513 473700 + A 187 (BB_0454) 
Chromosome 482310 482471 + I 161 (BB_t06/BB_0461) 
Chromosome 564460 564719 + A 259 (BB_0553) 
Chromosome 650007 650319 + A 312 (BB_0622) 
Chromosome 650660 650847 + A 187 (BB_0623) 
Chromosome 666067 666279 + A 212 (BB_0633) 
Chromosome 668772 669065 + p 293 (BB_0634) 
Chromosome 700413 700621 + A 208 (BB_0660) 
Chromosome 700661 700847 + A 186 (BB_0660) 
Chromosome 750817 751164 + I 347 (BB_0713/BB_0714) 
Chromosome 768395 768595 + A 200 (BB_0729) 
Chromosome 791352 791701 + A 349 (BB_0747) 
Chromosome 807263 807441 + A 178 (BB_0765) 
Chromosome 810040 810389 + A 349 (BB_0768) 
Chromosome 812086 812343 + A 257 (BB_0770) 
Chromosome 814113 814435 + A 322 (BB_0772) 
Chromosome 881440 881713 + A 273 (BB_0833) 
Chromosome 885663 885968 + A 305 (BB_0834) 
Chromosome 905118 905387 + pI 269 (BB_0845a,BB_0845a/BB_0845b) 
cp26 856 1050 + A 194 (BB_B03) 
cp26 1972 2272 + AI 300 (BB_B03,BB_B03/BB_B04) 
cp26 2273 2436 + I 163 (BB_B03/BB_B04) 
cp26 10733 10815 + I 82 (BB_B13/BB_B14) 
cp26 19419 19748 + IA 329 (BB_B22/BB_B23,BB_B23) 
cp26 19749 19819 + A 70 (BB_B23) 
cp26 19820 20014 + A 194 (BB_B23) 
cp26 20689 20829 + AI 140 (BB_B23,BB_B23/BB_B24) 
cp26 22625 22781 + A 156 (BB_B27) 
cp32-1 18165 18333 + A 168 (BB_P29) 
cp32-6 17753 18101 + A 348 (BB_M29) 
cp32-6 18102 18259 + A 157 (BB_M29) 
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lp17 2639 2711 + I 72 (BB_D04/BB_D05a) 
lp17 3121 3189 + P 68 (BB_D05a) 
lp17 11705 11846 + I 141 (BB_D18/BB_D20) 
lp17 16230 16515 +   285 ) 
lp25 3803 4067 + p 264 (BB_E02) 
lp25 12558 12885 + AA 327 (BB_E19,BB_E20) 
lp25 21073 21319 + IP 246 (BB_E23b/BB_E29a,BB_E29a) 
lp25 22726 23036 + I 310 (BB_E31/BB_E33) 
lp25 23037 23334 + I 297 (BB_E31/BB_E33) 
lp25 23583 23822 + I 239 (BB_E31/BB_E33) 
lp28-1 2136 2438 + A 302 (BB_F03) 
lp28-1 2439 2785 + AIP 346 (BB_F03,BB_F03/BB_F05,BB_F05) 
lp28-1 14609 14698 + A 89 (BB_F26) 
lp28-1 18004 18331 + I 327 (BB_F0040/BB_F32) 
lp28-2 11054 11212 + IA 158 (BB_G10/BB_G12,BB_G12) 
lp28-2 11213 11354 + A 141 (BB_G12) 
lp28-3 4412 4719 + A 307 (BB_H09) 
lp28-3 6970 7176 + A 206 (BB_H09) 
lp28-3 19454 19725 + I 271 (BB_H29/BB_H30) 
lp28-3 23441 23694 + I 253 (BB_H34/BB_H36a) 
lp28-3 24884 25057 + P 173 (BB_H36b) 
lp28-4 18054 18315 + I 261 (BB_I28/BB_I29) 
lp28-4 19230 19481 + I 251 (BB_I29/BB_I31) 
lp36 1150 1277 + Ip 127 (BB_K01/BB_K02a,BB_K02a) 
lp36 6780 7117 + IpI 337 (BB_K09/BB_K10,BB_K10,BB_K10/BB_K12) 
lp36 7720 7873 + P 153 (BB_K12) 
lp36 7874 8061 + PI 187 (BB_K12,BB_K12/BB_K13) 
lp36 27908 28155 + A 247 (BB_K45) 
lp36 33622 33878 + A 256 (BB_K50) 
lp36 35055 35386 + A 331 (BB_K52) 
lp38 4161 4359 + I 198 (BB_J05/BB_J08) 
lp38 10644 10962 + A 318 (BB_J16) 
lp38 11938 12150 + A 212 (BB_J18) 
lp38 12781 12939 + A 158 (BB_J19) 
lp38 14022 14267 + I 245 (BB_J20/BB_J0058) 
lp38 14272 14543 + I 271 (BB_J20/BB_J0058) 
lp38 26142 26384 + A 242 (BB_J34) 
lp38 27792 27981 + A 189 (BB_J36) 
lp38 29116 29322 + I 206 (BB_J37/BB_J41) 
lp38 29323 29534 + I 211 (BB_J37/BB_J41) 
lp38 29535 29878 + I 343 (BB_J37/BB_J41) 
lp38 29879 30085 + IA 206 (BB_J37/BB_J41,BB_J41) 
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lp38 37006 37165 + I 159 (BB_J50/BB_J51) 
lp38 37166 37383 + I 217 (BB_J50/BB_J51) 
lp38 37396 37695 + Ip 299 (BB_J50/BB_J51,BB_J51) 
lp54 2051 2257 + A 206 (BB_A04) 
lp54 11715 12027 + IP 312 (BB_A16/BB_A18,BB_A18) 
lp54 17337 17660 + I 323 (BB_A25/BB_A30) 
lp54 40761 41022 + A 261 (BB_A60) 
lp54 45194 45511 + A 317 (BB_A66) 
lp54 47286 47440 + I 154 (BB_A68/BB_A69) 
lp54 51333 51603 + I 270 (BB_A73/BB_A74) 
lp56 4121 4249 + IA 128 (BB_Q06/BB_Q07,BB_Q07) 
lp56 4250 4513 + A 263 (BB_Q07) 
lp56 5921 6144 + A 223 (BB_Q09) 
lp56 41696 41932 + A 236 (BB_Q67) 
lp56 43244 43500 + A 256 (BB_Q67) 
lp56 46949 47179 + I 230 (BB_Q74/BB_Q79) 
lp56 48312 48571 + p 259 (BB_Q80) 
lp56 49562 49860 + I 298 (BB_Q82/BB_Q0091) 
lp56 49861 50108 + I 247 (BB_Q82/BB_Q0091) 
lp56 52127 52401 + IA 274 (BB_Q85/BB_Q88,BB_Q88) 
 
Non-coding RNAs were identified as described in the materials and methods. Included are the genetic element, start position, end 
position, strand, relative location (I: Intergenic, A: Antisense, P: Pseudogene), length, associated genes, and those genes functions.  
Orders of numeric position and annotations are given according to order of the (+) strand. Note that Position 1 and Position 2 reflect 
start and stop sites differently depending on strand. For ncRNAs located on the (+) strand position 1 is the start and position 2 is the 
stop. For entries located on the (-) strand, position 1 is the end site and position 2 is the start site. Commas between associated genes 
and functional annotations indicate that the ncRNA overlaps both contiguously and “/” between them indicate that it is located 
intergenically between the two genes. 
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Table 8-6 Differentially abundant transcripts comparing WT to ∆rpoN 
 
Gene Name RefSeq CDS/Custom Transcript ID baseMean Log2 FC lfcSE stat pvalue padj 
A-(BB_0450) ncRNA0071 65.28090 -6.05115 0.70254 -8.61330 7.1000E-18 1.9400E-15 
A-(BB_F03) ncRNA0247 1699.00234 -1.50590 0.29570 -5.09261 3.5300E-07 4.8200E-05 
I-(BB_F11a/BB_F12) ncRNA0251 727.74533 -1.18687 0.18681 -6.35324 2.1100E-10 3.4600E-08 
BB_0449 lcl|NC_001318.1_cds_NP_212583.1_424 973.87220 1.05379 0.26434 3.98648 6.7100E-05 6.8695E-03 
rpoN lcl|NC_001318.1_cds_NP_212584.1_425 1371.15279 -3.84743 0.13386 -28.74303 1.1100E-181 1.8100E-178 
BB_F03 lcl|NC_001851.2_cds_NP_045439.1_1144 189.08402 -1.38167 0.37769 -3.65827 2.5393E-04 2.2687E-02 
BB_F20 lcl|NC_001851.2_cds_NP_045453.2_1150 136.22755 -1.21603 0.24468 -4.96992 6.7000E-07 8.4400E-05 
BB_F23 lcl|NC_001851.2_cds_NP_045456.1_1151 367.92274 -1.21157 0.24784 -4.88849 1.0200E-06 1.1896E-04 
 
The included transcripts met the criteria of >1 log2 fold-change and an adjusted P-value (padj) when comparing the ∆rpoN mutant to 
wild-type. A total of 6 transcripts were differentially regulated, not including the mutated gene, by the mutation. The first column contains 
the CDS/custom transcript ID which is the transcript ID for all coding sequences obtained from the NCBI Gene file format file or the 
transcript ID given to ncRNAs. RefSeq entries are further separated by the character “_”. The first portion gives the genetic  element 
from which it is derived, the second describes the type of element (CDS), the third provides RefSeq ID, and the fourth provides a 
number indicating the particular entries ordered number in the RefSeq entry. The second column is the gene information, for the 
ncRNAs it contains the location relative to other genes and for predicted or known genes it contains gene name. The remaining columns 
describe the various metrics of expression of each impacted transcript including, base mean (average library size normalized counts 
across all samples), log2FC (Fold change estimate), lfcSE (uncertainty of the log fold change estimate), stat (Wald statistic), pvalue, 
padj (pvalue following Benjamini-Hochberg adjustment). ORFs and ncRNAs are identified according to the names or numbers assigned 
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to genes and transcripts by the initial genome sequencing of B. burgdorferi strain B31 [56, 101] or from our previous analyses of that 
strain’s ncRNA transcriptome [14]. 
 
Table 8-7 Differentially abundant transcripts comparing WT to ∆rpoS 
 
Gene Name RefSeq CDS/Custom Transcript ID baseMean Log2 FC lfcSE stat pvalue padj 
I-(BB_A16/BB_A18) ncRNA0317 934.04967 1.30342 0.27937 4.66565 3.0800E-06 2.6196E-03 
rpoS lcl|NC_001318.1_cds_NP_212905.1_724 827.49827 3.86936 0.26638 14.52547 8.3600E-48 1.4200E-44 
 
The included transcript met the criteria of >1 log2 fold-change and an adjusted P-value (padj) when comparing the ∆rpoS mutant to 
wild-type. One transcript was impacted, not including the mutated gene, by the mutation. The first column contains the CDS/custom 
transcript ID which is the transcript ID for all coding sequences obtained from the NCBI Gene file format file or the transcript ID given 
to ncRNAs. RefSeq entries are further separated by the character “_”. The first portion gives the genetic element from which it is 
derived, the second describes the type of element (CDS), the third provides RefSeq ID, and the fourth provides a number indicating 
the particular entries ordered number in the RefSeq entry. The second column is the gene information, for the ncRNAs it contains the 
location relative to other genes and for predicted or known genes it contains gene name. The remaining columns describe the various 
metrics of expression of each impacted transcript including, base mean (average library size normalized counts across all samples), 
log2FC (Fold change estimate), lfcSE (uncertainty of the log fold change estimate), stat (Wald statistic), pvalue, padj (pvalue following 
Benjamini-Hochberg adjustment). The ncRNA is listed according to the nomenclature the previous analyses of the strain B31 ncRNA 
transcriptome [14]. 
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Table 8-8 Differentially abundant transcripts comparing WT to ∆badR 
Gene Name RefSeq CDS/Custom Transcript ID baseMean Log2 FC lfcSE stat pvalue padj 
PI-(BB_0003,BB_0003/BB_0004) ncRNA0001 968.82087 -1.09112 0.28077 -3.88617 1.0184E-04 6.9651E-04 
AI-(BB_0004,BB_0004/BB_0005) ncRNA0002 3041.85842 -1.46663 0.24896 -5.89114 3.8400E-09 6.8700E-08 
AA-(BB_0005,BB_0006) ncRNA0003 1243.57656 -1.40263 0.31154 -4.50219 6.7300E-06 5.7800E-05 
A-(BB_0013) ncRNA0006 3033.89498 -1.65126 0.33972 -4.86068 1.1700E-06 1.1800E-05 
A-(BB_0014) ncRNA0007 214.85270 -1.49644 0.48279 -3.09953 1.9382E-03 9.0932E-03 
A-(BB_0084) ncRNA0014 380.54610 -1.16896 0.38865 -3.00773 2.6321E-03 1.1626E-02 
AA-(BB_0198,BB_0199) ncRNA0031 400.71340 -1.25450 0.37399 -3.35434 7.9554E-04 4.3845E-03 
A-(BB_0208) ncRNA0035 510.91058 -1.36787 0.29213 -4.68233 2.8400E-06 2.6400E-05 
A-(BB_0211) ncRNA0037 1238.76926 -1.49984 0.31476 -4.76505 1.8900E-06 1.8100E-05 
A-(BB_0240) ncRNA0042 2021.45874 -1.86846 0.34914 -5.35166 8.7200E-08 1.1000E-06 
A-(BB_0244) ncRNA0043 577.79571 -2.19383 0.40474 -5.42038 5.9500E-08 7.7300E-07 
AIA-
(BB_0269,BB_0269/BB_0270,BB
_0270) ncRNA0050 
1285.29820 -1.97098 0.55621 -3.54357 3.9474E-04 2.3923E-03 
A-(BB_0347) ncRNA0057 34.51260 -1.77185 0.54862 -3.22963 1.2395E-03 6.2637E-03 
A-(BB_0374) ncRNA0061 321.08071 -1.22151 0.29276 -4.17242 3.0100E-05 2.2610E-04 
A-(BB_0381) ncRNA0063 391.05521 -1.49965 0.43302 -3.46324 5.3371E-04 3.1234E-03 
A-(BB_0446) ncRNA0070 529.31721 -2.03125 0.31340 -6.48129 9.0900E-11 2.1200E-09 
A-(BB_0450) ncRNA0071 65.28090 -4.49737 0.70339 -6.39389 1.6200E-10 3.6700E-09 
A-(BB_0454) ncRNA0072 396.65108 2.95589 0.65949 4.48209 7.3900E-06 6.2900E-05 
I-(BB_t06/BB_0461) ncRNA0073 2784.93399 1.60501 0.22993 6.98039 2.9400E-12 8.0900E-11 
AA-(BB_0465,BB_0466) ncRNA0076 1466.20007 -1.17375 0.25862 -4.53847 5.6700E-06 5.0000E-05 
p-(BB_0522) ncRNA0080 879.81309 -1.91147 0.23693 -8.06754 7.1700E-16 2.8100E-14 
AI-(BB_0556,BB_0556/BB_0557) ncRNA0083 349.18194 -1.07180 0.26873 -3.98835 6.6500E-05 4.7015E-04 
A-(BB_0581) ncRNA0084 87.52936 -2.55403 0.47013 -5.43263 5.5500E-08 7.3300E-07 
A-(BB_0588) ncRNA0087 1536.15642 -2.23217 0.70922 -3.14736 1.6475E-03 7.9482E-03 
A-(BB_0633) ncRNA0099 150.86401 -4.91216 0.64018 -7.67313 1.6800E-14 6.0800E-13 
A-(BB_0660) ncRNA0105 99.27360 -2.45137 0.75704 -3.23811 1.2032E-03 6.1168E-03 
A-(BB_0697) ncRNA0110 1608.78180 -1.36302 0.25646 -5.31467 1.0700E-07 1.3000E-06 
A-(BB_0747) ncRNA0117 270.28006 -1.17753 0.47325 -2.48819 1.2840E-02 4.3806E-02 
AIA-
(BB_0794,BB_0794/BB_0795,BB
_0795) ncRNA0125 
2242.03629 -1.57326 0.26039 -6.04184 1.5200E-09 2.9800E-08 
pI-
(BB_0845a,BB_0845a/BB_0845b
) ncRNA0132 
211.25465 -2.25855 0.53598 -4.21390 2.5100E-05 1.9255E-04 
A-(BB_B03) ncRNA0133 471.62837 -1.62632 0.24686 -6.58789 4.4600E-11 1.1000E-09 
AI-(BB_B03,BB_B03/BB_B04) ncRNA0134 130.50382 2.10478 0.37642 5.59151 2.2500E-08 3.2400E-07 
I-(BB_B03/BB_B04) ncRNA0135 1218.80954 3.52274 0.29625 11.89113 1.3200E-32 1.4900E-30 
AI-(BB_B09,BB_B09/BB_B10) ncRNA0136 476.36984 -2.09054 0.35434 -5.89983 3.6400E-09 6.5900E-08 
A-(BB_P21) ncRNA0148 93.09626 -1.90633 0.42832 -4.45076 8.5600E-06 7.2500E-05 
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I-(BB_P29/BB_P30) ncRNA0150 412.49914 1.15130 0.44834 2.56788 1.0232E-02 3.6685E-02 
IA-(BB_P32/BB_P33,BB_P33) ncRNA0152 276.35152 2.11738 0.36507 5.79987 6.6400E-09 1.1300E-07 
A-(BB_S11) ncRNA0154 104.52579 -1.47724 0.47704 -3.09671 1.9568E-03 9.1301E-03 
I-(BB_O29/BB_O30) ncRNA0185 1573.01516 1.54572 0.47774 3.23551 1.2143E-03 6.1544E-03 
AIA-
(BB_O32,BB_O32/BB_O33,BB_
O33) ncRNA0186 
90.75800 1.65807 0.32571 5.09068 3.5700E-07 3.9200E-06 
A-(BB_O36) ncRNA0188 23.57876 -1.93466 0.73137 -2.64525 8.1631E-03 3.0756E-02 
A-(BB_O44) ncRNA0191 8.70865 -1.95208 0.79305 -2.46149 1.3836E-02 4.6405E-02 
IA-(BB_L29/BB_L30,BB_L30) ncRNA0200 867.04480 -2.25465 0.35334 -6.38104 1.7600E-10 3.8900E-09 
A-(BB_L36) ncRNA0205 27.97465 -1.84728 0.73841 -2.50168 1.2360E-02 4.2697E-02 
IA-(BB_N32/BB_N33,BB_N33) ncRNA0218 29.86142 2.01267 0.51769 3.88782 1.0115E-04 6.9577E-04 
I-(BB_D04/BB_D05a) ncRNA0225 86.57889 -2.20574 0.54226 -4.06769 4.7500E-05 3.4119E-04 
P-(BB_D05a) ncRNA0226 56.82862 -4.17247 0.63131 -6.60919 3.8600E-11 9.6800E-10 
I-(BB_D18/BB_D20) ncRNA0229 117.85300 -1.35183 0.34541 -3.91370 9.0900E-05 6.3180E-04 
p-(BB_D23) ncRNA0233 46.44976 -2.51966 0.75095 -3.35527 7.9286E-04 4.3839E-03 
A-(BB_E09) ncRNA0239 1464.22355 -2.30974 0.42823 -5.39371 6.9000E-08 8.8400E-07 
A-(BB_E09) ncRNA0240 74.83749 -2.66273 0.85330 -3.12052 1.8053E-03 8.6120E-03 
I-(BB_E23b/BB_E29a) ncRNA0242 107.05005 -1.63438 0.59175 -2.76193 5.7461E-03 2.2704E-02 
I-(BB_E31/BB_E33) ncRNA0245 314.76149 -1.44551 0.48476 -2.98193 2.8644E-03 1.2381E-02 
PI-(BB_G05,BB_G05/BB_G06) ncRNA0257 56.23394 -3.93529 0.79525 -4.94850 7.4800E-07 8.0100E-06 
AA-(BB_G07,BB_G08) ncRNA0259 88.14975 1.10443 0.26314 4.19712 2.7000E-05 2.0553E-04 
IpI-
(BB_K09/BB_K10,BB_K10,BB_K
10/BB_K12) ncRNA0281 
166.24839 -1.37454 0.50527 -2.72043 6.5197E-03 2.5292E-02 
A-(BB_K17) ncRNA0284 123.82711 -2.10430 0.29631 -7.10179 1.2300E-12 3.6200E-11 
A-(BB_K19) ncRNA0286 219.94179 -1.26203 0.49759 -2.53627 1.1204E-02 3.9528E-02 
A-(BB_J18) ncRNA0297 206.52360 -4.03412 0.71716 -5.62515 1.8500E-08 2.7400E-07 
I-(BB_J20/BB_J0058) ncRNA0299 119.12666 -1.62021 0.32287 -5.01815 5.2200E-07 5.6200E-06 
I-(BB_J37/BB_J41) ncRNA0304 103.27966 -1.37834 0.48298 -2.85383 4.3195E-03 1.7515E-02 
I-(BB_J50/BB_J51) ncRNA0308 893.05821 -5.20270 0.49451 -10.52094 6.9200E-26 4.9100E-24 
A-(BB_A04) ncRNA0311 361.98141 2.13591 0.41127 5.19340 2.0600E-07 2.3800E-06 
IP-(BB_A16/BB_A18,BB_A18) ncRNA0318 1800.37672 -1.63311 0.56659 -2.88233 3.9474E-03 1.6317E-02 
I-(BB_A37/BB_A38) ncRNA0322 2507.45399 -1.82706 0.46457 -3.93284 8.3900E-05 5.8833E-04 
I-(BB_A66/BB_A68) ncRNA0326 456.29968 1.58132 0.36726 4.30573 1.6600E-05 1.3370E-04 
I-(BB_A68/BB_A69) ncRNA0327 288.56940 1.26427 0.41152 3.07217 2.1251E-03 9.7548E-03 
p-(BB_Q04) ncRNA0330 720.36163 -1.02436 0.39854 -2.57027 1.0162E-02 3.6573E-02 
I-(BB_Q37/BB_Q38) ncRNA0337 248.20404 1.38205 0.42404 3.25922 1.1172E-03 5.6963E-03 
tRNA-Ile-1 rna11 3677.25129 -1.07076 0.43186 -2.47941 1.3160E-02 4.4644E-02 
BB_0004 lcl|NC_001318.1_cds_NP_212138.2_3 3213.61271 -1.16128 0.35025 -3.31560 9.1445E-04 4.8065E-03 
BB_0008 lcl|NC_001318.1_cds_NP_212142.2_7 904.70176 -1.11034 0.15143 -7.33258 2.2600E-13 6.9900E-12 
BB_0010 lcl|NC_001318.1_cds_NP_212144.1_9 909.55235 -1.05158 0.24540 -4.28510 1.8300E-05 1.4536E-04 
ruvB lcl|NC_001318.1_cds_NP_212156.1_20 2074.85845 -1.61520 0.20259 -7.97292 1.5500E-15 5.8600E-14 
ruvA lcl|NC_001318.1_cds_NP_212157.1_21 1097.97296 -1.27309 0.15188 -8.38203 5.2000E-17 2.3900E-15 
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BB_0026 lcl|NC_001318.1_cds_NP_212160.1_24 1860.31604 -1.01008 0.18200 -5.54999 2.8600E-08 4.0200E-07 
BB_0027 lcl|NC_001318.1_cds_NP_212161.1_25 9710.08595 -2.08218 0.33747 -6.17004 6.8300E-10 1.4500E-08 
BB_0035 lcl|NC_001318.1_cds_NP_212169.1_33 2717.90772 1.16654 0.21471 5.43305 5.5400E-08 7.3300E-07 
cheR lcl|NC_001318.1_cds_NP_212174.1_38 2192.91826 -1.27180 0.18779 -6.77229 1.2700E-11 3.3200E-10 
malQ lcl|NC_001318.1_cds_NP_212300.1_155 848.92993 1.25223 0.32051 3.90697 9.3500E-05 6.4700E-04 
BB_0172 lcl|NC_001318.1_cds_NP_212306.2_161 2887.76489 -1.26105 0.12397 -10.17219 2.6400E-24 1.6100E-22 
BB_0240 lcl|NC_001318.1_cds_NP_212374.1_225 2634.82078 1.09613 0.21449 5.11029 3.2200E-07 3.5800E-06 
glpK lcl|NC_001318.1_cds_NP_212375.1_226 5175.05698 2.39201 0.33787 7.07965 1.4500E-12 4.1700E-11 
BB_0242 lcl|NC_001318.1_cds_NP_212376.1_227 990.14647 2.16828 0.41966 5.16676 2.3800E-07 2.7000E-06 
BB_0243 lcl|NC_001318.1_cds_NP_212377.1_228 6087.03774 2.00725 0.23639 8.49112 2.0500E-17 9.6800E-16 
BB_0285 lcl|NC_001318.1_cds_NP_212419.2_270 4139.07947 -1.00597 0.31761 -3.16732 1.5385E-03 7.5507E-03 
BB_0330 lcl|NC_001318.1_cds_NP_212464.1_313 9233.47510 1.24683 0.21901 5.69309 1.2500E-08 1.9500E-07 
BB_0331 lcl|NC_001318.1_cds_NP_212465.1_314 360.85379 1.05649 0.34945 3.02334 2.5000E-03 1.1234E-02 
gatC lcl|NC_001318.1_cds_NP_212477.1_326 285.30099 -1.21150 0.21671 -5.59038 2.2700E-08 3.2400E-07 
mgsA lcl|NC_001318.1_cds_NP_212498.1_345 3019.34634 1.88485 0.16473 11.44229 2.5700E-30 2.5700E-28 
la7 lcl|NC_001318.1_cds_NP_212499.1_346 8401.74564 1.98028 0.28233 7.01415 2.3100E-12 6.4600E-11 
metK lcl|NC_001318.1_cds_NP_212510.1_357 3414.26722 1.00717 0.30325 3.32125 8.9615E-04 4.7968E-03 
rpmG lcl|NC_001318.1_cds_NP_212530.1_377 7700.52393 -1.01428 0.22521 -4.50383 6.6700E-06 5.7800E-05 
BB_0408 lcl|NC_001318.1_cds_NP_212542.1_389 6219.62582 1.35986 0.22211 6.12252 9.2100E-10 1.8400E-08 
BB_0415 lcl|NC_001318.1_cds_NP_212549.1_394 1448.60433 -1.27909 0.22206 -5.76023 8.4000E-09 1.3900E-07 
BB_0427 lcl|NC_001318.1_cds_NP_212561.2_403 376.59155 -1.24518 0.39844 -3.12510 1.7774E-03 8.5027E-03 
BB_0428 lcl|NC_001318.1_cds_NP_212562.1_404 2667.65490 -1.13848 0.21358 -5.33050 9.7900E-08 1.2100E-06 
BB_0429 lcl|NC_001318.1_cds_NP_212563.1_405 2866.18584 -1.04523 0.20512 -5.09567 3.4800E-07 3.8400E-06 
BB_0430 lcl|NC_001318.1_cds_NP_212564.2_406 199.01921 -1.02289 0.32470 -3.15030 1.6310E-03 7.8911E-03 
BB_0434 lcl|NC_001318.1_cds_NP_212568.1_409 410.65472 -1.04234 0.30603 -3.40599 6.5924E-04 3.7175E-03 
rpmH lcl|NC_001318.1_cds_NP_212574.1_415 1315.25246 -1.11789 0.18134 -6.16445 7.0700E-10 1.4900E-08 
BB_0451 lcl|NC_001318.1_cds_NP_212585.1_426 435.99128 1.00758 0.20928 4.81442 1.4800E-06 1.4400E-05 
BB_0454 lcl|NC_001318.1_cds_NP_212588.1_429 2730.88885 -1.03160 0.18436 -5.59544 2.2000E-08 3.2100E-07 
BB_0465 lcl|NC_001318.1_cds_NP_212599.1_440 2885.54585 -1.00750 0.23048 -4.37136 1.2300E-05 1.0013E-04 
BB_0509 lcl|NC_001318.1_cds_NP_212643.1_482 8232.92191 -2.70977 0.36572 -7.40945 1.2700E-13 4.1500E-12 
BB_0533 lcl|NC_001318.1_cds_NP_212667.1_496 5644.77797 -1.06287 0.10687 -9.94531 2.6400E-23 1.5500E-21 
BB_0537 lcl|NC_001318.1_cds_NP_212671.1_500 1848.25226 1.05591 0.23840 4.42912 9.4600E-06 7.9000E-05 
BB_0543 lcl|NC_001318.1_cds_NP_212677.2_505 8778.76132 -1.01909 0.16382 -6.22080 4.9500E-10 1.0700E-08 
BB_0562 lcl|NC_001318.1_cds_NP_212696.1_524 1222.60891 1.05371 0.14723 7.15694 8.2500E-13 2.4600E-11 
BB_0577 lcl|NC_001318.1_cds_NP_212711.1_539 1867.11586 -1.51685 0.22326 -6.79418 1.0900E-11 2.9000E-10 
BB_0588 lcl|NC_001318.1_cds_NP_212722.1_550 1645.23671 -2.28085 0.13243 -17.22261 1.8000E-66 5.1000E-64 
murB lcl|NC_001318.1_cds_NP_212732.1_560 2605.56083 -1.09345 0.25655 -4.26217 2.0200E-05 1.6036E-04 
p66 lcl|NC_001318.1_cds_NP_212737.1_565 18788.96545 1.19152 0.37085 3.21297 1.3137E-03 6.6190E-03 
rnmV lcl|NC_001318.1_cds_NP_212760.1_587 17091.35904 -1.62228 0.41009 -3.95594 7.6200E-05 5.3647E-04 
BB_0627 lcl|NC_001318.1_cds_YP_008686584.1_588 1365.69883 -1.13722 0.23568 -4.82529 1.4000E-06 1.3800E-05 
BB_0637 lcl|NC_001318.1_cds_NP_212771.2_597 8048.19773 1.24731 0.26134 4.77279 1.8200E-06 1.7500E-05 
BB_0638 lcl|NC_001318.1_cds_NP_212772.1_598 3886.71871 1.37448 0.20993 6.54741 5.8500E-11 1.3800E-09 
BB_0639 lcl|NC_001318.1_cds_NP_212773.1_599 1482.68946 1.11139 0.28704 3.87185 1.0801E-04 7.3284E-04 
ylqF lcl|NC_001318.1_cds_NP_212777.1_603 699.04670 -1.01227 0.22468 -4.50538 6.6300E-06 5.7800E-05 
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BB_0644 lcl|NC_001318.1_cds_NP_212778.1_604 697.38844 1.09191 0.19929 5.47909 4.2800E-08 5.8200E-07 
BB_0678 lcl|NC_001318.1_cds_NP_212812.1_638 5061.70052 1.13088 0.18467 6.12376 9.1400E-10 1.8400E-08 
BB_0679 lcl|NC_001318.1_cds_NP_212813.2_639 4281.29084 1.09289 0.19250 5.67736 1.3700E-08 2.1200E-07 
BB_0681 lcl|NC_001318.1_cds_NP_212815.2_641 1841.56416 1.13210 0.19872 5.69708 1.2200E-08 1.9200E-07 
BB_0683 lcl|NC_001318.1_cds_NP_212817.1_643 9215.74716 -1.34261 0.20023 -6.70547 2.0100E-11 5.1800E-10 
fni lcl|NC_001318.1_cds_NP_212818.2_644 5419.35053 -1.36046 0.31096 -4.37507 1.2100E-05 9.8900E-05 
BB_0693 lcl|NC_001318.1_cds_NP_212827.1_652 1586.51137 -7.78866 0.50598 -15.39320 1.8200E-53 3.8700E-51 
ffh lcl|NC_001318.1_cds_NP_212828.2_653 14060.76269 -3.01855 0.37424 -8.06591 7.2700E-16 2.8100E-14 
rpsP lcl|NC_001318.1_cds_NP_212829.1_654 1323.09899 -1.03940 0.25376 -4.09602 4.2000E-05 3.0720E-04 
BB_0696 lcl|NC_001318.1_cds_NP_212830.1_655 1648.93321 -1.06417 0.33229 -3.20256 1.3621E-03 6.8226E-03 
BB_0724 lcl|NC_001318.1_cds_YP_008686588.1_680 3690.87567 -1.21343 0.26757 -4.53493 5.7600E-06 5.0600E-05 
BB_0739 lcl|NC_001318.1_cds_YP_008686589.1_694 1873.95784 -1.41965 0.17302 -8.20498 2.3100E-16 1.0100E-14 
BB_0765 lcl|NC_001318.1_cds_NP_212899.1_718 561.76005 1.07980 0.17529 6.16015 7.2700E-10 1.5100E-08 
cvpA lcl|NC_001318.1_cds_NP_212900.1_719 420.51092 1.35652 0.23960 5.66172 1.5000E-08 2.3000E-07 
murG lcl|NC_001318.1_cds_NP_212901.1_720 901.26760 1.56083 0.28107 5.55315 2.8100E-08 3.9800E-07 
BB_0768 lcl|NC_001318.1_cds_NP_212902.1_721 1156.42566 1.03455 0.23465 4.40882 1.0400E-05 8.5900E-05 
BB_0769 lcl|NC_001318.1_cds_NP_212903.1_722 1653.77636 1.26192 0.24096 5.23707 1.6300E-07 1.9300E-06 
BB_0770 lcl|NC_001318.1_cds_NP_212904.1_723 1364.05445 1.29725 0.24460 5.30344 1.1400E-07 1.3700E-06 
BB_0773 lcl|NC_001318.1_cds_NP_212907.1_727 467.79866 1.23579 0.17932 6.89159 5.5200E-12 1.4900E-10 
BB_0785 lcl|NC_001318.1_cds_NP_212919.1_739 2664.70377 1.60156 0.21191 7.55769 4.1000E-14 1.4600E-12 
BB_0794 lcl|NC_001318.1_cds_YP_008686594.1_748 8844.21241 -1.00439 0.17426 -5.76361 8.2300E-09 1.3700E-07 
BB_0798 lcl|NC_001318.1_cds_NP_212932.1_752 412.74295 -1.27472 0.23076 -5.52411 3.3100E-08 4.6200E-07 
arcA lcl|NC_001318.1_cds_NP_212975.1_793 2690.75653 3.20828 0.15655 20.49298 2.4900E-93 1.0600E-90 
argF lcl|NC_001318.1_cds_NP_212976.2_794 2452.38136 2.75300 0.24753 11.12176 9.8300E-29 8.3700E-27 
BB_0843 lcl|NC_001318.1_cds_NP_212977.2_795 9954.80128 2.00513 0.22501 8.91146 5.0400E-19 2.6800E-17 
BB_0852 lcl|NC_001318.1_cds_NP_212985.1_797 258.47242 -1.10879 0.36278 -3.05636 2.2405E-03 1.0175E-02 
BB_B04 lcl|NC_001903.1_cds_NP_046990.2_801 
11469.16755 5.57723 0.22386 24.91438 
5.2000E-
137 
4.4300E-
134 
BB_B05 lcl|NC_001903.1_cds_NP_046991.1_802 2551.06647 5.13641 0.27541 18.64996 1.2600E-77 4.3000E-75 
BB_B06 lcl|NC_001903.1_cds_NP_046992.2_803 
1687.19872 6.04192 0.26257 23.01027 
3.6800E-
117 
2.0900E-
114 
BB_B07 lcl|NC_001903.1_cds_NP_046993.1_804 
8409.80978 4.82405 0.16267 29.65532 
2.9000E-
193 
4.9300E-
190 
BB_B10 lcl|NC_001903.1_cds_NP_046996.1_806 3773.69113 -1.28185 0.38183 -3.35713 7.8755E-04 4.3687E-03 
BB_B29 lcl|NC_001903.1_cds_NP_047015.1_821 24118.64600 -2.30295 0.21295 -10.81453 2.9400E-27 2.1800E-25 
BB_P10 lcl|NC_000948.1_cds_NP_051171.1_830 89.29313 -1.80857 0.56895 -3.17880 1.4788E-03 7.3211E-03 
BB_P15 lcl|NC_000948.1_cds_NP_051176.1_835 57.75190 -1.51185 0.53321 -2.83538 4.5771E-03 1.8471E-02 
BB_P26 lcl|NC_000948.1_cds_NP_051187.2_846 172.83719 1.04426 0.26881 3.88475 1.0244E-04 6.9779E-04 
BB_P31 lcl|NC_000948.1_cds_NP_051192.1_851 319.42777 1.34368 0.33180 4.04963 5.1300E-05 3.6706E-04 
BB_P32 lcl|NC_000948.1_cds_NP_051193.1_852 812.84291 1.85498 0.23580 7.86670 3.6400E-15 1.3500E-13 
BB_P33 lcl|NC_000948.1_cds_NP_051194.2_853 507.55300 2.04110 0.24574 8.30588 9.9100E-17 4.4400E-15 
bdrA lcl|NC_000948.1_cds_NP_051195.1_854 840.20823 1.45969 0.30269 4.82243 1.4200E-06 1.4000E-05 
erpB lcl|NC_000948.1_cds_NP_051200.1_859 7072.92180 1.01694 0.34463 2.95083 3.1692E-03 1.3359E-02 
BB_S15 lcl|NC_000949.1_cds_NP_051218.1_876 10.07083 2.31542 0.80661 2.87056 4.0974E-03 1.6734E-02 
1
5
0
 
  
 
151 
BB_S26 lcl|NC_000949.1_cds_NP_051229.2_886 135.85820 1.00586 0.34907 2.88153 3.9575E-03 1.6319E-02 
BB_S31 lcl|NC_000949.1_cds_NP_051234.2_890 105.76745 -1.26827 0.50405 -2.51613 1.1865E-02 4.1491E-02 
BB_S35 lcl|NC_000949.1_cds_NP_051238.1_893 265.73103 1.02294 0.24110 4.24281 2.2100E-05 1.7166E-04 
bdrE lcl|NC_000949.1_cds_NP_051240.1_894 326.73654 1.38462 0.24237 5.71294 1.1100E-08 1.7800E-07 
BB_R25 lcl|NC_000950.1_cds_NP_051272.1_925 73.69031 1.56785 0.47258 3.31765 9.0777E-04 4.8065E-03 
bdrH lcl|NC_000950.1_cds_NP_051274.2_927 752.05999 -1.40743 0.23927 -5.88221 4.0500E-09 7.1100E-08 
BB_R34 lcl|NC_000950.1_cds_NP_051281.1_933 206.01635 1.06212 0.21925 4.84427 1.2700E-06 1.2700E-05 
BB_M25 lcl|NC_000951.1_cds_NP_051316.1_965 73.66911 1.56778 0.47277 3.31614 9.1270E-04 4.8065E-03 
BB_O32 lcl|NC_000952.1_cds_NP_051365.1_1013 381.81421 1.01708 0.24524 4.14728 3.3600E-05 2.5131E-04 
BB_O35 lcl|NC_000952.1_cds_NP_051368.1_1016 19.61632 1.53154 0.61461 2.49190 1.2706E-02 4.3593E-02 
erpM lcl|NC_000952.1_cds_NP_051373.1_1021 506.31238 1.17864 0.24099 4.89077 1.0000E-06 1.0300E-05 
BB_L10 lcl|NC_000953.1_cds_NP_051387.1_1034 89.29313 -1.80857 0.56895 -3.17880 1.4788E-03 7.3211E-03 
BB_L15 lcl|NC_000953.1_cds_NP_051392.1_1039 57.75190 -1.51185 0.53321 -2.83538 4.5771E-03 1.8471E-02 
erpO lcl|NC_000953.1_cds_NP_051417.1_1062 7072.82966 1.01694 0.34462 2.95088 3.1687E-03 1.3359E-02 
BB_N31 lcl|NC_000954.1_cds_NP_051443.1_1087 161.08556 1.59706 0.34921 4.57338 4.8000E-06 4.3000E-05 
BB_N32 lcl|NC_000954.1_cds_NP_051444.1_1088 241.99693 1.72863 0.30894 5.59530 2.2000E-08 3.2100E-07 
BB_N33 lcl|NC_000954.1_cds_NP_051445.1_1089 157.32165 1.90141 0.28879 6.58398 4.5800E-11 1.1100E-09 
bdrQ lcl|NC_000954.1_cds_NP_051446.1_1090 227.79632 1.58497 0.26408 6.00177 1.9500E-09 3.6900E-08 
erpQ lcl|NC_000954.1_cds_NP_051450.1_1094 1968.30569 1.24087 0.36008 3.44612 5.6870E-04 3.2609E-03 
BB_D13 lcl|NC_001849.2_cds_NP_045397.1_1115 908.20998 -1.44679 0.30477 -4.74717 2.0600E-06 1.9400E-05 
BB_D14 lcl|NC_001849.2_cds_NP_045398.1_1116 3487.08319 -1.95219 0.32696 -5.97068 2.3600E-09 4.3900E-08 
BB_D15 lcl|NC_001849.2_cds_NP_045399.2_1117 1008.77152 -1.19758 0.19885 -6.02263 1.7200E-09 3.3200E-08 
BB_D21 lcl|NC_001849.2_cds_NP_045404.1_1119 967.68593 -1.85289 0.44007 -4.21045 2.5500E-05 1.9463E-04 
BB_D22 lcl|NC_001849.2_cds_NP_045405.1_1120 128.56257 -1.39609 0.31811 -4.38872 1.1400E-05 9.3800E-05 
BB_D0031 lcl|NC_001849.2_cds_YP_004940417.1_1121 25.13307 -2.33283 0.70063 -3.32961 8.6968E-04 4.7318E-03 
BB_F03 lcl|NC_001851.2_cds_NP_045439.1_1144 189.08402 1.75394 0.35531 4.93638 7.9600E-07 8.4700E-06 
BB_F23 lcl|NC_001851.2_cds_NP_045456.1_1151 367.92274 2.20505 0.25695 8.58173 9.3500E-18 4.5500E-16 
BB_F25 lcl|NC_001851.2_cds_NP_045458.1_1153 156.06800 1.05922 0.43576 2.43078 1.5066E-02 4.9437E-02 
BB_G12 lcl|NC_001852.1_cds_NP_045472.1_1163 81.95387 -2.20532 0.67061 -3.28855 1.0070E-03 5.1969E-03 
BB_G22 lcl|NC_001852.1_cds_NP_045482.1_1174 64.42227 -3.12561 0.64182 -4.86995 1.1200E-06 1.1300E-05 
BB_G24 lcl|NC_001852.1_cds_NP_045484.2_1176 50.67292 -1.45041 0.56138 -2.58363 9.7765E-03 3.5652E-02 
BB_G25 lcl|NC_001852.1_cds_NP_045485.1_1177 3.96162 -2.09091 0.85482 -2.44603 1.4444E-02 4.7594E-02 
BB_G29 lcl|NC_001852.1_cds_NP_045489.1_1181 357.36922 -1.00911 0.37730 -2.67457 7.4825E-03 2.8443E-02 
BB_G31 lcl|NC_001852.1_cds_NP_045491.2_1183 41.00950 -1.49032 0.46959 -3.17367 1.5053E-03 7.4303E-03 
BB_H17 lcl|NC_001853.1_cds_NP_045510.1_1195 10.29556 -2.14867 0.80072 -2.68342 7.2872E-03 2.7825E-02 
BB_H26 lcl|NC_001853.1_cds_NP_045517.1_1197 1195.44669 -1.14494 0.46106 -2.48330 1.3017E-02 4.4248E-02 
BB_K01 lcl|NC_001855.1_cds_NP_045575.1_1225 1354.45058 1.45603 0.33410 4.35803 1.3100E-05 1.0593E-04 
BB_K23 lcl|NC_001855.1_cds_NP_045597.1_1234 2453.83614 -1.42525 0.38678 -3.68488 2.2881E-04 1.4816E-03 
BB_K24 lcl|NC_001855.1_cds_NP_045598.1_1235 377.57698 -1.45242 0.43696 -3.32396 8.8750E-04 4.7927E-03 
BB_K33 lcl|NC_001855.1_cds_NP_045606.1_1238 37.62541 -1.38194 0.44482 -3.10676 1.8915E-03 8.8986E-03 
BB_K40 lcl|NC_001855.1_cds_NP_045612.1_1242 3811.74482 -1.25835 0.23171 -5.43069 5.6100E-08 7.3500E-07 
BB_K47 lcl|NC_001855.1_cds_NP_045618.1_1246 2505.67165 1.67722 0.31704 5.29021 1.2200E-07 1.4700E-06 
BB_K49 lcl|NC_001855.1_cds_NP_045620.1_1248 1392.93963 1.63203 0.35449 4.60395 4.1500E-06 3.7600E-05 
BB_K53 lcl|NC_001855.1_cds_NP_045624.1_1252 359.83957 -1.24036 0.48431 -2.56107 1.0435E-02 3.7334E-02 
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BB_J09 lcl|NC_001856.1_cds_NP_045633.1_1254 24951.96368 1.39691 0.37730 3.70236 2.1361E-04 1.3884E-03 
BB_J18 lcl|NC_001856.1_cds_NP_045642.1_1259 652.40141 -1.21354 0.49348 -2.45913 1.3927E-02 4.6598E-02 
BB_J19 lcl|NC_001856.1_cds_NP_045643.1_1260 8721.99449 -1.17852 0.35743 -3.29718 9.7661E-04 5.0552E-03 
BB_J24 lcl|NC_001856.1_cds_NP_045648.1_1264 96.33456 -1.44666 0.37916 -3.81544 1.3594E-04 9.1144E-04 
BB_J36 lcl|NC_001856.1_cds_NP_045660.1_1272 1399.44454 -1.03854 0.23544 -4.41111 1.0300E-05 8.5400E-05 
BB_J37 lcl|NC_001856.1_cds_NP_045661.2_1273 15.94581 -1.80958 0.69423 -2.60661 9.1443E-03 3.3490E-02 
BB_J43 lcl|NC_001856.1_cds_NP_045667.1_1276 43.39694 -1.68354 0.66952 -2.51453 1.1919E-02 4.1513E-02 
BB_J45 lcl|NC_001856.1_cds_NP_045669.1_1277 396.44271 -1.38960 0.38796 -3.58180 3.4124E-04 2.1209E-03 
BB_A03 lcl|NC_001857.2_cds_NP_045676.1_1287 12443.29488 2.36516 0.33649 7.02897 2.0800E-12 5.9100E-11 
BB_A04 lcl|NC_001857.2_cds_NP_045677.1_1288 322.05765 1.18668 0.43938 2.70082 6.9170E-03 2.6711E-02 
BB_A23 lcl|NC_001857.2_cds_NP_045696.2_1302 697.32621 -1.50946 0.58734 -2.57002 1.0169E-02 3.6573E-02 
dbpA lcl|NC_001857.2_cds_NP_045697.1_1303 424.40618 -1.29417 0.53236 -2.43101 1.5057E-02 4.9437E-02 
BB_A30 lcl|NC_001857.2_cds_NP_045703.1_1305 869.61499 1.58222 0.21686 7.29613 2.9600E-13 9.0100E-12 
BB_A31 lcl|NC_001857.2_cds_NP_045704.1_1306 693.65642 1.99326 0.26890 7.41253 1.2400E-13 4.1400E-12 
BB_A32 lcl|NC_001857.2_cds_NP_045705.1_1307 110.74219 1.11056 0.32443 3.42311 6.1910E-04 3.5144E-03 
BB_A34 lcl|NC_001857.2_cds_NP_045707.1_1309 190.08384 -1.75906 0.57717 -3.04771 2.3059E-03 1.0416E-02 
BB_A37 lcl|NC_001857.2_cds_NP_045710.1_1311 93.94412 -1.86769 0.65266 -2.86168 4.2140E-03 1.7127E-02 
BB_A52 lcl|NC_001857.2_cds_NP_045725.1_1323 1613.06144 1.07870 0.31276 3.44902 5.6262E-04 3.2590E-03 
BB_A53 lcl|NC_001857.2_cds_NP_045726.1_1324 375.69121 1.38055 0.37584 3.67323 2.3950E-04 1.5334E-03 
BB_A54 lcl|NC_001857.2_cds_NP_045727.1_1325 599.96245 1.95210 0.36710 5.31758 1.0500E-07 1.2900E-06 
BB_A58 lcl|NC_001857.2_cds_NP_045731.1_1327 8350.06409 1.31910 0.29668 4.44625 8.7400E-06 7.3700E-05 
BB_A60 lcl|NC_001857.2_cds_NP_045733.1_1329 1031.73146 1.63033 0.22173 7.35286 1.9400E-13 6.1200E-12 
BB_A66 lcl|NC_001857.2_cds_NP_045739.1_1334 625.48633 1.00938 0.33861 2.98095 2.8735E-03 1.2389E-02 
osm28 lcl|NC_001857.2_cds_NP_045747.1_1339 12273.60539 2.10264 0.39422 5.33374 9.6200E-08 1.2000E-06 
BB_Q05 lcl|NC_000956.1_cds_NP_051469.1_1342 100.93680 1.79670 0.59584 3.01542 2.5662E-03 1.1411E-02 
BB_Q27 lcl|NC_000956.1_cds_NP_051489.1_1361 184.69201 2.14346 0.44678 4.79760 1.6100E-06 1.5600E-05 
BB_Q29 lcl|NC_000956.1_cds_NP_051491.1_1363 93.20451 1.48726 0.36228 4.10530 4.0400E-05 2.9640E-04 
BB_Q32 lcl|NC_000956.1_cds_NP_051494.1_1366 73.68259 1.56809 0.47196 3.32251 8.9213E-04 4.7927E-03 
BB_Q40 lcl|NC_000956.1_cds_NP_051502.1_1373 481.17033 1.26206 0.36821 3.42753 6.0909E-04 3.4692E-03 
bdrV lcl|NC_000956.1_cds_NP_051504.1_1374 634.19622 2.37238 0.31762 7.46914 8.0700E-14 2.8100E-12 
BB_Q62 lcl|NC_000956.1_cds_NP_051521.1_1385 20.48709 3.14255 0.53526 5.87107 4.3300E-09 7.5200E-08 
 
The included transcripts met the criteria of >1 log2 fold-change and an adjusted P-value (padj) when comparing the ∆badR mutant to 
wild-type sorted by fold change. A total of 239 transcripts were differentially regulated, not including the mutated gene, by the mutation. 
The first column contains the CDS/custom transcript ID which is the transcript ID for all coding sequences obtained from the NCBI 
Gene file format file or the transcript ID given to ncRNAs. RefSeq entries are further separated by the character “_”. The fi rst portion 
gives the genetic element from which it is derived, the second describes the type of element (CDS), the third provides RefSeq ID, and 
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the fourth provides a number indicating the particular entries ordered number in the RefSeq entry. The second column is the gene 
information, for the ncRNAs it contains the location relative to other genes and for predicted or known genes it contains gene name. 
The remaining columns describe the various metrics of expression of each impacted transcript including, base mean (average library 
size normalized counts across all samples), log2FC (Fold change estimate), lfcSE (uncertainty of the log fold change estimate), stat 
(Wald statistic), pvalue, padj (pvalue following Benjamini-Hochberg adjustment). ORFs and ncRNAs are identified according to the 
names or numbers assigned to genes and transcripts by the initial genome sequencing of B. burgdorferi strain B31 [56, 101] or from 
our previous analyses of that strain’s ncRNA transcriptome [14]. 
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Table 8-9 Differentially abundant transcripts comparing WT to ∆csrA 
Gene Name RefSeq CDS/Custom Transcript ID baseMean Log2 FC lfcSE stat pvalue padj 
AI-
(BB_0004,BB_0004/BB
_0005) ncRNA0002 
3041.85842 -1.36714 0.24879 -5.49508 3.9100E-08 7.5600E-07 
AA-(BB_0005,BB_0006) ncRNA0003 1243.57656 -1.54533 0.31157 -4.95977 7.0600E-07 1.0300E-05 
A-(BB_0013) ncRNA0006 3033.89498 -1.60870 0.33963 -4.73659 2.1700E-06 2.7400E-05 
A-(BB_0014) ncRNA0007 214.85270 -1.21565 0.48187 -2.52277 1.1643E-02 4.0193E-02 
A-(BB_0084) ncRNA0014 380.54610 -1.35790 0.38875 -3.49295 4.7771E-04 2.8849E-03 
AA-(BB_0198,BB_0199) ncRNA0031 400.71340 -1.33223 0.37396 -3.56255 3.6727E-04 2.3603E-03 
A-(BB_0208) ncRNA0035 510.91058 -1.07338 0.29111 -3.68721 2.2673E-04 1.5262E-03 
A-(BB_0211) ncRNA0037 1238.76926 -1.36930 0.31459 -4.35262 1.3500E-05 1.3476E-04 
A-(BB_0240) ncRNA0042 2021.45874 -1.87999 0.34911 -5.38509 7.2400E-08 1.3300E-06 
A-(BB_0244) ncRNA0043 577.79571 -1.25665 0.40387 -3.11154 1.8611E-03 9.0300E-03 
AIA-
(BB_0269,BB_0269/BB
_0270,BB_0270) ncRNA0050 
1285.29820 -1.69651 0.55613 -3.05059 2.2839E-03 1.0686E-02 
A-(BB_0347) ncRNA0057 34.51260 -1.88774 0.54860 -3.44101 5.7954E-04 3.3685E-03 
A-(BB_0381) ncRNA0063 391.05521 -1.63583 0.43307 -3.77733 1.5852E-04 1.1202E-03 
A-(BB_0446) ncRNA0070 529.31721 -1.78518 0.31267 -5.70938 1.1300E-08 2.5400E-07 
A-(BB_0450) ncRNA0071 65.28090 -4.68307 0.69731 -6.71589 1.8700E-11 7.7600E-10 
A-(BB_0454) ncRNA0072 396.65108 2.95600 0.65946 4.48249 7.3800E-06 8.1600E-05 
I-(BB_t06/BB_0461) ncRNA0073 2784.93399 1.30508 0.23004 5.67324 1.4000E-08 3.1000E-07 
p-(BB_0522) ncRNA0080 879.81309 -1.66871 0.23588 -7.07443 1.5000E-12 6.7300E-11 
A-(BB_0581) ncRNA0084 87.52936 -1.86383 0.46531 -4.00556 6.1900E-05 4.9008E-04 
A-(BB_0588) ncRNA0087 1536.15642 -1.98302 0.70918 -2.79621 5.1706E-03 2.0916E-02 
A-(BB_0633) ncRNA0099 150.86401 -2.11214 0.59679 -3.53920 4.0135E-04 2.5315E-03 
AIA-
(BB_0794,BB_0794/BB
_0795,BB_0795) ncRNA0125 
2242.03629 -1.51380 0.26026 -5.81640 6.0100E-09 1.4200E-07 
pI-
(BB_0845a,BB_0845a/B
B_0845b) ncRNA0132 
211.25465 -1.88231 0.53454 -3.52136 4.2935E-04 2.6492E-03 
A-(BB_B03) ncRNA0133 471.62837 -1.01768 0.24563 -4.14310 3.4300E-05 2.9925E-04 
AI-
(BB_B09,BB_B09/BB_B
10) ncRNA0136 
476.36984 -1.31493 0.35221 -3.73333 1.8897E-04 1.3029E-03 
AIA-
(BB_P01,BB_P01/BB_P
02,BB_P02) ncRNA0144 
5.38658 -2.40525 0.85509 -2.81287 4.9102E-03 2.0150E-02 
A-(BB_P21)  ncRNA0148 93.09626 -1.05797 0.42004 -2.51875 1.1777E-02 4.0193E-02 
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IA-
(BB_P32/BB_P33,BB_P
33) ncRNA0152 
276.35152 2.16730 0.36494 5.93882 2.8700E-09 7.6400E-08 
AIA-
(BB_P35,BB_P35/BB_P
36,BB_P36) ncRNA0153 
34.01766 -1.98207 0.79874 -2.48151 1.3083E-02 4.3686E-02 
A-(BB_R43) ncRNA0168 73.05907 -1.33932 0.46258 -2.89530 3.7879E-03 1.6127E-02 
I-(BB_O29/BB_O30) ncRNA0185 1573.01516 1.54399 0.47773 3.23193 1.2296E-03 6.4036E-03 
AIA-
(BB_O32,BB_O32/BB_
O33,BB_O33) ncRNA0186 
90.75800 1.56315 0.32570 4.79931 1.5900E-06 2.0600E-05 
A-(BB_O36) ncRNA0187 30.42656 -1.80347 0.72033 -2.50366 1.2291E-02 4.1403E-02 
A-(BB_O44) ncRNA0191 8.70865 -2.53078 0.79762 -3.17293 1.5091E-03 7.5146E-03 
IA-
(BB_L29/BB_L30,BB_L
30) ncRNA0200 
867.04480 -1.76368 0.35213 -5.00855 5.4800E-07 8.1200E-06 
IA-
(BB_N32/BB_N33,BB_N
33) ncRNA0218 
29.86142 2.06059 0.51686 3.98676 6.7000E-05 5.2566E-04 
P-(BB_D05a) ncRNA0226 56.82862 -5.38102 0.67964 -7.91751 2.4200E-15 1.2900E-13 
I-(BB_D18/BB_D20) ncRNA0229 117.85300 -1.45064 0.34542 -4.19961 2.6700E-05 2.4882E-04 
p-(BB_D20) ncRNA0231 3348.60358 -1.31010 0.38751 -3.38080 7.2276E-04 4.0892E-03 
I-(BB_D22/BB_D23) ncRNA0232 141.50067 -1.09254 0.25214 -4.33312 1.4700E-05 1.4641E-04 
p-(BB_D23) ncRNA0233 46.44976 -2.61541 0.75070 -3.48395 4.9407E-04 2.9732E-03 
A-(BB_E09) ncRNA0239 1464.22355 -2.36320 0.42819 -5.51901 3.4100E-08 6.9100E-07 
A-(BB_E09) ncRNA0240 74.83749 -2.99150 0.85344 -3.50523 4.5621E-04 2.7648E-03 
I-(BB_E23b/BB_E29a) ncRNA0242 107.05005 -1.83201 0.59248 -3.09208 1.9876E-03 9.5347E-03 
I-(BB_E31/BB_E33) ncRNA0245 314.76149 -1.87552 0.48535 -3.86424 1.1144E-04 8.2511E-04 
I-(BB_E31/BB_E33) ncRNA0246 124.51613 -1.36783 0.43230 -3.16405 1.5559E-03 7.7252E-03 
A-(BB_F03) ncRNA0247 1699.00234 -3.04305 0.29398 -10.35133 4.1300E-25 5.4100E-23 
AIP-
(BB_F03,BB_F03/BB_F
05,BB_F05) ncRNA0248 
239.22758 -1.69134 0.55610 -3.04145 2.3545E-03 1.0985E-02 
pI-
(BB_F05,BB_F05/BB_F
06) ncRNA0249 
9.67900 -2.37442 0.74116 -3.20366 1.3569E-03 6.9319E-03 
PI-
(BB_F11a,BB_F11a/BB
_F12) ncRNA0250 
15.60877 -2.95591 0.73380 -4.02824 5.6200E-05 4.5389E-04 
I-(BB_F11a/BB_F12) ncRNA0251 727.74533 -3.62895 0.25387 -14.29478 2.3600E-46 1.0000E-43 
Ip-
(BB_F14/BB_F14a,BB_
F14a)  ncRNA0252 
58.86305 -1.38969 0.45918 -3.02643 2.4746E-03 1.1514E-02 
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pIp-
(BB_F14a,BB_F14a/BB
_F16,BB_F16) ncRNA0253 
16.14596 -1.98672 0.79362 -2.50337 1.2302E-02 4.1403E-02 
I-(BB_F0040/BB_F32) ncRNA0255 49.42843 -2.20005 0.63767 -3.45014 5.6030E-04 3.2790E-03 
PI-
(BB_G05,BB_G05/BB_
G06) ncRNA0257 
56.23394 -3.08570 0.78871 -3.91233 9.1400E-05 6.9495E-04 
AA-(BB_G07,BB_G08) ncRNA0259 88.14975 1.50710 0.26069 5.78118 7.4200E-09 1.7100E-07 
IA-
(BB_G28/BB_G29,BB_
G29) ncRNA0263 
24.07894 -1.66874 0.65024 -2.56633 1.0278E-02 3.6239E-02 
P-(BB_H30) ncRNA0271 22.38916 -1.76720 0.65562 -2.69548 7.0288E-03 2.6366E-02 
IpI-
(BB_K09/BB_K10,BB_K
10,BB_K10/BB_K12) ncRNA0281 
166.24839 -1.67274 0.50558 -3.30857 9.3773E-04 5.0536E-03 
A-(BB_K17) ncRNA0284 123.82711 -2.27394 0.29672 -7.66354 1.8100E-14 8.8000E-13 
A-(BB_K19) ncRNA0285 59.46916 -1.71066 0.51499 -3.32174 8.9459E-04 4.8829E-03 
A-(BB_K19) ncRNA0286 219.94179 -1.50018 0.49802 -3.01233 2.5925E-03 1.1877E-02 
I-(BB_K55/BB_K56) ncRNA0287 86.56071 -2.02386 0.57269 -3.53396 4.0939E-04 2.5632E-03 
AIA-
(BB_K33,BB_K33/BB_K
34,BB_K34) ncRNA0289 
54.01824 -1.71061 0.41699 -4.10228 4.0900E-05 3.4835E-04 
A-(BB_J18) ncRNA0297 206.52360 -2.30714 0.68815 -3.35269 8.0030E-04 4.4394E-03 
I-(BB_J20/BB_J0058) ncRNA0299 119.12666 -1.71310 0.32271 -5.30853 1.1100E-07 1.9000E-06 
I-(BB_J20/BB_J0058) ncRNA0300 169.44276 -1.62217 0.54796 -2.96038 3.0726E-03 1.3687E-02 
I-(BB_J37/BB_J41) ncRNA0304 103.27966 -1.32101 0.48244 -2.73820 6.1776E-03 2.3910E-02 
I-(BB_J37/BB_J41) ncRNA0306 3515.78937 1.03960 0.35567 2.92291 3.4678E-03 1.4951E-02 
IA-
(BB_J37/BB_J41,BB_J4
1) ncRNA0307 
1187.10572 1.02844 0.37532 2.74014 6.1413E-03 2.3824E-02 
I-(BB_J50/BB_J51) ncRNA0308 893.05821 -5.42145 0.49484 -10.95597 6.2200E-28 1.0600E-25 
Ip-
(BB_J50/BB_J51,BB_J5
1) ncRNA0310 
106.49195 -1.60068 0.60746 -2.63505 8.4125E-03 3.0810E-02 
A-(BB_A04) ncRNA0311 361.98141 1.92915 0.41140 4.68926 2.7400E-06 3.3600E-05 
IP-
(BB_A16/BB_A18,BB_A
18) ncRNA0318 
1800.37672 -2.04790 0.56668 -3.61387 3.0166E-04 1.9835E-03 
I-(BB_A37/BB_A38) ncRNA0322 2507.45399 -1.93472 0.46456 -4.16467 3.1200E-05 2.7656E-04 
A-(BB_A66) ncRNA0325 457.92944 -1.54003 0.33922 -4.53991 5.6300E-06 6.3500E-05 
I-(BB_A66/BB_A68) ncRNA0326 456.29968 1.39790 0.36727 3.80618 1.4113E-04 1.0141E-03 
I-(BB_A68/BB_A69) ncRNA0327 288.56940 1.13475 0.41155 2.75730 5.8281E-03 2.2764E-02 
I-(BB_A73/BB_A74) ncRNA0328 55.68358 -1.57915 0.64646 -2.44275 1.4576E-02 4.7921E-02 
A-(BB_Q52) ncRNA0344 10.93289 -2.49207 0.85894 -2.90133 3.7158E-03 1.5860E-02 
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IA-
(BB_Q85/BB_Q88,BB_
Q88) ncRNA0353 
66.89125 -1.49930 0.61692 -2.43030 1.5087E-02 4.9219E-02 
BB_0004 lcl|NC_001318.1_cds_NP_212138.2_3 3213.61271 -1.01184 0.35019 -2.88940 3.8597E-03 1.6311E-02 
ruvB lcl|NC_001318.1_cds_NP_212156.1_20 2074.85845 -1.07657 0.20208 -5.32751 9.9600E-08 1.7500E-06 
BB_0027 lcl|NC_001318.1_cds_NP_212161.1_25 9710.08595 -1.78806 0.33744 -5.29896 1.1600E-07 1.9600E-06 
BB_0035 lcl|NC_001318.1_cds_NP_212169.1_33 2717.90772 1.11041 0.21469 5.17204 2.3200E-07 3.6500E-06 
BB_0172 lcl|NC_001318.1_cds_NP_212306.2_161 2887.76489 -1.21732 0.12374 -9.83751 7.7600E-23 8.8100E-21 
csrA lcl|NC_001318.1_cds_NP_212318.1_173 568.07262 -7.89432 0.51931 -15.20141 3.4600E-52 1.9600E-49 
BB_0185 lcl|NC_001318.1_cds_NP_212319.1_174 1345.32378 1.34977 0.21874 6.17069 6.8000E-10 1.9300E-08 
BB_0285 lcl|NC_001318.1_cds_NP_212419.2_270 4139.07947 -1.15495 0.31761 -3.63636 2.7651E-04 1.8395E-03 
BB_0330 lcl|NC_001318.1_cds_NP_212464.1_313 9233.47510 1.14909 0.21901 5.24680 1.5500E-07 2.5600E-06 
BB_0334 lcl|NC_001318.1_cds_NP_212468.1_317 3335.87046 1.04932 0.15772 6.65313 2.8700E-11 1.1400E-09 
mgsA lcl|NC_001318.1_cds_NP_212498.1_345 3019.34634 1.74256 0.16475 10.57677 3.8200E-26 5.4200E-24 
la7 lcl|NC_001318.1_cds_NP_212499.1_346 8401.74564 1.81349 0.28233 6.42324 1.3300E-10 4.0900E-09 
manA lcl|NC_001318.1_cds_NP_212541.1_388 2887.10319 1.17975 0.14930 7.90190 2.7500E-15 1.4200E-13 
BB_0408 lcl|NC_001318.1_cds_NP_212542.1_389 6219.62582 1.50125 0.22207 6.76041 1.3800E-11 5.8600E-10 
BB_0415 lcl|NC_001318.1_cds_NP_212549.1_394 1448.60433 -1.23145 0.22193 -5.54874 2.8800E-08 5.9800E-07 
BB_0434 lcl|NC_001318.1_cds_NP_212568.1_409 410.65472 -1.02624 0.30576 -3.35635 7.8977E-04 4.4098E-03 
BB_0451 lcl|NC_001318.1_cds_NP_212585.1_426 435.99128 1.06529 0.20899 5.09729 3.4500E-07 5.3300E-06 
rpmC lcl|NC_001318.1_cds_NP_212620.2_459 492.18291 1.00774 0.20234 4.98052 6.3400E-07 9.3100E-06 
BB_0509 lcl|NC_001318.1_cds_NP_212643.1_482 8232.92191 -2.92550 0.36573 -7.99904 1.2500E-15 6.8900E-14 
dnaK lcl|NC_001318.1_cds_NP_212652.1_488 5264.98352 1.17822 0.19904 5.91943 3.2300E-09 8.2100E-08 
BB_0537 lcl|NC_001318.1_cds_NP_212671.1_500 1848.25226 1.23238 0.23828 5.17209 2.3100E-07 3.6500E-06 
BB_0538 lcl|NC_001318.1_cds_NP_212672.1_501 967.74510 1.12146 0.23907 4.69092 2.7200E-06 3.3600E-05 
BB_0562 lcl|NC_001318.1_cds_NP_212696.1_524 1222.60891 1.19559 0.14703 8.13164 4.2400E-16 2.4900E-14 
BB_0577 lcl|NC_001318.1_cds_NP_212711.1_539 1867.11586 -1.43804 0.22294 -6.45042 1.1200E-10 3.5900E-09 
BB_0588 lcl|NC_001318.1_cds_NP_212722.1_550 1645.23671 -1.76961 0.13087 -13.52170 1.1600E-41 3.3100E-39 
BB_0617 lcl|NC_001318.1_cds_NP_212751.1_578 777.72142 1.01563 0.22639 4.48609 7.2500E-06 8.0700E-05 
rnmV lcl|NC_001318.1_cds_NP_212760.1_587 17091.35904 -1.23733 0.41006 -3.01746 2.5491E-03 1.1824E-02 
BB_0637 lcl|NC_001318.1_cds_NP_212771.2_597 8048.19773 1.09516 0.26134 4.19047 2.7800E-05 2.5591E-04 
BB_0638 lcl|NC_001318.1_cds_NP_212772.1_598 3886.71871 1.10557 0.20998 5.26502 1.4000E-07 2.3400E-06 
BB_0639 lcl|NC_001318.1_cds_NP_212773.1_599 1482.68946 1.25421 0.28693 4.37118 1.2400E-05 1.2527E-04 
BB_0644 lcl|NC_001318.1_cds_NP_212778.1_604 697.38844 1.07361 0.19917 5.39034 7.0300E-08 1.3200E-06 
BB_0678 lcl|NC_001318.1_cds_NP_212812.1_638 5061.70052 1.19085 0.18463 6.45005 1.1200E-10 3.5900E-09 
BB_0679 lcl|NC_001318.1_cds_NP_212813.2_639 4281.29084 1.08726 0.19246 5.64926 1.6100E-08 3.4700E-07 
ffh lcl|NC_001318.1_cds_NP_212828.2_653 14060.76269 -2.51168 0.37419 -6.71235 1.9200E-11 7.7700E-10 
BB_0724 lcl|NC_001318.1_cds_YP_008686588.1_680 3690.87567 -1.14649 0.26750 -4.28595 1.8200E-05 1.7607E-04 
cvpA lcl|NC_001318.1_cds_NP_212900.1_719 420.51092 1.15754 0.23978 4.82754 1.3800E-06 1.8600E-05 
murG lcl|NC_001318.1_cds_NP_212901.1_720 901.26760 1.36619 0.28113 4.85964 1.1800E-06 1.6200E-05 
BB_0768 lcl|NC_001318.1_cds_NP_212902.1_721 1156.42566 1.01241 0.23459 4.31566 1.5900E-05 1.5664E-04 
BB_0769 lcl|NC_001318.1_cds_NP_212903.1_722 1653.77636 1.25352 0.24092 5.20315 1.9600E-07 3.1800E-06 
BB_0770 lcl|NC_001318.1_cds_NP_212904.1_723 1364.05445 1.31817 0.24452 5.39077 7.0200E-08 1.3200E-06 
BB_0773 lcl|NC_001318.1_cds_NP_212907.1_727 467.79866 1.27392 0.17883 7.12344 1.0500E-12 4.8400E-11 
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BB_0785 lcl|NC_001318.1_cds_NP_212919.1_739 2664.70377 1.26140 0.21198 5.95051 2.6700E-09 7.2300E-08 
BB_0794 lcl|NC_001318.1_cds_YP_008686594.1_748 8844.21241 -1.02084 0.17424 -5.85885 4.6600E-09 1.1500E-07 
BB_0798 lcl|NC_001318.1_cds_NP_212932.1_752 412.74295 -1.36726 0.23061 -5.92898 3.0500E-09 7.9400E-08 
arcA lcl|NC_001318.1_cds_NP_212975.1_793 2690.75653 1.01162 0.15753 6.42193 1.3500E-10 4.0900E-09 
argF lcl|NC_001318.1_cds_NP_212976.2_794 2452.38136 1.16126 0.24793 4.68373 2.8200E-06 3.4300E-05 
BB_B01 lcl|NC_001903.1_cds_NP_046987.2_798 877.53814 1.38832 0.21556 6.44047 1.1900E-10 3.7600E-09 
BB_B02 lcl|NC_001903.1_cds_NP_046988.1_799 2128.09907 1.09381 0.19651 5.56617 2.6000E-08 5.4700E-07 
BB_B04 lcl|NC_001903.1_cds_NP_046990.2_801 11469.16755 1.51829 0.22423 6.77099 1.2800E-11 5.5800E-10 
BB_B05 lcl|NC_001903.1_cds_NP_046991.1_802 2551.06647 1.80247 0.27613 6.52767 6.6800E-11 2.4200E-09 
BB_B06 lcl|NC_001903.1_cds_NP_046992.2_803 1687.19872 2.39923 0.26394 9.08997 9.9100E-20 8.8800E-18 
BB_B07 lcl|NC_001903.1_cds_NP_046993.1_804 8409.80978 1.37986 0.16316 8.45724 2.7400E-17 1.7900E-15 
guaA lcl|NC_001903.1_cds_NP_047004.2_812 11235.00282 1.12297 0.13674 8.21263 2.1600E-16 1.3200E-14 
BB_B19 lcl|NC_001903.1_cds_NP_047005.1_813 292.24252 -1.44479 0.48707 -2.96630 3.0140E-03 1.3508E-02 
BB_B23 lcl|NC_001903.1_cds_NP_047009.2_815 2583.01398 1.19428 0.15392 7.75903 8.5600E-15 4.2900E-13 
BB_B27 lcl|NC_001903.1_cds_NP_047013.1_819 1716.86092 1.09086 0.18403 5.92752 3.0800E-09 7.9400E-08 
BB_B28 lcl|NC_001903.1_cds_NP_047014.1_820 4249.14215 1.26673 0.14368 8.81609 1.1900E-18 9.1800E-17 
BB_B29 lcl|NC_001903.1_cds_NP_047015.1_821 24118.64600 1.40725 0.21269 6.61638 3.6800E-11 1.4200E-09 
BB_P10 lcl|NC_000948.1_cds_NP_051171.1_830 89.29313 -1.66558 0.56815 -2.93158 3.3724E-03 1.4651E-02 
BB_P29 lcl|NC_000948.1_cds_NP_051190.1_849 117.59027 -1.92535 0.65110 -2.95706 3.1059E-03 1.3738E-02 
BB_P31 lcl|NC_000948.1_cds_NP_051192.1_851 319.42777 1.45061 0.33148 4.37613 1.2100E-05 1.2328E-04 
BB_P32 lcl|NC_000948.1_cds_NP_051193.1_852 812.84291 1.90916 0.23564 8.10216 5.4000E-16 3.0600E-14 
BB_P33 lcl|NC_000948.1_cds_NP_051194.2_853 507.55300 2.13541 0.24544 8.70025 3.3100E-18 2.4500E-16 
bdrA lcl|NC_000948.1_cds_NP_051195.1_854 840.20823 1.32762 0.30269 4.38603 1.1500E-05 1.1915E-04 
bppA lcl|NC_000948.1_cds_NP_051196.1_855 59.03590 -1.40683 0.55848 -2.51902 1.1768E-02 4.0193E-02 
bppB lcl|NC_000948.1_cds_NP_051197.1_856 16.41223 -1.50057 0.59553 -2.51971 1.1745E-02 4.0193E-02 
BB_S31 lcl|NC_000949.1_cds_NP_051234.2_890 105.76745 -1.61577 0.50478 -3.20094 1.3698E-03 6.9634E-03 
BB_S34 lcl|NC_000949.1_cds_NP_051237.1_892 208.77819 1.12270 0.37216 3.01674 2.5551E-03 1.1824E-02 
BB_S35 lcl|NC_000949.1_cds_NP_051238.1_893 265.73103 1.32530 0.23976 5.52756 3.2500E-08 6.6600E-07 
bdrE lcl|NC_000949.1_cds_NP_051240.1_894 326.73654 1.35838 0.24208 5.61123 2.0100E-08 4.2800E-07 
bppA lcl|NC_000949.1_cds_NP_051241.2_895 41.41867 -2.50757 0.64449 -3.89080 9.9900E-05 7.5289E-04 
bdrH lcl|NC_000950.1_cds_NP_051274.2_927 752.05999 -1.01933 0.23870 -4.27032 1.9500E-05 1.8675E-04 
BB_R31 lcl|NC_000950.1_cds_NP_051278.1_930 1579.32556 -1.11301 0.44312 -2.51176 1.2013E-02 4.0672E-02 
BB_R33 lcl|NC_000950.1_cds_NP_051280.1_932 295.78915 1.07063 0.25471 4.20341 2.6300E-05 2.4602E-04 
BB_R34 lcl|NC_000950.1_cds_NP_051281.1_933 206.01635 1.16113 0.21843 5.31579 1.0600E-07 1.8500E-06 
bppA lcl|NC_000950.1_cds_NP_051282.1_934 20.65803 -2.41916 0.67216 -3.59907 3.1935E-04 2.0758E-03 
BB_M10 lcl|NC_000951.1_cds_NP_051301.1_951 26.57919 -1.78380 0.55298 -3.22580 1.2562E-03 6.5025E-03 
erpK lcl|NC_000951.1_cds_NP_051329.2_978 89.22936 -1.23805 0.47123 -2.62728 8.6071E-03 3.1253E-02 
BB_M39 lcl|NC_000951.1_cds_NP_051330.1_979 174.83403 -1.36451 0.51840 -2.63215 8.4846E-03 3.1007E-02 
BB_O05 lcl|NC_000952.1_cds_NP_051338.1_986 56.56386 -1.29221 0.46550 -2.77593 5.5044E-03 2.1851E-02 
BB_O29 lcl|NC_000952.1_cds_NP_051362.1_1010 207.63259 -1.10670 0.44193 -2.50423 1.2272E-02 4.1403E-02 
BB_O32 lcl|NC_000952.1_cds_NP_051365.1_1013 381.81421 1.02602 0.24502 4.18743 2.8200E-05 2.5591E-04 
BB_O33 lcl|NC_000952.1_cds_NP_051366.1_1014 262.11731 1.01035 0.21034 4.80344 1.5600E-06 2.0400E-05 
erpL lcl|NC_000952.1_cds_NP_051372.1_1020 12.95800 -1.94971 0.71378 -2.73153 6.3041E-03 2.4180E-02 
BB_L10 lcl|NC_000953.1_cds_NP_051387.1_1034 89.29313 -1.66558 0.56815 -2.93158 3.3724E-03 1.4651E-02 
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BB_N31 lcl|NC_000954.1_cds_NP_051443.1_1087 161.08556 1.62741 0.34882 4.66543 3.0800E-06 3.6900E-05 
BB_N32 lcl|NC_000954.1_cds_NP_051444.1_1088 241.99693 1.58643 0.30895 5.13489 2.8200E-07 4.4100E-06 
BB_N33 lcl|NC_000954.1_cds_NP_051445.1_1089 157.32165 1.88871 0.28826 6.55200 5.6800E-11 2.1000E-09 
bdrQ lcl|NC_000954.1_cds_NP_051446.1_1090 227.79632 1.70185 0.26326 6.46453 1.0200E-10 3.4600E-09 
erpQ lcl|NC_000954.1_cds_NP_051450.1_1094 1968.30569 1.45829 0.35989 4.05207 5.0800E-05 4.1566E-04 
BB_D04 lcl|NC_001849.2_cds_NP_045388.1_1111 31.08243 -1.09455 0.42826 -2.55581 1.0594E-02 3.7123E-02 
BB_D13 lcl|NC_001849.2_cds_NP_045397.1_1115 908.20998 -1.39490 0.30458 -4.57973 4.6600E-06 5.3600E-05 
BB_D14 lcl|NC_001849.2_cds_NP_045398.1_1116 3487.08319 -1.74493 0.32686 -5.33844 9.3700E-08 1.6600E-06 
BB_D21 lcl|NC_001849.2_cds_NP_045404.1_1119 967.68593 -1.89590 0.44002 -4.30864 1.6400E-05 1.5985E-04 
BB_D22 lcl|NC_001849.2_cds_NP_045405.1_1120 128.56257 -1.23419 0.31627 -3.90230 9.5300E-05 7.2118E-04 
BB_D0031 lcl|NC_001849.2_cds_YP_004940417.1_1121 25.13307 -2.77368 0.70351 -3.94261 8.0600E-05 6.2677E-04 
BB_E09 lcl|NC_001850.1_cds_NP_045416.1_1133 524.59592 -1.11888 0.39643 -2.82240 4.7666E-03 1.9799E-02 
BB_E21 lcl|NC_001850.1_cds_NP_045428.1_1139 8358.69302 -1.13151 0.25337 -4.46583 7.9800E-06 8.7600E-05 
BB_E31 lcl|NC_001850.1_cds_NP_045436.1_1141 93.10927 -1.87910 0.38170 -4.92292 8.5300E-07 1.2100E-05 
BB_F01 lcl|NC_001851.2_cds_YP_004940409.1_1142 9.14003 -1.99841 0.81867 -2.44104 1.4645E-02 4.7972E-02 
BB_F03 lcl|NC_001851.2_cds_NP_045439.1_1144 189.08402 -2.28693 0.37858 -6.04085 1.5300E-09 4.2100E-08 
BB_F06 lcl|NC_001851.2_cds_NP_045442.1_1145 11.18133 -2.26114 0.82738 -2.73287 6.2785E-03 2.4136E-02 
BB_F08 lcl|NC_001851.2_cds_NP_045444.1_1146 152.54532 -1.25312 0.41564 -3.01495 2.5702E-03 1.1848E-02 
BB_F0034 lcl|NC_001851.2_cds_YP_004940410.1_1147 131.68027 -1.22031 0.49845 -2.44823 1.4356E-02 4.7565E-02 
BB_F14 lcl|NC_001851.2_cds_NP_045449.2_1148 47.65069 -3.14409 0.73615 -4.27096 1.9500E-05 1.8675E-04 
BB_F17 lcl|NC_001851.2_cds_YP_004940411.1_1149 21.28081 -2.38055 0.75923 -3.13549 1.7157E-03 8.4444E-03 
BB_F20 lcl|NC_001851.2_cds_NP_045453.2_1150 136.22755 -2.84907 0.29514 -9.65321 4.7600E-22 4.7700E-20 
BB_F24 lcl|NC_001851.2_cds_NP_045457.1_1152 283.27478 -2.12742 0.36857 -5.77202 7.8300E-09 1.7800E-07 
BB_F25 lcl|NC_001851.2_cds_NP_045458.1_1153 156.06800 -1.98978 0.45128 -4.40918 1.0400E-05 1.0976E-04 
BB_F26 lcl|NC_001851.2_cds_NP_045459.1_1154 1080.03777 -2.75640 0.44494 -6.19502 5.8300E-10 1.6800E-08 
BB_F0041 lcl|NC_001851.2_cds_YP_004940414.1_1157 431.59447 -2.39330 0.51679 -4.63111 3.6400E-06 4.2700E-05 
BB_G02 lcl|NC_001852.1_cds_NP_045464.1_1159 182.65163 1.36790 0.39719 3.44397 5.7325E-04 3.3433E-03 
BB_G12 lcl|NC_001852.1_cds_NP_045472.1_1163 81.95387 -2.35931 0.67080 -3.51717 4.3617E-04 2.6720E-03 
BB_G21 lcl|NC_001852.1_cds_NP_045481.1_1172 257.53631 -1.92019 0.71077 -2.70154 6.9019E-03 2.6120E-02 
BB_G22 lcl|NC_001852.1_cds_NP_045482.1_1174 64.42227 -2.66476 0.63847 -4.17370 3.0000E-05 2.6863E-04 
BB_H04 lcl|NC_001853.1_cds_NP_045498.1_1188 146.02448 -1.76483 0.51766 -3.40925 6.5141E-04 3.7605E-03 
BB_H17 lcl|NC_001853.1_cds_NP_045510.1_1195 10.29556 -2.23494 0.80032 -2.79255 5.2294E-03 2.0966E-02 
BB_H25 lcl|NC_001853.1_cds_NP_045516.1_1196 30.47678 -1.56105 0.51826 -3.01211 2.5943E-03 1.1877E-02 
BB_H26 lcl|NC_001853.1_cds_NP_045517.1_1197 1195.44669 -1.59160 0.46118 -3.45118 5.5814E-04 3.2776E-03 
BB_K22 lcl|NC_001855.1_cds_NP_045596.1_1233 260.18235 -1.08282 0.34636 -3.12624 1.7706E-03 8.6399E-03 
BB_K23 lcl|NC_001855.1_cds_NP_045597.1_1234 2453.83614 -1.76011 0.38683 -4.55008 5.3600E-06 6.0900E-05 
BB_K24 lcl|NC_001855.1_cds_NP_045598.1_1235 377.57698 -1.77495 0.43727 -4.05913 4.9300E-05 4.0524E-04 
BB_K54 lcl|NC_001855.1_cds_YP_004940636.1_1236 131.60135 -1.95752 0.65270 -2.99911 2.7077E-03 1.2362E-02 
BB_K32 lcl|NC_001855.1_cds_NP_045605.1_1237 213.65101 -1.87343 0.48966 -3.82601 1.3024E-04 9.4379E-04 
BB_K33 lcl|NC_001855.1_cds_NP_045606.1_1238 37.62541 -1.37927 0.44404 -3.10618 1.8952E-03 9.1690E-03 
BB_K34 lcl|NC_001855.1_cds_NP_045607.1_1239 221.99723 -1.17304 0.21314 -5.50367 3.7200E-08 7.4500E-07 
BB_K0058 lcl|NC_001855.1_cds_YP_004940637.1_1241 51.97230 -1.39907 0.54440 -2.56994 1.0172E-02 3.5978E-02 
BB_K40 lcl|NC_001855.1_cds_NP_045612.1_1242 3811.74482 -1.35989 0.23172 -5.86859 4.4000E-09 1.1000E-07 
BB_K47 lcl|NC_001855.1_cds_NP_045618.1_1246 2505.67165 1.24932 0.31710 3.93979 8.1600E-05 6.3129E-04 
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BB_K49 lcl|NC_001855.1_cds_NP_045620.1_1248 1392.93963 1.08561 0.35461 3.06146 2.2026E-03 1.0333E-02 
BB_K52 lcl|NC_001855.1_cds_NP_045623.1_1251 62.12418 -1.65067 0.58619 -2.81594 4.8634E-03 2.0054E-02 
BB_K53 lcl|NC_001855.1_cds_NP_045624.1_1252 359.83957 -1.31984 0.48424 -2.72560 6.4185E-03 2.4508E-02 
BB_J09 lcl|NC_001856.1_cds_NP_045633.1_1254 24951.96368 1.80964 0.37729 4.79639 1.6200E-06 2.0700E-05 
BB_J19 lcl|NC_001856.1_cds_NP_045643.1_1260 8721.99449 -1.22674 0.35743 -3.43214 5.9884E-04 3.4688E-03 
BB_J23 lcl|NC_001856.1_cds_NP_045647.2_1263 37.83775 -2.45297 0.48759 -5.03081 4.8800E-07 7.3100E-06 
BB_J24 lcl|NC_001856.1_cds_NP_045648.1_1264 96.33456 -1.30741 0.37642 -3.47326 5.1418E-04 3.0455E-03 
BB_J26 lcl|NC_001856.1_cds_NP_045650.1_1266 38.55969 -1.05461 0.37975 -2.77712 5.4843E-03 2.1851E-02 
BB_J43 lcl|NC_001856.1_cds_NP_045667.1_1276 43.39694 -1.94798 0.67037 -2.90582 3.6629E-03 1.5713E-02 
BB_A03 lcl|NC_001857.2_cds_NP_045676.1_1287 12443.29488 2.13654 0.33649 6.34946 2.1600E-10 6.4600E-09 
dbpB lcl|NC_001857.2_cds_NP_045698.1_1304 89.46809 -2.64700 0.55833 -4.74096 2.1300E-06 2.7000E-05 
BB_A30 lcl|NC_001857.2_cds_NP_045703.1_1305 869.61499 1.35254 0.21700 6.23299 4.5800E-10 1.3400E-08 
BB_A31 lcl|NC_001857.2_cds_NP_045704.1_1306 693.65642 1.56591 0.26915 5.81799 5.9600E-09 1.4200E-07 
BB_A34 lcl|NC_001857.2_cds_NP_045707.1_1309 190.08384 -2.16419 0.57789 -3.74501 1.8039E-04 1.2533E-03 
BB_A36 lcl|NC_001857.2_cds_NP_045709.2_1310 46.52933 -2.13048 0.58213 -3.65982 2.5239E-04 1.6856E-03 
BB_A37 lcl|NC_001857.2_cds_NP_045710.1_1311 93.94412 -1.91041 0.65253 -2.92769 3.4149E-03 1.4777E-02 
BB_A52 lcl|NC_001857.2_cds_NP_045725.1_1323 1613.06144 1.01788 0.31273 3.25479 1.1348E-03 5.9646E-03 
BB_A53 lcl|NC_001857.2_cds_NP_045726.1_1324 375.69121 1.34683 0.37570 3.58488 3.3724E-04 2.1837E-03 
BB_A54 lcl|NC_001857.2_cds_NP_045727.1_1325 599.96245 1.90054 0.36702 5.17833 2.2400E-07 3.6000E-06 
BB_A58 lcl|NC_001857.2_cds_NP_045731.1_1327 8350.06409 1.29824 0.29668 4.37597 1.2100E-05 1.2328E-04 
BB_A60 lcl|NC_001857.2_cds_NP_045733.1_1329 1031.73146 1.00642 0.22212 4.53102 5.8700E-06 6.5800E-05 
BB_A65 lcl|NC_001857.2_cds_NP_045738.1_1333 185.75096 -1.57120 0.49676 -3.16287 1.5622E-03 7.7338E-03 
BB_A0078 lcl|NC_001857.2_cds_YP_004940408.1_1337 99.05634 -1.78179 0.58155 -3.06389 2.1848E-03 1.0300E-02 
BB_A73 lcl|NC_001857.2_cds_NP_045746.1_1338 233.22334 -1.82910 0.42445 -4.30931 1.6400E-05 1.5985E-04 
osm28 lcl|NC_001857.2_cds_NP_045747.1_1339 12273.60539 2.23417 0.39421 5.66748 1.4500E-08 3.1600E-07 
BB_Q27 lcl|NC_000956.1_cds_NP_051489.1_1361 184.69201 1.47825 0.44760 3.30263 9.5783E-04 5.1425E-03 
BB_Q40 lcl|NC_000956.1_cds_NP_051502.1_1373 481.17033 1.46362 0.36788 3.97853 6.9300E-05 5.4169E-04 
bdrV lcl|NC_000956.1_cds_NP_051504.1_1374 634.19622 2.69953 0.31722 8.51007 1.7400E-17 1.1800E-15 
BB_Q62 lcl|NC_000956.1_cds_NP_051521.1_1385 20.48709 2.09146 0.54478 3.83906 1.2351E-04 9.0270E-04 
BB_Q85 lcl|NC_000956.1_cds_NP_051533.1_1388 31.08243 -1.09455 0.42826 -2.55581 1.0594E-02 3.7123E-02 
 
The included transcripts met the criteria of >1 log2 fold-change and an adjusted P-value (padj) when comparing the ∆csrA mutant to 
wild-type. A total of 239 transcripts were differentially regulated, not including the mutated gene, by the mutation. The first column 
contains the CDS/custom transcript ID which is the transcript ID for all coding sequences obtained from the NCBI Gene file format file 
or the transcript ID given to ncRNAs. RefSeq entries are further separated by the character “_”. The first portion gives the genetic 
element from which it is derived, the second describes the type of element (CDS), the third provides RefSeq ID, and the fourth provides 
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a number indicating the particular entries ordered number in the RefSeq entry. The second column is the gene information, for  the 
ncRNAs it contains the location relative to other genes and for predicted or known genes it contains gene name. The remaining columns 
describe the various metrics of expression of each impacted transcript including, base mean (average library size normalized counts 
across all samples), log2FC (Fold change estimate), lfcSE (uncertainty of the log fold change estimate), stat (Wald statistic), pvalue, 
padj (pvalue following Benjamini-Hochberg adjustment). ORFs and ncRNAs are identified according to the names or numbers assigned 
to genes and transcripts by the initial genome sequencing of B. burgdorferi strain B31 [56, 101] or from our previous analyses of that 
strain’s ncRNA transcriptome [14]. 
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